Dr. David Rabin speaks about How to Manage Stress using the Apollo wearable with Dr. Ben Weitz.

[If you enjoy this podcast, please give us a rating and review on Itunes, so more people will find The Rational Wellness Podcast. Also check out the video version on YouTube at https://www.youtube.com/user/weitzchiro/]

 

Podcast Highlights

3:27  The Apollo is a wearable device that was first conceived of while Dr. Rabin was studying psychiatry at the University of Pittsburgh and he was inspired by the ancient practices of meditation and breathing that change the way we handle stress. So many people today have stress related chronic problems, including anxiety, depression, PTSD, insomnia, and many others. When we are experiencing real or perceived threat, our nervous systems will be in our fight or flight, sympathetic mode much of the time, instead of being in the rest and digest and recovery response, parasympathetic mode of our nervous system. This also translates into low heart rate variability, negative effects on our digestive system, reduced ability to absorb nutrients, negative effects on our reproductive system, our creativity, and our sleep.  This also translates into various physical ailments as well, including chronic pain.  Safety makes our heart rate variability go up, which is a good thing. Safety and the perception of safety turns on our immune system, our metabolism, our digestive system, our ability to absorb nutrients, our reproductive system, our creativity, and our sleeping system. All of this good stuff that makes our lives really lovely.  But this can’t happen if we under real or perceived threat and in modern life many of us feel that stress much of the day, which means that we are in flight or fight sympathetic mode much of the time, instead of being in parasympthetic mode most of the time.

7:48  All mammals, including humans have developed this system where as soon as there’s a perceived survival threat of something coming to eat us or kill us or the lack of shelter, food, water, or air, our survival system kicks in, as you said, to divert all available resource to our muscles, to our heart, to our lungs, and to the motor cortex of our brain to fight, flight, or freeze, get out of that situation to safety.  If we are accidentally diverting resources to our reproductive system at a time or digestion when we’re supposed to be running from a bear or a lion, we will not likely make it out of that situation. So that system is tightly evolved to save us.  But we no longer have bears and lions around, but that sympathetic nervous system gets turned on by too many emails or cell phone notifications or our work responsibilities, etc.  Gentle touch applied to our skin can help to create balance by sending a signal to our amygdala, which is the fear center in our brain, that we are safe.  If you are safe enough to take the time to feel like you could pay attention to the feeling of gentle touch on your body, you can’t possibly be running from a lion right now.  This happens on a subconscious level. 

11:32  Dr. Rabin chose touch as the type of stimuli because touch can stimulate the release of a number of hormones, from our brain, including dopamine, serotonin, oxytocin, endorphins, natural endogenous opioids.  The other thing about touch is that you can be touched while you’re doing other things, including performing surgery, giving a talk, seeing a patient, running a meeting, driving, etc..  You can be touched gently, and it’s not distracting, and it can improve your performance and your presentness and focus.

13:54  Different vibrations have different effects on the body.  Different types of music, different rhythms, tempos, and styles have different effects on our body. The Apollo is based on how music affects us in waking us up, stimulating us, relaxing us, or making us fall asleep. The frequency patterns of touch in the Apollo is based on what music makes us feel good and these patterns are predictable for 90 to 95% of people.

22:00  The Apollo can help manage stress and reduce anxiety and depression.  A significant percentage of people with depression, anxiety, and PTSD do not respond that well to treatment, so it’s great to have another alternative approach to helping patients. 50% of patients with PTSD and 30% of patients with depression do not respond well to treatment.  And this is a very safe, natural approach that does not involve invasive procedures or pharmaceutical drugs.  A number of people who have been using the Apollo have reported that they voluntarily were able to taper off their medications, including opioid narcotics, benzodiazepines, and methamphetamine.

27:50  Heart Rate Variability.  Heart rate variability (HRV) is a marker for anti-aging, for various diseases, and for athletic performance. We want to have a high heart rate variability, which means that when stress occurs, our heart rate jumps up quickly to respond to the situation.  This means we will more likely recover from our workout or from illness.  If we have a consistently lower HRV, we are more likely to develop mental and physical health problems, our immune system isn’t going to work as well, and we will probably not sleep as well on a regular basis and not feel as good on a regular basis.  If we, on the other hand, use techniques like deep breathing, getting at least 30 minutes of exercise most days of the week, eating healthy, doing meditation, yoga, mindfulness, or soothing touch, listen to soothing music, and getting good sleep, then we can reverse that process and train our nervous system to be more in balance more of the time, which is reflected as high heart rate variability and more likelihood of recovering from illness, better likelihood of performing consistently at a high level and a better likelihood of just feeling good more of the time.  While the most accurate way to measure heart rate variability is with an EKG, outside of a clinical setting, the Apple Watch, the Oura Ring, and the WHOOP do a decent job of measuring HRV.

 

                       

                             

         



Dr. David Rabin is a board-certified psychiatrist and neuroscientist, is the co-founder & chief innovation officer at Apollo Neuroscience, the first scientifically-validated wearable system to improve heart rate variability, focus, relaxation, and access to meditative states by delivering gentle layered vibrations to the skin. Here is more information about the Apollo wearable: https://apollo-neuro-fact-sheet.carrd.co/  The following affiliate link will give you a 10% discount if you would like to order one:  Get 10% off Apollo, the wearable wellness device for stress relief | Apollo Neuroscience, Inc

Dr. Ben Weitz is available for nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also specializing in Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure and also weight loss, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111 or go to www.drweitz.com.



 

Podcast Transcript

Dr. Weitz:            Hey, this is Dr. Ben Weitz, host of the Rational Wellness Podcast. I talk to the leading health and nutrition experts and researchers in the field to bring you the latest in cutting-edge health information. Subscribe to the Rational Wellness Podcast for weekly updates, and to learn more, check out my website, drweitz.com. Thanks for joining me, and let’s jump into the podcast. Hello, Rational Wellness Podcasters.

Today we will be speaking about stress, the science of the part of our nervous system that regulates stress and about a new wearable device, the Apollo that uses gentle vibrations to help us to activate our parasympathetic nervous system known as our rest and digest nervous system so we can have a better balance with our sympathetic flight or fight nervous system.  In today’s fast-paced world made even more stressed by worrying about getting COVID-19 and dying, many people are in sympathetic mode too much of the time. This can lead to a number of symptoms and health problems. In fact, it’s a very long list, but it can include anxiety, depression, insomnia, hypertension, adrenal dysfunction, other hormonal imbalances, and a weakened immune system. Given that we’re still dealing with COVID-19, having a weakened immune system is not exactly a good thing right now.

                                The Apollo wearable device, which is the wearable device that we’re speaking about also improves heart rate variability, which also translates to better athletic performance. Today we’ll be speaking with the inventor of the Apollo, Dr. David Rabin, MD, PhD, a board-certified psychiatrist, a neuroscientist. He’s the co-founder and chief innovation officer at Apollo Neuroscience, which is the first scientifically validated wearable system to improve heart rate variability, focus, relaxation, and access to meditative states by delivering gentle, layered vibrations to the skin.  In addition to his clinical psychiatry practice, Dr. Rabin is the co-founder and executive director of the Board of Medicine and a psychedelic clinical researcher currently evaluating the mechanism of psychedelic assisted psychotherapy in treatment-resistant mental illness. Dr. Rabin, thank you so much for joining us today.

Dr. Rabin:            Thank you so much for having me. It’s a pleasure.

Dr. Weitz:            So tell us how you developed the Apollo wearable device and about some of the research that went into it.

Dr. Rabin:            Sure. Happy to. So Apollo was a technology that originally wasn’t called Apollo, was just an idea starting in 2014 at the University of Pittsburgh-

Dr. Weitz:            Was there an original name?

Dr. Rabin:            There were a couple names actually. So the first name was Emoto, which was named after the famous Japanese scientist, who discovered that water can store vibrations and frequency patterns.

Dr. Weitz:            Interesting.

Dr. Rabin:            So the idea that applying a vibration pattern to water creates what’s called structured water, which actually changes the way that the water molecules interact with each other, and that can be a visualized in what people call cymatics, which is like patterns of vibration in water or some kind of liquid. You could just google cymatics with a C, C-Y-M-A-T-I-C-S, and you’ll see a lot of this stuff. But there was a lot of inspiration that goes back thousands of years to the ancient practices of breathing and meditation that change the way that we interact with different parts of our bodies and how we become aware of our bodies that led to a lot of this work.  I think you kind of summed it up in the introduction with the balance of the stress response, sympathetic nervous system, and the parasympathetic rest and digest and recovery response nervous system, which we can get into in more detail. But the main gist of it is that people who have chronic stress-related illnesses, and I’m just going to talk about mental illnesses, for the time being, but this does apply to physical illnesses like chronic pain as well, and nerve pain and things of that nature. People who have these illnesses tend to have higher. The illnesses that you mentioned earlier, depression, PTSD, anxiety, insomnia, these kinds of illnesses get worse with stress almost all the time. Invariably, the symptoms get worse with stress.

                                So we can measure this by looking at heart rate variability, as you mentioned earlier, which is a measure. It’s one of our most accurate measures of the way that our heartbeat changes in response to stress in the environment or safety from the environment. Safety makes our heart rate variability go up. Safety makes us feel recovered and helps us feel like it’s safe enough for us to allow our recovery nervous system to turn on, which means recovery means turning on the immune system, turning on metabolism, turning on our digestive system, our ability to absorb nutrients effectively, our reproductive system, and our creativity system, and our sleeping system. All of this good stuff that makes our lives really lovely.

                                But we can’t be under threat, or we can’t perceive that we are under threat or believe that we are under threat for that system to turn on. So many of us who have experienced any kind of trauma or negative experiences, and this is the population that I worked with at the University of Pittsburgh that kind of spurred this idea, a lot of veterans and people who have treatment-resistant PTSD, and we saw that they all have low heart rate variability. This was actually seen in the literature for many other scientists and doctors who were looking at these folks and that they’re meaning low heart rate variability, meaning their stress response system is always up here, always on and very active, and their parasympathetic recovery nervous system is always underactive. They’re always perceiving themselves to be unsafe or in a survival threat situation and-

Dr. Weitz:            Just to interrupt for a second.

Dr. Rabin:            Yeah, sure.

Dr. Weitz:            That’s where the whole concept of the sympathetic and parasympathetic nervous system, it’s often explained by thinking about the zebra on the Savannah, and it sees a lion. So we’re designed for our sympathetic nervous system to put us in this state of stress and have all the blood go to the muscles, which means there’s no time to deal with digestion or all the other things that the parasympathetic nervous system is associated with, because right now, the zebra has to run for its life to avoid being eaten by the lion. Under normal circumstances, maybe that occurs once or twice during the day and the rest of the time, the zebra is calm, and-

Dr. Rabin:            Exactly.

Dr. Weitz:            … our body’s designed to go into this sympathetic nervous system, but only for short periods of time.

Dr. Rabin:            Right, and only-

Dr. Weitz:            In modern life, we-

Dr. Rabin:            Yeah. And only to get us out of danger in the moment.

Dr. Weitz:            Exactly. In modern life, we’re constantly feeling like we’re in this state of stress, real or perceived, that we constantly have to be in this revved up state.

Dr. Rabin:            Right. Part of the reason for that is evolutionary, right? We purposely evolve the system, which is not unique to us. All mammals, almost all animals on the known earth that have brains have this system in place, even going back to very ancient sea snails that only have like 12,000 neurons. Just give you an idea, we have like a hundred billion neurons. So all of these animals have the system where as soon as there’s a perceived survival threat, lack of something coming to eat us or kill us, lack of shelter, food, water, or air, our survival system kicks in, as you said, to divert all available resource to our muscles, to our heart, to our lungs, and to the motor cortex of our brain to fight, flight, or freeze, get out of that situation to safety. Right?   If we are accidentally diverting resources to our reproductive system at a time or digestion when we’re supposed to be running from a bear or a lion, we will not likely make it out of that situation. So that system is tightly evolved to save us. But we don’t have bears and lions around us most of the time anymore. So that system unfortunately starts to get turned on by other things, like too many emails or too many cell phone buzzes and pings or our kids screaming or work responsibilities or you name it, pandemic thoughts and the election and whatever else is going on in the world, right? Every little thing starts to trigger this system because we don’t have the context to say, “Oh wait, this isn’t a survival threat. This is just something that’s annoying me.” All right.

                                So that is critically important to understand, because what is important, because that helps us to know that we are in control of the outcome. So if we recognized that our emails are not actually a survival threat, even just for a moment or our kids or our work responsibilities, whatever it is, is not actually a survival threat that’s triggering us, and we can recognize that by taking a deep breath, taking a walk, pressing on our chest, doing some basic self-touch exercises, doing a brief meditation. This is not necessarily easy. It can be tricky to do in the moment.  But all of these activities naturally bring us very quickly back into balance because they send a signal to our brains, our amygdala, which is that fear center in our brains that governs the balance of this stress response and recovery response system that says, “Hey, bud. If you’re safe enough to take the time to feel like you could pay attention to your breathing right now or pay attention to the feeling of a gentle touch on your body or the feeling of Apollo vibrating on your body, you can’t possibly be running from a lion right now.” Right?

Dr. Weitz:            Right.

Dr. Rabin:            That’s mostly subconscious. It’s beneath our awareness, and that creates an instant loop. That’s a positive loop that says, “I am safe enough to be able to think about myself right now. I’m safe enough to feel my breath right now. I can’t be in a survival situation.” That gradually brings the amygdala activity down, and that helps us to cope with stress more effectively. So Apollo, we designed at the university to tap into this network and activate the safety response system to help people who are struggling with treatment-resistant mental illnesses recover and be able to have more of their cognitive resources available at any time when they would normally feel unsafe by helping them remember that, “Hey, you’re actually safe.”   If you can feel Apollo right now, you’re safe enough to take your time to make a good decision rather than a decision that’s impulsive and based on a past pattern that isn’t serving you.

Dr. Weitz:            So the various types of stimuli, why did you choose touch?

Dr. Rabin:            So we chose touch because, number one, touch is the most evolutionarily tight pathway that connects to safety. So if you look back at ancient animals, like we were talking about, we don’t even have to go back into sea snails, but we can go into old mammals, right, like monkeys, and earlier than monkeys, all of these mammals, which are millions of years older evolutionarily than we are, they all use touch to convey safety to each other. A mother holds their young, right? That comforting of touch in and of itself allows the body to reregulate itself through the secretion of natural hormones that many of us, unfortunately, self-medicate to get those hormones released, but they actually could be secreted by our brains naturally, and those hormones are the best ones that come from touch.  They’re dopamine, serotonin, oxytocin, endorphins, natural endogenous opioids from our own brain that makes opioids that are natural that reduce pain, and even endocannabinoids that reduce inflammation and help balance our nervous system through the endocannabinoid receptors in our body. There’s others too, but those pathways get activated by touch. They get activated by touch, not just in us and all of these other animals, and then those pathways help to reduce inflammation in the body very, very quickly and help to remind us very quickly that we’re safe.   The best part about touch is you can be touched while you’re doing other things, right? So if you’re performing surgery, giving a talk, seeing a patient, running a meeting, whatever it is, driving, you can be touched gently, and it’s not distracting, and it can improve your performance and your presentness and focus.  Music is harder to do that with.  Music’s great, but it’s harder to take with you everywhere you go. So based on convenience and the evolutionary psychology and the biology, that is how we ended up settling on touch.

Dr. Weitz:            Interesting. How do certain vibrations and the Apollo wearable device work to create this balance? Explain why certain vibrations have a different effect.

Dr. Rabin:            Sure. So I think this is one of the most interesting things about neuroscience in the body, because we’re actually experiencing this phenomenon that you described in every day of our lives. When we turn on a song in our house, right, or in our headphones or wherever we are, that song has a certain tempo, a certain rhythm, a certain energy level to it, and we don’t listen to the same kind of music when we’re working out or dancing or hanging out with our friends that we listen to when we’re meditating or relaxing or going to bed. Right?   We would almost never switch those musical types, because they are very different energy levels and different mood states. So that pathway of frequency rhythm, that impacting our energy level and our mood is well described and characterized in music for thousands of years. It’s not new by any stretch. Actually, our whole founding research team all had musical backgrounds. We all either played instruments growing up or still played instruments or were just heavily influenced and lovers of music, and we were always fascinated by the way that music affects our bodies.  So when I started doing this work in 2014, a lot of my strategy was, what can I take from our understanding of the neuroscience of music, the understanding of the neuroscience of touch and use what we know to compose songs for the skin instead of the ears. Right?

Dr. Weitz:            Right.

Dr. Rabin:            That’s really what Apollo is. Apollo is music that is composed for our touch receptors on our skin instead of our ears that you can wear with you and take with you at any time. So the frequency patterns are in large part derived from what music makes us feel good, what music rhythms make us feel good, and also what breathing rhythms make us feel good, and we kind of mash the two together based on the scientific literature that had been done before us, and we ended up coming to these really incredibly powerful patterns that are not just powerful. They’re predictable for 90% to 95% of people where we can send this to you, and as long as your goal is aligned with the energy of the frequency vibration, you’re very likely to get the outcome that you desire, which is really interesting, which is very similar to what happens with music.

Dr. Weitz:            Interesting. I think you just answered my next question, which is going to be, do all people respond in the same way to the same types of vibrations? Is there a range of response?

Dr. Rabin:            Yeah, there is a range. Not everyone is the same. The reason for that is because we have different associations with the stimuli, right? We have different associations with vibration, just like not everybody likes the same kind of music, not everybody’s going to like the same kind of vibration. So we did a lot of testing before we put this out onto the market. Apollo was released in January of 2020. We had been working on it in the lab for about five to six years before that, and then we had done I think three clinical trials and about 2000 case studies in the real world with prototypes before we released the commercial device to figure out how to get the best results.   We tried to remove as much of the subjective experience as possible in terms of, from music where somebody could say, “Oh, I like the song. I don’t like the song.” We didn’t want that. Right?

Dr. Weitz:            Right.

Dr. Rabin:            It shouldn’t be personal. It should just be the bare minimum that activates the nervous system in a soothing way. So after a lot of refinement and an enormous amount of experimentation in the lab and the real world, we figured out that there are specific rhythms that work in, as I said earlier, roughly 90% to 95% of people based on a goal-directed behavior. So you say, “I want to wake up.” If I want to wake up, you set up the wake-up frequency, 90%, 95% of people will wake up. Same for clear and focus, same for socializing and creativity, same for recovering after exercise.  But if you say, I want to wake up and you put it on a sleepy mode, it probably won’t wake you up. Right. It’s going to do the opposite. So the whole goal is to align your outcome with what your action is and for anything we do. So the way that we’ve designed the app sort of helps with that alignment. It’s going to get better over time, and that helps increase the outcomes, because people are goal directed in their behavior.  There are about 5% to 10% of people who interestingly we call paradoxical responders, and there’s a lot of reasons why people respond differently. But again, this is a wellness product that is not… No product works 100% of the time for everyone. Right?

Dr. Weitz:            Right.

Dr. Rabin:            So what we always tell people is if you’re one of those people who this doesn’t work the way you expected, play around with the different modes, because sometimes the modes that energize you might actually be the modes that calm other people down, and the modes that calm you down might be the modes that energize other people.

Dr. Weitz:            Yeah. I have patients, the same thing. They’ll say that any drug or nutritional product that is designed to stimulate me makes me tired and the opposite.

Dr. Rabin:            That’s exactly right. A lot of that has to do with, I think, two things, one of which is just our body’s makeup, that we’re mostly the same, but we’re a little bit different between each of us. I think the other part of it is just our past experience and the association we have with that feeling. So for example, if you have a negative association with touch and that you’ve never been touched in a loving way, or it was always associated with pain or discomfort, then it may take a little longer for you to get comfortable using the Apollo if you associate it with touch in that way.   Again, that’s a cognitive association that’s associated with trauma. So that’s just one example, but there are lots of other situations that are fairly uncommon, but people do have these kinds of experiences where there’s a little bit of variability. In the future, looking into 2021, 2022, we’re really excited to increase customization of the Apollo. So the software will grow and learn about each user to deliver a more personalized experience for each person starting with timing and then gradually customizing the patterns as well.

 



 

Dr. Weitz:                            I’ve really been enjoying this discussion, but now, I’d like to pause to tell you about the sponsor for this episode of the Rational Wellness Podcast. This episode is sponsored by Pure Encapsulations, which is one of the few lines of professional nutritional supplements that I use in my office. Pure Encapsulations manufactures a complete line of hypoallergenic research-based dietary supplements. Pure products are meticulously formulated using pure scientifically-tested and validated ingredients. They are free from magnesium stearate, gluten, GMOs, hydrogenated fats, artificial colors, sweeteners and preservatives.

Among other things, one of the great things about Pure Encapsulations is not just the quality products but the fact that they often provide a range of different dosages and sizes, which makes it easy to find the right product for the right patient, especially since we do a lot of testing and we figure out exactly what the patients need. For example, with DHEA, they offer five, 10 and 25-milligram dosages in both 60 and 180 capsules per bottle size, which is extremely convenient.

                                                Now, back to our discussion.

 



                           

Dr. Weitz:            How can Apollo improve anxiety and stress and depression, and can it be an alternative for people who maybe don’t do well on antidepressants or want to get off them, and they’re phenomenally difficult to get off of?

Dr. Rabin:            Right. Yeah. So that’s a great question. That was actually the focus of when we first developed Apollo. The whole goal was, how do we help these people who have treatment-resistant depression, treatment-resistant PTSD, anxiety disorders, substance use disorders, people who have tried everything under the sun nearly and never had good results and outcomes. How do we help those people feel better?  The reason why we focused on that group, because in PTSD populations, that’s like 50% of the population, maybe more. In populations of depression, that’s 30% or more of people. These are two of the most common mental illnesses worldwide. So it’s a real problem. It’s-

Dr. Weitz:            Anxiety is really growing, especially among younger people.

Dr. Rabin:            Right. So it’s a real problem if 30% to 50% of people are not getting better with what is considered to be the gold standard of treatment or several gold standards of treatment. So when we originally developed a technology, this population was a huge focus for us, and veterans were a big part of that and still are. So we have found that these people in our preliminary findings from people just telling us about their experiences in the real world, but also from our early clinical trials actually respond really, really well to the Apollo. It’s hard to say exactly why, but we do know that certain stress response, stress recovery techniques actually work better when people are more stressed out.   When the body is more activated on the stress response side, there’s a bigger shift and for longer. There’s a bigger shift noticeable when people experience an intervention that makes them feel safe because all of a sudden, they’re like, “Oh, wow. I haven’t felt this feeling in a really long time.” So that in and of itself is therapeutic because it helps them recognize that, “Hey, I didn’t really have to do that much to achieve this, but it didn’t require a medicine. It didn’t require a pill, and I can just press these buttons and activate the state as often as I need to and kind of deep breathing it over time actually trains the body or trains us to remember and learn how to enter these states more effectively without the device.”

                                So oftentimes people who use it start using it a lot from the beginning. They use it every day for a month or three months, and then after several months of using it, they actually start to decrease their usage naturally because they’re getting more benefit with less frequent use, and they start to use it more intentionally for specific goals. But yes. So the goal was to develop the technology down the medical path, which we are going in addition to the consumer path to help these people with these illnesses. From the report so far, which again, are not published yet. They’re still in progress, but from the report so far, we are seeing really incredible results for these illnesses, and it’s incredible.  Again, I will say as a caveat, this is not yet a FDA approved or clear treatment tool. It is a consumer wellness product, and we are working down that path. But right now, it’s a consumer wellness product, and we’re not making any treatment claims about it. But it does help with- It does help a lot.

Dr. Weitz:            Yeah. It’d be great if you included in that if you could do study with people who are on SSRI and similar medications

Dr. Rabin:            Oh, I forgot to mention that.

Dr. Weitz:            … who are trying to get off those medications and use this as part of the program of weaning them off those medications as well as maybe other lifestyle factors.

Dr. Rabin:            Yeah, that’s a great point. I forgot to mention that. So that is one of the most interesting things that we found is we do see that people who use Apollo are voluntarily able to taper off of some of these medicines, everything from… SSRIs, we haven’t done a study yet with those, but-

Dr. Weitz:            Those are really, really hard to get off of.

Dr. Rabin:            They are really hard to get off of. But the medicines that we’ve been seeing people come off of are, I would say, harder to get off of, they’re opioid narcotics, benzodiazepines, and methamphetamine. So I would say they’re in the same category of tough to taper. We’ve seen people who have chronic illnesses who are using Apollo, people in the real world, They’re just writing us, and people from our trials are writing us and telling us that they are using Apollo, and they’re finding that they don’t need their Xanax anymore. They don’t need their benzodiazepines for sleep. You’re able to use less or none of their pain medicine. We just had a person write in today that on our reviews, they decrease their pain medicine dosing from every day to once a week within a month of use. I mean, yeah.

Dr. Weitz:            That’s amazing.

Dr. Rabin:            So this is why this is so exciting, because it starts to show us how much of our suffering might actually be caused by our stress and how we address stress and how we approach it, which is completely 150% within our control most of the time.

Dr. Weitz:            Absolutely. I treat a lot of patients with the functional medicine approach for gut health challenges, like IBS, reflux, and I could see where this device could be really helpful. Have you tested for digestive disorders?

Dr. Rabin:            We have not tested it for that yet. We have a lot of interest from folks in the microbiome community. So we will be looking at that, but we don’t have any of those studies ongoing currently.

Dr. Weitz:            Yeah. Cool. So you mentioned heart rate variability. Maybe you can explain more about exactly what this is and how heart rate variability can be improved with the Apollo and then also how heart rate variability is associated both with various types of diseases. I was looking at some of the data. It’s associated with increased risk of coronary heart disease, risk of death from heart disease, and it’s also associated with improved athletic performance. It seems to me HRV should really be a good anti-aging marker as well.

Dr. Rabin:            Yeah. I mean, I think that’s really where this is going, because we haven’t for many years, I mean, forever. We haven’t had good biomarkers in science for tracking the effects of aging or stress and how quickly we are aging. HRV, heart rate variability is a really interesting biomarker because what it is is it’s a measurement of the rate of change, how quickly our heart rate goes up or down with the environment. So as you were saying, if we have a low heart rate variability, meaning our heart rate takes longer to go up in response to stress and longer to come down when the stress is gone and we’re in a safe environment, then we are more likely to perform inconsistently. We are more likely to be injured in intense performance, to demanding performance, especially in the elite athletics literature, more likely to become sick and more likely to have to suffer from a metabolic disorder, heart disease and to die if we get sick. Right?   So what this is saying… The complete contrary is true. If we have high heart rate variability, which means that when stress comes, our heart rate jumps up really quick to adapt to the situation, and then when stress has gone, our heart rate comes down very quickly to adapt to the situation of safety and enter a recovery mode. So what this is really saying is that if we’re in a chronically stressed state more of the time, then we can measure this as low heart rate variability. That is a biomarker that shows that if we stay in that situation without doing anything about it, we are more likely to develop mental and physical health problems, and our immune system isn’t going to work as well, and we’re going to probably not sleep as well on a regular basis and not feel as good on a regular basis.

                                If we, on the other hand, train ourselves using the techniques like deep breathing, getting at least 30 minutes of exercise most days of the week, eating healthy, doing meditation practices, yoga, mindfulness, or soothing touch, listen to soothing music, and getting good sleep, and all of these kinds of things are a combination of some of these things, then we can reverse that process and train our nervous system to be more in balance more of the time, which is reflected as high heart rate variability and more likelihood of recovering from illness, better likelihood of performing consistently at a high level and a better likelihood of just feeling good more of the time.

Dr. Weitz:            What’s the preferred way to measure heart rate variability. What do you use?

Dr. Rabin:            So that’s a tough question, because the preferred way as a scientist or a doctor is an EKG machine, and you have to do… Traditionally, to measure heart rate variability accurately, you actually have to do an EKG of a person at rest for three minutes, and that is not easy to do outside of a laboratory or outside of a clinical setting. So now there’s wearables that can measure heart rate variability, because a lot of companies have realized, “Hey, this is really cool, and we’re already tracking heart rate. So why don’t we just try to measure HRV from the heart rate data that’s coming in.” Because it’s just taking a fancy… It’s just taking the heart rate data and doing a fancy mathematical calculation.

Dr. Weitz:            Are there devices that do a better job of this?

Dr. Rabin:            Yeah. So the Apple Watch is fairly decent and the Oura Ring. This guy is fairly decent. I would say those are two of the best. However, the caveat is that the quality of the measurement has a lot to do with when you’re taking the measurement. Right? So if you’re taking the measurement when you’re moving in any respect or you’re in a an environment that has lots of noise or physical, electrical noise, sound noise, lots of ambient vibration, like you’re in a car or a plane or something like that, you will get consistently inaccurate unreliable results from these measurements. Even with an EKG, you would get unreliable results in a noisy environment.  So it’s really critical for people to understand that the wearables they use at home to track their biometrics, like HRV are notoriously unreliable, and they have to be looked at in an over time kind of fashion, not in a short-term fashion. The short-term data is sometimes useful, but most of the time it’s not, and it’s hard to tell when it is and when it’s not. So the trends over time are way more interesting, and what we want to aim for is trending our resting heart rate, coming down, our HRV, heart rate variability going up, and our deep sleep and REM sleep going up, and our total sleep efficiency going up, which is a… These are all the common measures these devices use.

Dr. Weitz:            So right now, there’s no really good device for just regular every day clinical usage if you’re not going to be doing an EKG for three minutes.

Dr. Rabin:            There’s no great devices for HRV specifically for the average person to use at home right now. For heart rate, there is good stuff, like the ones I mentioned. WHOOP is also good, and resting heart rate is a pretty good measure that could be very useful. We’re getting there on the HRV front. Devices are getting better. The technology is rapidly getting better, getting smaller, getting more precise. But I think we’re just at a point where we’re not quite there yet. Even if you are using these other wearables, you really have to be in a quiet setting to get accurate measures that you trend over time. But we will get there eventually.

Dr. Weitz:            Right. What about arrhythmia. I, not long ago, interviewed Dr. Aseem Desai who has a book about arrhythmia, and he talked a lot about training, emphasized the parasympathetic state and how nervous system stress plays a big role in arrhythmia. That’s a really common problem for people these days. (See episode 181: https://www.drweitz.com/2020/11/atrial-fibrillation-with-dr-aseem-desai-rational-wellness-podcast-181/)

Dr. Rabin:            It is.

Dr. Weitz:            I could see where this would be beneficial.

Dr. Rabin:            Yeah. We don’t have any studies on arrhythmia yet, but we do have a number of people, and I work with a cardiologist in Pittsburgh, an interventional cardiologist who’s a really wonderful help to us.

Dr. Weitz:            Is that Joseph Maroon?

Dr. Rabin:            No, Dr. Brian Donahue. Joseph Maroon is a neurosurgeon who we also work with.

Dr. Weitz:            Oh, okay.

Dr. Rabin:            But we all work together, and it’s been really interesting to see how many people have used Apollo for atrial fibrillation or for arrhythmias, as you said on their own. We don’t instruct anybody to do it, but people will use it, and they have told us that they feel like they have less frequent arrhythmias because they’re calmer on a regular basis. I think that it just shows again how much stress actually impacts us without us knowing it. When we haven’t been taught to recognize what’s going on because it’s just of the normal day-to-day, being stressed all the time, we sometimes forget that stress really does play a major role in our health.

Dr. Weitz:            Absolutely. So yeah. You mentioned that there’s different modes that the Apollo device has. So I know there’s one mode to help improve concentration and work performance. Maybe you can explain how that works differently, and it’s fascinating that the same device that can improve sleep can also improve alertness and performance.

Dr. Rabin:            Yeah. So again, going back to the music analogy, right, our speakers can do this too. As long as you choose the right song and the right volume, we can do the same thing with music. I think that with Apollo, what we did was we were in the lab at the University of Pittsburgh, and we wanted originally because people with PTSD and people who are chronically stressed out have notoriously struggled with intense cognitive performance tasks and they require a lot of attention, and especially boring tasks.   So we ended up giving 38 healthy subjects one of these very boring and taxing tasks that NASA gives to astronauts before they go into space to test their ability to do very tedious work under frustrating conditions. So what was really fascinating was when we put people through this task, our goal was, and this was the first study that we did, which was a double-blind, randomized, placebo-controlled, crossover study in healthy folks at the University of Pittsburgh.  We found that there was a specific increase in heart rate variability in these folks with Apollo frequencies only and not with placebo and with no vibration conditions, and every subject had every condition and had no idea what condition they were getting. Nobody knew what was what this was supposed to do. To clear and focus mode was the mode that put people into the best of what we would call a peak performance or flow state, where people felt like zoned in.  So people on this mode, some of them had up to 25% increase in performance in three minutes. So if you could imagine what that is, that’s like the amount of difference on this kind of task that people see with amphetamines, with just a vibration on.

Dr. Weitz:            [crosstalk 00:38:36] stimulate the sympathetic nervous system in some way, like amphetamines do?

Dr. Rabin:            So it’s both. So I think what’s really interesting about flow or peak performance is that it’s not… The sympathetic and parasympathetic systems, they coexist all the time. They are never just one or just the other. They coexist all the time, just at least a little bit, and because we need both systems to function. So what’s interesting is if you can boost parasympathetic and sympathetic together, which is what many scientists have classified as the state necessary to access flow or peak performance, then you can bring the body into a state where there’s increased energy, sympathetic, right, increased awareness, sympathetic, but also increased attention control and increased emotion regulation, and the combination of those things directly increases performance. Right?

So that was what we aimed for in that trial, and we hit it right on the money, which was really exciting. So then we started looking at, what other states can we induce, right? That was also initially a part of that study as well, where we gave people like 20 different frequency patterns that we came up with in the lab, and we just said, “Feel this for 30 seconds and rate on the scale how it makes you feel.” Is it possible for people to tell in 30 seconds that a brief vibration changes the way they feel?   We actually saw there was pretty reliable reporting. People generally said close to the same answers for the same vibration pattern. So that started to give us the beginnings of an algorithm that was not just one pattern or two patterns that can induce one or two states, but really a mathematical understanding of how you can change the frequencies reliably a little bit in different directions to reliably and do certain states because our states of energy are actually on a spectrum from sleep to running from a bear, right?   So all the performance and recovery states actually when we’re awake, lie in between running from a bear and sleeping. So everything exists between those two, and those are the two that form the top end and the bottom end of the Apollo modes.

Dr. Weitz:            So what are the modes that the Apollo has?

Dr. Rabin:            So the most energizing mode, which is not… I would not say this is calming at all, personally, but it’s very energizing. It’s like having a shot of espresso for most people, but it lasts a shorter time, and that’s the energy and wake-up. Then there’s the social and open, which is like a social creative flow state that’s a calm… Most people use it when they’re working in groups or socializing when they’re tired. Clear and focused is the next one down, and these go in order from most energizing to least energizing.  So energy and wake-up, social and open, clear and focused is that deep focus flow that’s kind of like amphetamines, and then the one lower than clear and focused is rebuild and recover, which is basically the most balanced, even sympathetic and parasympathetic, which is with the goal of just rapidly calming the body down after a physical or mental or emotional stress of any kind. I really use that after travel or after exercise in particular, and we’ve shown that brings heart rate down much faster after exercise, which is really interesting.   Then we go into the much more calming parasympathetic frequency. So that’s meditation and mindfulness, which is great for meditating. It’s also great for what we call calm flow. So this is just like being like a Buddha master, just going throughout your day, just feeling in the zone and calm, but not worry, not anxious, not like you have to do anything.

Dr. Weitz:            You can use this while you meditate to reach a deeper meditation state, right?

Dr. Rabin:            Yes. We showed that in a study at the University of Pittsburgh as well that’s in the works and then-

Dr. Weitz:            It’s really fascinating, because people say you have to spend enormous numbers of hours meditating before you can finally reach this state. People say you have to spend 12 hours a day for weeks on end to reach a deeper state if that’s something that could be achieved.

Dr. Rabin:            Yup. Yeah. Sometimes hundreds of thousands of hours of breath work and meditation to learn how to enter deeper states, which is really interesting. So we’ve shown that Apollo within 12 minutes can start to make a non-meditator’s brainwave patterns look like an experienced meditator’s brainwave patterns.

Dr. Weitz:            Wow, fascinating.

Dr. Rabin:            So that’s something that is really exciting because transitioning into a meditative state, it’s also like a safety situation, right? When we’re meditating or sleeping, and for us to really recover deeply, which is doing things like meditation, yoga, sleep, that kind of stuff, we have to feel safe, right? When you’re meditating and your eyes are closed and where you’re sleeping, “That’s the time that we are more physically vulnerable than any other time.” So if there’s any part of our reptilian old brain, the amygdala that thinks that we are not safe in those situations, we won’t be able to meditate, and we will not be able to sleep, and we will not be able to access these higher states of consciousness that facilitate very powerful healing for ourselves.   Which is what I teach people in my clinical practice. So Apollo helps people state change, and whether that’s going from stress to calm, calm to work, calm to focus, focus to meditation, meditation to socializing, whatever the state change is, automatically, all state change for human beings or any animal creates a stressor. So what Apollo does is it just smooths out the transitions. By calming the body, it reminds us that this change of state is not threatening to us.

Dr. Weitz:            Wow.

Dr. Rabin:            In and of itself. Then that smooths out the transition from one state to another.

Dr. Weitz:            This is really fascinating, right? I just can’t believe how fascinating the applications of this device can be.

Dr. Rabin:            I mean, we couldn’t either at first, and then it was really exciting when these results came back, because I’ve been doing research for a long time. My colleagues that I worked with on this have been doing research for a long time, and I can tell you that it’s like once in a lifetime that you actually come up with something that works this well.

Dr. Weitz:            Now, where do you wear the device? You wear it on your wrist, or you wear it-

Dr. Rabin:            I actually wear it on my ankle? The device comes with an ankle strap and a wrist strap. Most people I think prefer to wear it on the ankle, and the main reason for that is because the primary use case of Apollo that most people use it for is relaxation and sleep. Then the second one is focus. So for sleeping, most people prefer to have the wearable on the ankle, where it will never be near anyone’s head when they’re sleeping and-

Dr. Weitz:            Are there EMFs produced by this?

Dr. Rabin:            Only what is produced by any Bluetooth device. It’s been tested for all of that radio frequency signaling. So it’s under all the legal limits and all that. That being said, there are people who are still sensitive to EMF below the legal limits, and we have included an airplane mode from the beginning to turn off all signaling for people. So the device actually works and can be completely untethered from the phone, and you could turn off the radios entirely so there’s zero EMF in airplane mode, and we have-

Dr. Weitz:            [crosstalk 00:46:36].

Dr. Rabin:            Yeah. The device doesn’t use EMF as a therapy. It uses sound waves. So the sound waves are very safe. They’re one of the safest things that we know of to deliver to the body. So the sound waves can be still delivered and activated with the device on the buttons on the device, and you can adjust the intensity with the buttons on the device even when it’s not connected to the phone, which is really nice because personally, I get it. I don’t want to have my phone on me all the time or have to have my phone on me all the time to feel good. I want to be able to set my phone down and be able to still have my tools with me that work without requiring the phone. Then if I want to go back to the phone, I can go back to the phone. But it’s more intentional with that.

Dr. Weitz:            Will it hold a charge for a long time?

Dr. Rabin:            So it holds a charge if you don’t… In standby mode, I think it’s something like 12 days, 15 days.

Dr. Weitz:            Oh, wow.

Dr. Rabin:            If you use it, it will last… If you use it as we recommend, which is roughly two, two and a half hours a day or two to three hours a day, then you get about two days out of it. If you use it more than that, then you have to charge it more frequently. That’s not a big deal. You just find a time to charge it, and it charges within one to two hours, and then you have another full battery capacity out of that. We are constantly working to make the battery life better, but it just takes time and-

Dr. Weitz:            Yeah. As long as it goes through your whole night sleep or most of your day, that should be fine, I would think.

Dr. Rabin:            Yeah. Yeah. It does. I think the people who do use it more often, that use it all, all the time when they first get it, they actually schedule in time during their day and usually during a meal to plug it in, which is funny. But it’s good because that structure of having a schedule is also very helpful to us in terms of recovering, because it sets boundaries that says, “Hey, it’s time for recovery now, not time for work.” Right? Then you kind of have these from self-imposed, but still from boundaries that allow us to disengage from one state of mind or activity and then enter into another.

Dr. Weitz:            Interestingly, I talked to a lot of people are working from home right now, and that’s become increasingly difficult when they’re working at home, and they just end up, can keep working.

Dr. Rabin:            Yup. Yeah, I did that too. I am a complete perpetrator of that. It is very difficult, and it’s something that I’ve really struggled with in the last year, in particular with COVID. But now, it’s really just a matter. What I started do now is I made a schedule, and I just really hold myself to it, and I just got it because I know that if I do it, I just feel so much better. That’s all there is to it. I want to feel good.

Dr. Weitz:            Oh, I feel the same thing. Besides my full-time practice, I do the podcast, and I’m always working on show notes or working on notes for the next interview or et cetera. So it’s hard to shut off. That’s one of the reasons why we need a device like this.

Dr. Rabin:            Oh, yeah. I mean, yeah, the struggle is real, for sure. I think that’s why, especially with doctors. I used to work in the psychiatric ER when we first had this prototype, a prototype of the Apollo. I was working in the psychiatric ER a lot. I was seeing a lot of very, very high risks mental health patients. Having the Apollo was just a game changer, to be able to have something that allowed me or helped me figure out again how to call myself down quickly without taking a supplement to help me sleep or without having a glass of wine or… Not that having a glass of wine is a bad thing. It’s not, but we shouldn’t be dependent on it for rest because it doesn’t actually help us sleep. It actually just makes us feel like we sleep better, but we actually sleep a lot worse and are actually less rested at more of a sleep deficit down the road.  So I think ultimately, what working on Apollo really taught me that was so incredible was that we have the ability in ourselves to heal ourselves. We through learning how to use the tools that we have access to in ourselves, we have the ability to heal ourselves and to really make ourselves so much better than we are. Life is like a constant game of growth, and how fast can we grow out as well as we can grow in the direction we want to grow. Right? We think we want to grow.

Dr. Weitz:            Absolutely.

Dr. Rabin:            Working on Apollo really taught me and using Apollo over time taught me that there’s a hell of a lot more going on in here than I thought there was.

Dr. Weitz:            Cool.

Dr. Rabin:            Because the anxiety and the fear is what… Kathryn, my wife is the CEO of Apollo, we came up with this funny term, which I think is really true, which is the fear that we are either taught to feel or feel for whatever reason about uncertainty or newness or unfamiliarity or anxiety or whatever, it’s really fear of the unknown. It’s fear of uncertainty and fear of losing control of our lives, our situation, and that creates a box around us that we eloquently entitled the fear box, that literally creates the reality that we live in.  In every moment of our day, we have the opportunity to pay attention to love or fear. There’s love and fear and every moment coexisting together in every moment of our day, and if we direct our attention to fear, we will live in that fear box, and if we direct our attention to love, we will climb out of the fear box, and we will find our actual path.

Dr. Weitz:            Right. Awesome. Great way to end this interview. It’s been very fascinating. How can people find out… How can they order the Apollo and find out more information about you-

Dr. Rabin:            Well-

Dr. Weitz:            … and the device?

Dr. Rabin:            Sure. Yeah. So, for Apollo, you can go to apolloneuroscience.com or apolloneuro.com, A-P-O-L-L-O-N-E-U-R-O, dot com. I believe we have some sales that are either going on or coming up. So stay tuned there. You can also sign up for our newsletter on the website where we send out a lot of very helpful tips that I have helped to write myself based on things that I’ve done and that I do with my clients, which is basically free information to help people feel good at a time where things are really crazy in our world and to feel frankly just more in control of our own lives. That’s what this is about.

                                If we spend more time paying attention to things we can control, we will feel more in control. Breath is the start of that, and movement, and these things, everything we’ve been talking about. If you’d like to find me or get in touch, you can check out my website. It’s drdave.io. That’s my clinical practice website. I also can be reached through social media at Twitter @DaveRabin and on Instagram @drdavidrabin.

Dr. Weitz:            Awesome. Awesome. Thank you so much, and I’ll send you links after we post this in about six weeks.

Dr. Rabin:            Sounds good. Thank you so much for having me. I really appreciate it, Ben.

 

Dr. Preet Khangura discusses Hydrogen Sulfide SIBO (Small Intestinal Bacterial Overgrowth) and SIFO (Small Intestinal Fungal Overgrowth) with Dr. Ben Weitz.

[If you enjoy this podcast, please give us a rating and review on Itunes, so more people will find The Rational Wellness Podcast. Also check out the video version on YouTube at https://www.youtube.com/user/weitzchiro/]

 

Podcast Highlights

1:34  Dr. Khangura learned about naturopathic medicine when his wife had some significant gastrointestinal issues and after multiple visits to the ER and to her family MD, who prescribed Proton Pump Inhibitors, she saw a Naturopathic doctor who really turned her health around. Dr. Khangura switched his career path from medical physics to naturopathic medicine with a focus on gut health.  Dr. Preet started exploring SIBO (Small Intestinal Bacterial Overgrowth) in Naturopathic college, even though it was not taught very well in Naturopathic school.  SIBO became one of the focus points of his practice from day one.

5:08  IBS (Irritable Bowel Syndrome) is a lazy diagnosis because it is really more of a label and it does not indicate the cause of the symptoms.  Conventional MDs will often say, “You just have IBS.” “You’re just going to have to deal with it.” “You’re just going to have to take a laxative.” “You’re just going to have to take a PPI.” 

7:04  While SIBO is the most common cause of IBS, another cause is pancreatic insufficiency, which involves a lack of sufficient digestive enzymes being produced like lipase, proteases and amylase.  One way to diagnose pancreatic insufficiency is to run a stool elastase test, and while 200 is the lab designated cutoff point, anything less than 500 is potentially indicative of the need for enzymes.

9:43  Some of the cases of patients with constipation, esp. if there is methane, can be some of the most difficult cases to treat till resolution.  While some constipation patients have methane overgrowth on the SIBO breath test, others may have a low level of methane that may not show positive on a breath test, but may still induce constipation.  For example, while on the SIBO breath test, the cutoff for methane is 10, perhaps it should be 3. You may have to get rid of virtually all of the methanogens to resolve the constipation.  One natural product that Dr. Khangura will use is an herbal tincture called the Tincture of Death, which contains a very concentrated combination of the three herbs: golden seal, myrrh and thyme.  Allicin extract can also be very effective.  Oregano can work and he likes the emulsified oregano formula from Biotics, ADP.  He also finds the combination of Candibactin BR and Candibactin AR from Metagenics very effective.  If he uses pharmaceuticals for methane SIBO, Dr. Khangura will use Rifaximin and neomycin or Rifaximin and metronidizole.  He may also use Amoxicillin/clavulanate or trimethoprin/sulfamethoxazole.

17:25  Biofilms. Bacteria biofilm is one of the reasons why we can’t eradicate the bacteria in stubborn SIBO cases. We need to pick a good biofilm disruptor and the best biofilm disrupting complex would be what’s called the Bismuth thiol complex.  It is typically bismuth subnitrate mixed with either DMPA or DMSA along with alpha lipoic acid and this is usually compounded by a pharmacy.  There are phase one and phase two biofilms. Phase two is a very mature biofilm that is much more difficult to disrupt.  There are metalloid lengths within the biofilm, which is what the Bismuth Thiol complex acts on by forming a wedge to open the biofilm.  NAC can be very effective and Dr. Khangura recommends a dosage of 1000 mg of NAC twice per day on an empty stomach.  A lot of practitioners will use enzyme formulas, like Interphase Plus, but these are pretty weak at opening biofilms and are probably better for prevention to prevent relapse.  If you are a practitioner that can’t prescribe DMPS or DMSA, Dr. Paul Anderson developed a bismuth thiol product without DMPS or DMSA that combines bismuth subnitrate with alpha lipoic acid and black cumin seed.  Dr. Khangura will often have patients continue with biofilm disruptors until they get a flareup of symptoms, which indicates that the biofilm is being broken up.  Dr. Anderson teaches that when the biofilm is broken, the bacterial colonies will become more active and they start fermenting more, leading to more symptoms.  It can be difficult to kill the bacteria until the biofilm is broken up.  Once the biofilm is broken, the immune system will more likely now activate to reduce the overgrowth. 

26:29  Erradication period.  To erradicate the bacterial overgrowth, Dr. Khangura will either use Rifaximin or herbals for 2 to four weeks and he expects to see some significant improvement in two weeks or he will not continue.

28:35  Dr. Khangura does not recommend patients to follow a strict anti-SIBO diet at the same time as the erradication process, since the bacteria may go dormant and produce even more biofilm.  It can help to use guar gum with rifaximin, since guar gum will feed the bacteria and make it easier to kill them.  The other reason is that if you have them follow a low FODMAP diet and put them on rifaximin and they feel 50% better, you don’t know which intervention worked.

31:36  Dr. Khangura recommends not giving broad spectrum probiotics to SIBO patients and he finds that most SIBO patients feel worse if they eat fermented foods like sauerkraut or drink kombucha.  The probiotics contain bacteria that can take up residence in the small intestine and studies have found that lactabacillus are hydrogen producers and have been found in 25% of cases of SIBO.  Dr. Khangura sees less issues with using bifido species and with spore based probiotics. 

35:15  Hydrogen sulfide SIBO.  While the flat line on a SIBO breath test might be an indication of hydrogen sulfide SIBO, Dr. Khangura finds that medical history and symptoms can often alert him to this condition. Patients may report a very pungent, rotten egg smelling gas that occurs on a regular basis or they may have an unexplained halitosis.  The new Trio Smart Breath Test, which also measures hydrogen sulfide gas, is not yet available in Canada, so Dr. Khangura has not been able to use it yet. 

The bacteria that produce hydrogen sulfide typically don’t feed on fermentable fiber or sugar, but they feed on foods rich in sulfur compounds, like garlic and onions.  Chronic or reoccurring UTIs occur from hydrogen sulfide producing bacteria.  Drinking well water is an easy way to pickup hydrogen sulfide bacteria if they’re not using UV light to kill the bacteria.  Some of the most common hydrogen sulfide producing bacteria are klebsiella, proteus, citrobacter, E. coli, and morganella.

For treatment of hydrogen sulfide SIBO, Dr. Khangura usually uses Rifaximin or Amoxicillin/clavulanate or trimethoprin/sulfamethoxazole.  Natural treatments for hydrogen sulfide SIBO include Uva Ursi, which is often used for UTIs.  He will have a good herb dispenser in Canada make a one to one or a one to two tincture of Uva Ursi, whereas most health food stores carry a one to four or a one to five, which is less potent. This herb does contain a hydroquinone, which some people worry might affect the liver, but using it for a few weeks he has never seen it cause a problem. Silver can also be very effective against hydrogen sulfide producers either as colloidal silver or silver hydrosol.  He may use a combination of Uva Ursi plus Silver Hydrosol.

47:30  SIFO (Small Intestinal Fungal Overgrowth).  Candida or other fungal overgrowth can occur in the small intestine or the colon or in other parts of the digestive tract. There is no breath test for SIFO for fungal dysbiosis. Stool tests might show yeast/fungus like candida in the colon and this might indicate fungal overgrowth in the small intestines as well.  While Rifaximin only works in the small intestine and does not affect the microbiome, other antibiotics like neomycin, metronidazole, Amoxicillin/clavulanate, and trimethoprin/sulfamethoxazole could make the fungal growth worse. If they have a chronic gastrointestinal fungal issue it may present systemically as oral thrush or fungal scalp problems or recurrent skin fungal infections or athlete’s foot, or recurrent vaginal yeast infections.  You can ask the patient how they feel after eating a candy bar or having a drink?  Fungal overgrowth can lead to the production of acetaldehyde, which can cause brain fog, a hung over feeling, nausea, tachycardia, increased heart rate.

 

 



Dr. Preet Khangura is a Naturopathic Doctor with an integrative and functional medicine practice at Juniper Family Health in Victoria, British Columbia, Canada. Dr. Khangura has a practice focus on treating gastrointestinal conditions, including SIBO – the #1 cause of IBS.  Dr. Khangura has also been educating doctors about SIBO at in person and now at online conferences. To learn more, here is a course that Dr. Khangura offers: Beyond Superseding SIBO.

Dr. Ben Weitz is available for nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also specializing in Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure and also weight loss, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111 or go to www.drweitz.com.



 

Podcast Transcript

Dr. Weitz:                            Hey, this is Dr. Ben Weitz, host of the Rational Wellness podcast. I talk to the leading health and nutrition experts, and researchers in the field, to bring you the latest in cutting edge health information. Subscribe to the Rational Wellness podcast for weekly updates. To learn more, check out my website, DrWeitz.com. Thanks for joining me, and let’s jump into the podcast.

                                                Hello Rational Wellness podcasters. Our topic for today is hydrogen sulfide SIBO and SIFO, and difficult SIBO cases with Dr. Preet Khangura. Dr. Preet Khangura is a naturopathic physician with an integrative and functional medicine practice at Juniper Family Health in Victoria, British Columbia in Canada. Dr. Khangura has a practiced focused on treating gastrointestinal issues including SIBO which is the main cause if IBS. Dr. Khangura has also been educating doctors about SIBO in person and now with COVID at online conferences. My goal for this interview with Dr. Khangura is to gain some insights into treating some of the more difficult SIBO cases. We would like to highlight the diagnosis and treatment of hydrogen sulfide SIBO and small intestinal fungal overgrowth in particular. Thank you so much for joining me, Dr. Khangura.

Dr. Khangura:                    My pleasure, thank you for having me.

Dr. Weitz:                          That’s great. Perhaps you can explain to our listeners how you came to become so interested in SIBO and in functional gut disorders?

Dr. Khangura:                    It’s kind of an interesting story. My wife always takes credit for it, of course. There’s some truth to that. Years ago-

Dr. Weitz:                          You’re not going to win by denying that.

Dr. Khangura:                    Exactly, that’s true. Years ago, before I even went to naturopathic medical school, my wife and I have been married for close to 14 years but we’ve been dating for 20 plus. In our early 20s she came down with some very significant gastrointestinal issues. It kind of came out of nowhere at such a young age and her hair started falling out, she started getting arthritic joint pains but it all started with very significant gastrointestinal issues. I had to take her to the ER a few times, of course they couldn’t find anything. Her family doctor was just prescribing her antacids even though she never had GERD. I was talking to my friend’s mother-

Dr. Weitz:                          That’s the classic treatment for everything.

Dr. Khangura:                    Yeah. Throw a PPI at it.  I was talking to one of my friend’s mothers over Christmas break one time and she said, “Oh that sounds like what our daughter dealt with last year. We saw this great naturopathic doctor that focused on gut health.” That sparked my interest. She saw a naturopathic doctor here in B.C. all those years ago, within three months completely turned her health around. That really sparked my interest in not just naturopathic medicine, functional medicine but gut health. At that time I was doing my degree in physics. I was going to go into medical physics but I totally switched gears. Went to naturopathic medical school and always had a sight on gastrointestinal disorders. When I started practice I started really diving into SIBO even in naturopathic medical school, even today, especially back then. SIBO’s not really taught very well even in naturopathic medical schools. I had to do a lot of it myself. I dove right into it and really focused on it since day one of practice. As you know, whatever we practice more of, that’s why it’s called practice, we get better at.

Dr. Weitz:                            Right. Of course, SIBO is one of those conditions that on the one hand seems like a really simple condition. We do have our cases where everything fits, they have the symptoms, you get the breath test back, you do your normal treatment, whether it be antimicrobials from the natural world or rifaximin or whatever. Then they resolve, end of story. Then we have our 50% or so of cases that don’t seem to come along so easily.

Dr. Khangura:                    Yeah, exactly, that’s exactly it. I see a ton of that in my practice because I do have expertise in SIBO and other GI disorders, dysbiosis disorder especially. I get a lot of these very stubborn cases referred to me. I’d say in my practice, more than 50% are the stubborn cases but that’s where you really learn as a practitioner and that’s why I try to get across in my courses and seminars for other doctors. Keep your fingers crossed that you get a really easy case because it’s good for you and the patient, of course. But where you’re really going to learn, especially the individualistic treatments for patients as opposed to protocols or blueprints are those patients where they’ve already tried this, they’ve tried this. The SIBO is not resolving or it’s coming back quickly or whatever it may be.

Dr. Weitz:                           Right. I heard you say that IBS is the lazy diagnosis, what did you mean by this?

Dr. Khangura:                    Yes. That ruffles a lot of feathers, especially more M.D. colleagues-

Dr. Weitz:                           Conventional GI docs.

Dr. Khangura:                    Conventional GI docs, yeah. Really what I mean by that is kind of tongue in cheek. Obviously it is a diagnosis however it’s more of a label than a diagnosis, kind of like fibromyalgia is a label, chronic fatigue syndrome is a label. There’s obviously always root causes to these conditions and digger deeper to find out that root cause, then you can actually treat that as your therapeutic target and actually not just mask signs and symptoms but actually resolve the case, hopefully, for these patients. The problem is, I’m sure you know this yourself, when the patients get that label of IBS, so many times that’s where the doctor stops. They just the word “just” quite often. They’ll say, “You just have IBS.” “You’re just going to have to deal with it.” “You’re just going to have to take a laxative.” “You’re just going to have to take a PPI.”

Dr. Weitz:                           Partially it’s a diagnosis of exclusion, they’ve excluded IBD, their scope is negative, there’s no parasites. It’s a functional gut disorder.

Dr. Khangura:                    Exactly. It’s becoming a lazy diagnosis because those doctors will stop at that point and give maybe some dietary recommendations. Now a lot of doctors are recommending the low-FODMAP diet and other things. But that’s really the extent they get other things to slow down the diarrhea or slow down the cramping or whatever it might be. That’s basically why I call it a lazy diagnosis. By no means is SIBO always the root cause of someone’s IBS. It’s definitely near the top of the list for a lot of the patients but of course there are cases of “IBS” that SIBO is not the root cause. But definitely SIBO should be there on a practitioner’s DB-

Dr. Weitz:                          What are some of the other causes of IBS besides SIBO?

Dr. Khangura:                    One that mimics SIBO extremely well, definitely a lot more rare than SIBO would be something like pancreatic insufficiency. This would be a condition where the patient’s pancreas is not producing enough of the digestive enzymes like lipase, proteases and amylase.

Dr. Weitz:                          How often do you think that happens?

Dr. Khangura:                    I couldn’t really give you a number but I have seen it a decent amount in my practice whether I suspected it and I prescribed actual prescription strength enzymes to see if it made a significant difference or we ran a stool elastase test which is very diagnostic of pancreatic insufficiency if the number comes back lower than usually a threshold of 200. It depends on what units they’re using. But-

Dr. Weitz:                          Actually I recently spoke to Dr. Stephen Sandberg Lewis. Even though the labs usually give 200 as a cutoff point, he feels that really a normal elastase should be over 500.

Dr. Khangura:                    Yeah, exactly. In that kind of gray zone, if a patient comes back with 300 I’ll still usually prescribe the enzymes just in case because the reason why it’s a perfect mimicker of SIBO is when you boil down SIBO, you get into all the patho-physiology, you can get into all the nitty gritty details of why we develop it, what happens, what bacteria is there. But really what it comes down to is over fermentation from an over pooling of bacteria in the small intestine. Now, pancreatic insufficiency, even if a patient does not have SIBO, they have a regular amount of small, tiny amount of bacteria in the small intestine but if they now don’t produce enough enzymes to break their proteins, carbs and fats down properly, the meals they’re eating are just sitting there in their small intestines much longer than they should be. Even that small, regular amount of bacteria can now over ferment the fibers and sugars that came in that meal because it’s just sitting there. They can produce SIBO-like levels of gas even though the actual community count isn’t at an overgrowth level.   That’s one that I’d say is almost a perfect mimicker of SIBO.  You’ll sometimes hear that, okay sometimes pancreatic insufficiency, they definitely are going to have diarrhea because of the fact that the food isn’t breaking down well, fats aren’t breaking down well.  The gut will send things out. We do see that very often, IBS-D caused by pancreatic insufficiency but I’ve had many constipation cases where pancreatic insufficiency was the big root cause.  Those are things also to watch out for.  It doesn’t always have diarrhea.

Dr. Weitz:                            I’ve found some of the constipation cases are some of the most challenging of cases. They often don’t fit the classic, they don’t have elevated methane and a lot of times getting rid of that constipation seems to be really, really tough.

Dr. Khangura:                    They can be, they probably are the most stubborn cases to crack. I find when we talk about methane, there is that big connection between methane production in the small intestines and slowing of the colon motility leading to constipation. I think the reason why they can be the toughest cases to crack is that if you do not resolve the constipation aspect, it can be very difficult to have the patient feel better even as you’re getting rid of, say, their hydrogen sulfide SIBO because if the colon motility is not very good and they’re not evacuating their bowels very well, they are going to have higher levels of discomfort, gas, bloating, just not feeling well, low appetite. Until you can resolve that constipation, if that means eradicating enough methane bacteria to do that, okay, great. But the problem is, as you probably know and your listeners may know is that there is methane producing SIBO and then there’s something called methane induced constipation. These can be two separate things. Obviously if someone has methane SIBO, they have an overgrowth of methane bacteria that can very easily lead to constipation, not always. It just depends on what else is going on.   But there’s some patients that have what’s called methane induced constipation where they don’t actually need a full overgrowth of the methane bacteria colony. They’re just the unfortunate subset of patients where they need a small amount of methane production to cause their constipation. You as a practitioner and any other practitioners out there may see this in SIBO breath tests where they say, “Okay, the cutoff for methane producing SIBO is between 10 to 12 parts per million of methane.” But then as soon as you see this fine print saying, “But some practitioners see 3 parts per million as a positive diagnosis.” But they don’t tell you positive diagnosis for what. Really, what they’re trying to say is some patients if they have constipation and they have at least 3 parts per million of methane, there can be a big correlation. Those patients can be really tough.

Dr. Weitz:                            When we see those recommendations for how these tests should be interpreted, like the North American Consensus, that’s a consensus of different doctors that had to all agree. I’ve spoken to Dr. Pimentel before, he had recommended a cutoff of three but the consensus was ten.

Dr. Khangura:                    Yeah. That’s exactly it. That’s something I brought up in a lecture I did the past summer I did on breath analysis. Really what the real data shows and how this consensus was just decided by a group of docs based on some research but the research is quite flawed in some ways. I do agree with Dr. Pimentel with the whole three parts per million aspect because I’ve had many patients where we have to eradicate virtually all of the methane bacteria in that small intestinal tract before that constipation resolved. Until we can do that, the patient was getting some benefit in a lot of these cases because we were getting rid of maybe some other problems, hydrogenic SIBO, whatever else. But because they were not able to move their bowels properly until we were able to eradicate enough of the methane bacteria, archaea technically, then these sometimes can be the tougher cases.    What I also will mention to practitioners is that if you have a patient that has methane induced constipation where you need to get their methane levels down to below three parts per million, these are also cases that their constipation will very likely relapse very easily because it won’t, even if you have them on a good pro-kinetic and you’re doing all these good things. The reason being is that it won’t take much over pooling or re-pooling of methane archaea again to get back to three parts per million and all of a sudden they get constipated again. Even if you’re able to resolve one of those cases, you’ve got to be on top of even prophylactic treatments and good prevention- [crosstalk 00:13:51]

Dr. Weitz:                          What are your favorite prophylactic or what are your favorite treatments for breaking the constipation cycle until you eradicate the methane?

Dr. Khangura:                    The way I look at it is, if I do suspect that the methane growth and methane production is the cause of the constipation, eradicating that growth is the treatment that I go with. Of course, you could do things like some pro-kinetics that can help colon motility, like prucalopride for example. You can get their bowels moving in a sense artificially because you’re inducing the contractions or even other over the counter laxatives or high dose magnesium or senna, whatever it might be. That’s not getting to the root cause. The way I look at it is, if a patient needs to be on something as we begin treatment just to get their bowels moving otherwise, only going twice a week or something like that, I’m fine with them remaining on something like that at the beginning but my goal is to eradicate the methane archaea to a point where they don’t have to be on those laxatives anymore, they don’t need the actual pro-kinetic to have a bowel movement. That’s where there’s a lot of confusion on what a pro-kinetic is for. It’s really for retraining the migrating motor complex contractions as opposed to making sure patients have bowel movements. That’s the way I look at it. If that means using pharmaceutical antibiotics, if that means using specific herbal extracts to kill the methane archaea, elemental diet, picking the right agents in that scenario.

Dr. Weitz:                          What are your favorite herbal agents for killing the methane?

Dr. Khangura:                    For the methane? I have this one tincture, I just call it my SIBO tincture.  A lot of docs here in Canada, they know it by the name Tincture of Death.  It goes back to a story of one of the first patients I gave it to, I asked them, because the tincture has a really strong taste. I go, “How did you handle the tincture?” He goes, “Oh, you mean the tincture of death?” and I go, “What do you mean by that?” He goes, “Well, it obviously worked at killing the bacteria because I’m feeling better but it also tasted like death.” I’m like, “Okay.” Basically I just call it my SIBO tincture, calling it the Tincture of Death is a great marketing ploy. Basically this is personally what I use and a lot of docs I taught use it but it’s a very concentrated combination of the three herbs golden seal, myrrh and thyme. Some docs do equal parts, I do a little bit more of the golden seal and myrrh than the thyme in the tincture. But that tincture I’ve seen work over and over for methane overgrowth. Also it can help with hydrogenic overgrowth. Probably not the best choice for hydrogen sulfide overgrowth, which we can get into in a little bit. But that tincture I use quite often.  Allicin extract can be good, I specifically use a product called Allimax.  A lot of docs know about that one.

Dr. Weitz:                          We use the same one.

Dr. Khangura:                   That one can work well in some cases. You’ll hear that oregano is better for hydrogenic SIBO.  It’s definitely not black and white. I’ve seen oregano work well for methane overgrowth. There’s a very specific emulsified oregano that I use called ADP emulsified oregano from Biotics Research. That’s a good one. I’ve seen that one work well. Of course there’s other good formulas that can work, Candibactin AR, Candibactin BR products when used in combo they can work. There’s a lot of options. Definitely the methane archaea will be tougher than the hydrogenic bacteria. But if you use the right agents, then you can hit them pretty good.

Now, the caveat to all of this is whether it’s hydrogenic, hydrogen sulfide or methane producing SIBO. I talk a lot about this when I do my courses is biofilm production. Bacteria biofilm is, in my opinion, the number one reason why we see a lot of those very stubborn SIBO cases out there where you can’t even start an eradication. You either give them rifaximin or neomycin. Rifaximin and metronidizole, you give them all these herbs but the SIBO is just not budging. You retest, the numbers aren’t getting better. They even may be getting worse. Bacterial biofilm is definitely a big problem in a lot of these cases. A good, good biofilm disruptor, no matter what you pick to kill the bacteria, a good biofilm disrupting agent is key for a lot of these cases.

Dr. Weitz:                          What are the best biofilm disruptors?

Dr. Khangura:                    There’s some very simple single ingredient things you can use. But by far, the best biofilm disrupting complex would be what’s called the bismuth thiol complex. Bismuth like the bismuth that’s in Pepto Bismol. But it’s a little bit different version of it. It’s bismuth sub-nitrate as opposed bismuth salycilate. But the Bismuth vial complex is bismuth sub-nitrate mixed together with either DMPS or DMSA. One or the other and also alpha lipoic acid. ALA- 

Dr. Weitz:                          Is this something that’s compounded?

Dr. Khangura:                    This is something that has to be compounded. Here in Canada there’s a couple of pharmacies that do compound it for clinicians. I know in the states there’s some pharmacies that do a lot of this product as well. This product has had some good research on it showing that … There’s two different forms of biofilms.  There’s phase one biofilm, there’s phase two biofilm. There’s a lot of agents that can work on phase one biofilm, especially a lot of natural agents.  But once the biofilm gets to phase two, essentially what that means is, it’s very much matured biofilm. It’s been getting produced for many, many years, at least many, many months. There’s significant amounts of metalloid lengths within the biofilm, you need something better than what can open up the phase one biofilm. That’s where the bismuth vial complex comes in.

                                                When the compounding pharmacy mixes the three ingredients together in the right ratio, the ALA and the DMPS will bind tightly to the bismuth sub-nitrate and this will form one whole new agent. It’s not like taking three separate, really awesome biofilm disruptors, they’re actually all really mediocre at opening up biofilm but when they combine they form this one whole new agent. In an analogy sense, it forms a wedge that opens up the metalloid lengths and it’s been shown to open up phase two biofilm, at least at this point, probably the best compared to anything else. But if you weren’t going to use that or you couldn’t use it, then something as simple as NAC can work very, very well. Very good research on that with inhibiting biofilm protection and also opening up biofilm. There will be cases where it fails, if it’s significant phase two biofilm

Dr. Weitz:                          What dosage do you like for the NAC?

Dr. Khangura:                    I typically will do a little bit higher dose than we normally do for NAC. 1,000 milligrams twice a day empty stomach. Empty stomach for any disruptors is important to get to the gut biofilm including the bismuth vial complex you want to do empty stomach. A lot of people will talk about enzymes. They’ll do enzyme formulas to open up biofilm. They’re pretty weak at actually opening up biofilm. They’re more so for prevention so they can inhibit biofilm production by the microorganisms. In a lot of cases, especially my cases that have been pretty tough to crack or I do see we can solve it but there is a relapse rate that happens, a lot of times we’ll put patients on these enzyme formulas or lower dose NAC long term after we actually resolve the case just to inhibit more biofilm production as time goes on.

Dr. Weitz:                          Which is your favorite enzyme formula?

Dr. Khangura:                    If I was going to use an enzyme formula, I don’t use it often because I’ll typically prescribe the bismuth vial complex but there is, I’m forgetting the actual name of the product now but it’s made by the company Klaire Labs.

Dr. Weitz:                          Yeah, yeah. Interphase Plus.

Dr. Khangura:                    Interphase Plus, yeah. That would probably be one of the better ones and then here in Canada there’s one called BioFilm X by Vita Aid, which is a fairly similar formula to that one. But like I said, if I had to choose and I wasn’t using the bismuth vial complex, I would still pick high dose NAC over the enzyme formulas.

Dr. Weitz:                          I think Paul Anderson developed a bismuth thiol product that just doesn’t have the DMP-S or DMS-A.

Dr. Khangura:                    That’s exactly … Thanks for bringing that up because I was going to say that an alternative if you’re a practitioner that can’t, let’s say, prescribe the DMPS or DMSA, Paul did formulate for the comfortable Priority One and it’s a product called Phase Two Biofilm which has the bismuth sub-nitrate which is just over the counter and then alpha lipoic acid and then black cumin seed. The black cumin seed will bind to the bismuth in a similar way as the DMP-S but just not as tightly and as strong but it’s a very good alternative formula.

Dr. Weitz:                          Okay. You use that for which forms of SIBO? Or all of them?

Dr. Khangura:                    Pretty much all of them because virtually all microorganisms produce biofilm directly including fungal species, candida species. They produce a lot of biofilm when they co-colonize with certain bacterial species. I’ll use a biofilm disruptor pretty much with every SIBO case. Now, not all SIBO cases need it but I like to hedge my bets because if I do a very well rounded treatment on a patient and two or three weeks later they tell me they’ve had zero resolution of any symptoms, zero improvement at all, then the next step would be, “Well, we probably should have done that with a biofilm disruptor. Let’s try again.” I’d rather not do that. I’ll do the biofilm disruption along with the eradication agents. In some cases what I’ll do is, especially if it’s a case that comes to me and I see in their history they’ve already tried everything under the sun for their SIBO and their SIBO is very much there still, I’ll do very good biofilm disruption like bismuth vial complex all by itself for a set period of time before we even go back to eradication. There’s going to be some cases out there that are going to need extensive biofilm disruption before anything is going to work. I have cases where three, four months of biofilm disruption and then we go back to something they’ve already tried. All of a sudden they get full resolution. 

Dr. Weitz:                            How did you decide that three or four months is the right amount of time?

Dr. Khangura:                    Yeah. For some of these cases I’ll have them stay on the biofilm disruptor until they get a flareup of symptoms. Paul teaches a lot about this as well. Basically what happens is when biofilm is produced and these colonies are living within it, it actually can inhibit how bad that patient’s SIBO symptoms are because what happens is the colonies are living within the biofilm and then when that patient eats, only some of the SIBO comes out of the biofilm to feed. The rest stays behind, dormant and protected in the biofilm. It actually limits how bad the fermentation can be. When you put a patient on just biofilm disruption, a lot of times I’ll tell them, “You’re going to stay on this until you get an unexplained flareup of your symptoms.” A lot of these patients, they don’t believe me because their symptoms are already quite significant. How could it get worse? It does. When this biofilm opens up, all of a sudden there’s two things that happen. One is the actual colonies, the overgrowth actually become more active. They’re going to ferment more. They’re going to give you more symptoms.

                                                But the other thing that happens is that the gut’s immune system can now activate against the overgrowth, because that’s one major reason why bacteria produce biofilm isn’t just to adhere to a surface, it’s to protect themselves from your immune system, from the environment, whatever else is out there. For two reasons the patient might get a flareup. Gut’s immune system activates, the actual overgrowth gets more active and I tell them, “We’re looking for an unexplained flareup so it’s not because you change your diet, it’s not because you’re getting sick. You’re doing your every day old thing and all of a sudden for the last two or three days you thought your bloating was a 10 out of 10, it’s a 12 out of 10 now. Diarrhea has increased, constipation has gotten worse, whatever it might be. That’s when I’ll add in the eradication agent. When I talk about those cases that took three or four months, those are cases where the patient had enough patience to stick with that protocol until they got that flareup. It can be tough, I don’t lie about that because the patient is like, “Okay I’ve been doing this for a very long time, I haven’t got that flareup you told me is coming.”   Sometimes practitioners will start the eradication before that flareup. Sometimes it still works because the flareup isn’t always distinct but it can be very distinct. It’s a good hallmark so you know it’s time to start the actual eradication.

Dr. Weitz:                            For eradication agents, rifaximin we know is 10 days or 2 weeks, but what about when you use herbal agents? What length of time do you usually prescribe them for?

Dr. Khangura:                    Regardless if I prescribe pharmaceuticals or herbal agents, I’ll prescribe about two weeks’ worth at a time. Some cases I’ll do up to four weeks because we already have a history, you already had an idea that this body will take more than two weeks. I know that the patient is okay with these agents, there’s no side effects I’m worried about or anything like that. But in general I’ll break down treatments into two week chunks because the way I look at it is, if a SIBO treatment is working, actually working at a significant level, even if it doesn’t completely resolve someone’s SIBO case in two weeks, which is very common that it doesn’t, you want to still see at least moderate to good improvement with that treatment protocol you have set. I know a lot of practitioners will give a patient six weeks of the same combo of herbs and then say, “We’ll chat in six weeks.” Then they find out in six weeks that did nothing in those six weeks. It was a waste of time, also a waste of the patient’s money because if that combo was going to work, they should see some improvements within the first couple weeks. It may only be 20, 30% or it might be 80, 90% or anything in between. You want to see some improvements. I’ll still prescribe in that manner. Then go from there. But there are cases where I do prescribe for longer.

                                                When it comes to pharmaceuticals, typically it is a maximum two weeks at once. Herbs, sometimes I’ll go longer than two weeks. Rifaximin is very, very safe in general when it comes to antibiotics. If you were going to do an antibiotic for more than two weeks at a time, that would be the one that I wouldn’t be too worried about at all. It doesn’t absorb. It’s pretty much inactive in the large intestine. It doesn’t eradicate where you want to keep bacteria. But those other antibiotics, neomycin, metronidazole, amoxi/clav, trimethoprin/sulfa, all those other ones, definitely I wouldn’t prescribe more than two weeks at once. You just want to make sure you’re doing more good than harm, of course.

Dr. Weitz:                           Do you recommend specific dietary changes at the same time as the eradication process?

Dr. Khangura:                    My recommendation is not to do a strict anti-SIBO diet, not to do a strict low-FODMAP diet, biphasic diet, whatever anti-SIBO diet that the practitioner uses. Dr. Pimentel talks about this a good amount as well. It actually has to do with biofilm. If you do a very strict anti-SIBO diet, however you classify it, what can happen is the bacteria can produce potentially more biofilm because you’re not feeding them as much. They start to produce more biofilm, they start to go more dormant. There’s that research that a lot of people cite and quote about rifaximin with guar gum showing that rifaximin works better if you give guar gum with it. Essentially what the research was showing- 

Dr. Weitz:                           I think in the U.S. they call it guar gum. 

Dr. Khangura:                    Guar gum? Tomato, tomato. Basically what the research is really showing is that if you bring the bacteria out to feed by giving that gum, the rifaximin will hit the bacteria better.

Dr. Weitz:                            I think that’s the main reason why Dr. Pimentel actually recommends not restricting the diet-

Dr. Khangura:                    Exactly.

Dr. Weitz:                            … because antibiotics work by acting on the cell walls during replication. If the bacteria happily fed, they’re going to be reproducing so it will be more effective.

Dr. Khangura:                    Exactly, yep.

Dr. Weitz:                            But we don’t know that herbs are going to work the same way. In fact, we don’t think that they do.

Dr. Khangura:                    They might not but the way I look at it is there’s another reason why I don’t have patients do one of those strict anti-SIBO diets, especially if the patient has never done it before. If they come to me saying, “I’ve been doing a low-FOBMAP diet for three months straight. It helps reduce my symptoms by 50%.” Okay, we have that benchmark, we know what that diet is doing. We then know if they only get better with the antimicrobials that they are actually doing something. Whereas if a patient has never done that diet before and I’m starting them on eradication and I say, “You know what? You’re also going to do a low-FODMAP diet.” Then in two weeks they tell me they’re 50% better, at that point I don’t know how much is because they’re not feeding the bacteria or how much is because the eradication is working. Then you just have to figure that out. I’d rather not do that. The thing is, it’s not like I tell patients or Dr. Pimentel tells patients to do the opposite of the low-FODMAP diet. Just go nuts on high FODMAPs. Patients aren’t going to feel well if you do.

                                                It’s really about just having some fermentable fibers or sugars in those meals, especially the ones they take the antibiotics with or even the herbal microbials just to cover your bases, just enough that this can potentially help. If they only get better with antimicrobials and you’ve done nothing to the diet, then you know the antimicrobials are very likely the reason for that. There’s actual eradication occurring. That’s the other reason why. There’s certain things I still tell them not to do. For example, there’s that controversy over probiotics and SIBO. What I will say is it’s not black and white but what I do see is that most patients with SIBO will do worse with broad spectrum probiotics. Not always the case but-

Dr. Weitz:                          Dr. Ruscio is a huge fan of using probiotics.

Dr. Khangura:                    I know.

Dr. Weitz:                          His first line for SIBO.

Dr. Khangura:                    That’s one place I think we disagree on. Really what it comes down to is we can all have theories on it but it also is patient experience. A lot of my patients, when I ask about do probiotics make you feel better, no different, worse? This is before I even mention the word SIBO to patients, the patient might not even know what SIBO is. So many patients that have SIBO will say, “That’s interesting you say that because I’m told to take probiotics and I get worse when I take them.” Or this is the dietary thing I tell them not to do, “I’ll drink kombucha and I’ll feel horrible.” Or, “I started eating sauerkraut every day and I just felt worse, worse and worse.” They’re just probiotic foods. Those type of foods I will tell SIBO patients to actually if they are eating to limit them or completely eliminate because if taking a probiotic is actually making their SIBO worse, we’ve got to eliminate those probiotic foods at least while you’re trying to deal with the SIBO. It doesn’t mean they have to eliminate them forever but at least at that point because it’s counterproductive otherwise.

                                                Now, the reason why probiotics may make SIBO worse, it all comes down to the root cause of developing SIBO. It’s not the same for everybody but the majority of SIBO patients is because their migrating motor complex or their phase three contractions of their migrating motor complex have become weakened. Aka the sweeping action of the small intestines. If they’re putting a bunch of bacteria in through the oral route and they’re not being forced into the large intestine where they’re supposed to go and they’re just pooling in the small intestines, they’re still fermenters. They’re still gas producers. They’ve done separate studies on SIBO patients and one study quite a few years ago found that 25% of the SIBO patients had lactobacillus overgrowing. They’re still hydrogen producers. That’s the side I’m on when it comes to probiotics and SIBO.

                                                Bifido species I’m not so worried about because bifido species, they never really have been implicated in causing SIBO, like in separate studies. They don’t seem to be the species that over pools. The one theory on why that is, is that they don’t really survive well in the small intestines whereas lactobacillus species do. Of that 1% of bacteria that’s supposed to live in the small intestines, it’s supposed to mainly be lactobacillus. If they are not forced out, they can survive there. A bifido-only probiotic, which there’s now more on the market as “SIBO okay probiotics.” I don’t see as much trouble with them but with lactobacillus, with probiotic foods I do see quite a few patients have issues with them-

Dr. Weitz:                           We’ve had good luck recommending spore-based probiotics with SIBO patients.

Dr. Khangura:                    Yes, that’s another one I think I’ve seen less issues with. I don’t use a lot of the spore based probiotics with the practice but not for any real reason like that. I haven’t really included it in my practice too much but that is something I’ve seen with patients that, once again, when they mention spore-based probiotics aren’t so bad but this other probiotic is.

Dr. Weitz:                           Yeah, particular the mega spore products we’ve found to be really helpful.

Dr. Khangura:                    Mm-hmm (affirmative).

Dr. Weitz:                           Let’s get into hydrogen sulfide.

Dr. Khangura:                    Sure.

Dr. Weitz:                           So far we’ve been diagnosing hydrogen sulfide SIBO by patients who have IBS SIBO symptoms. We do the breath test and they have essentially a flat line. We see no significant increase in hydrogen or methane. Of course, now Dr. Pimentel has finally come out with the new breath test, the trio, that also includes not only methane and hydrogen but also hydrogen sulfide, which I haven’t used yet but I just got a couple kits.

Dr. Khangura:                    The flat line test results on the hydrogen methane breath test can indicate hydrogen sulfide SIBO. Not always but it can. The other thing I think that really needs to be known is something I really focused on in that lecture I gave in the summer when it came to the SIBO breath test is that, I see it’s been practiced all the time is that when someone has hydrogen sulfide SIBO, they can still have regular looking SIBO test results. Spikes of hydrogen or elevated methane and hydrogen or elevated methane causing hydrogen flat line. All these are still in the realm of possibility. If a patient has hydrogen sulfide SIBO, don’t only look for the flat lines. I think that’s where we’re going to get a lot of value out of the new trio smart test is that now a lot of practitioners are going to see, “Oh wow this patient actually does have a hydrogen spike and they have hydrogen sulfide SIBO.” If I was only looking for the flat line I would have missed the hydrogen sulfide SIBO aspect. That’s why I always teach about don’t just go based on flat lines, go based on medical history and hallmark symptoms of hydrogen sulfide SIBO.

                                                A lot of us know a couple of those hallmark symptoms. One can be chronic, very pungent, rotten egg smelling gas. Not just once in a while but it’s always there. Obviously that smell is produced by hydrogen sulfide gas. Another symptom that can happen is unexplained halitosis. Unexplained bad breath. If their hydrogen sulfide overgrowth is high enough in the small intestines, hydrogen sulfide gas will come up into the stomach, up the esophagus and cause unexplained bad breath. We know that these can be hallmarks of hydrogen sulfide SIBO because when you treat the hydrogen sulfide SIBO very specifically with specific agents, which we can get to in a few minutes, all of a sudden that bad breath starts to go away. The pungent smell goes away. You can also use that as an indicator of your treatment, even if you aren’t using the trio smart breath test.

                                                For example, here in Canada, the trio smart still is not available in Canada just yet. They’re hoping to get it available here hopefully by early mid next year. But up until that point, if you’re not using the trio smart test, looking for those couple hallmark symptoms but there are other things to look for. For example, a lot of us know that high FODMAPs or fermentable fiber foods and fermentable sugars will trigger a lot of classic SIBO symptoms. But hydrogen sulfide bacteria, I call them hypo-fermenters because they don’t just feed on fibers, they don’t just feed on sugars, they also are sulfate reducing bacteria. Foods rich in sulfur compounds will also trigger a lot of the symptoms. Of course, garlic and onions, they’re sulfur containing foods but anyone with SIBO, garlic and onions could cause symptoms. What I ask a lot of patients when I’m trying to figure out if it’s hydrogen sulfide SIBO is I’ll ask them have they ever noticed just eating eggs causes the same bloating or the same gas smell or cramping, diarrhea? Does eating just red meat do the same thing? If they haven’t tested just eating red meat, go ahead and just have a steak and tell me what happens.  It’s because the sulfur compounds in those foods may still be enough to trigger the hydrogen sulfide symptoms. Things such as that, of course the medical history stuff as well. Chronic or reoccurring UTIs, a lot of times, can stem from hydrogen sulfide dysbiosis. Most UTIs are hydrogen sulfide producing bacteria. Well water use, that definitely is an easy way to pickup hydrogen sulfide bacteria if they’re not using the UV light.

Dr. Weitz:                         Okay. What are some of the favorite treatments for hydrogen sulfide SIBO?

Dr. Khangura:                   Naturally there’s less options than we have against hydrogenic and methanogenic SIBO cases. A big reason why … Same thing with pharmaceutically although there’s some really good options in both realms. Hydrogen sulfide bacteria are notoriously resistant to a lot of different antimicrobials and antibiotics. This is why a lot of the hydrogen sulfide bacteria that live in the human gut and propagate in human gut are actually very dysbiotic bacteria. With hydrogen sulfide-

Dr. Weitz:                          Do we know what some of the most common bacteria are that produce hydrogen sulfide?

Dr. Khangura:                    Yeah. The most common ones and the ones that are most common overgrowing, unfortunately in the human gut would be dysbiotic species such as klebsiella species, klebsiella with a K, especially klebsiella pneumonia, proteus species with a P, citrobacter species with a C. Those three are ones I focus a lot on in my seminars because they don’t just cause hydrogen sulfide SIBO, these guys just overgrowing in the colon terrain where we’re supposed to have a lot of bacteria, they are very enterotoxic bacteria. They’re very much correlated with developing autoimmune conditions including Crohn’s and ulcerative colitis and even things like rheumatoid arthritis, proteus and rheumatoid arthritis go hand and hand. Ankylosing spondylitis and klebsiella go hand in hand. They can be bad for us throughout the gut. Now there are some regular bacteria that produce hydrogen sulfide. E. Coli is one. Not the food poisoning E. Coli but the regular E. Coli is a hydrogen sulfide producer. The majority of the hydrogen sulfide producers in the human gut, especially in these gut cases, are the dysbiotic species. Morganella morganii is another species, that’s a big time histamine producer as well. A lot of these histamine cases that doctors see, for some of them it’s actually stemming from the gastrointestinal tract. Obviously Morganella is not the only histamine producer but it’s a big one. That’s another dysbiotic hydrogen sulfide species.

                                                When you diagnose someone with hydrogen sulfide SIBO, just like if you diagnose them with hydrogenic SIBO and you just do it based on a breath test or just based on symptoms, obviously you don’t know exactly what species are overgrowing. Some docs will talk about running a stool test and trying to determine that but the problem with the stool test is it only tells you what’s going on in the colon terrain. It doesn’t tell you what’s going on higher up. You can maybe use the stool test to say, “Look at that. There’s heavy growth of klebsiella, heavy growths of let’s say proteus, maybe they’re overgrowing higher up as well.” But you can’t guarantee that. To treat them, to go back to that question, is that because these guys are notoriously resistant, that’s why they hang around a lot after heavy antibiotic use. That’s another history thing for practitioners to ask their patients is their antibiotic history. Did things get much worse after that?

                                                What I found that works the best when it comes to pharmaceutical antibiotics, if it’s primarily hydrogen sulfide SIBO, you only need to get rid of them in the small intestines and they’re not overgrowing in the colon, rifaximin is a pretty good option. Rifaximin does have proven activity against most of these species but what I’ve seen work even better than rifaximin from the pharmaceutical side would be amoxicillin clavulanic acid or sulfatrim, the sulfur-based antibiotic. When one of these works, it works extremely quickly. I only typically prescribe a five to seven day course of the amoxiclav or the sulfatrim because when it’s working, the patient should see significant changes in those five to seven days. If they haven’t seen much change in five to seven days, I don’t typically continue the same antibiotic. I’ll switch to something else.

                                                Now, of course, these antibiotics do come with some side effect risk and things such as that. If you want to go natural or you can’t prescribe the antibiotics, what I find works best for hydrogen sulfide SIBO naturally, I do this combination quite a bit but it’s the herb uva ursi which a lot of us know or use for UTIs. The biggest reason why it’s used for UTIs is most UTIs are caused by hydrogen sulfide producing bacteria. Uva ursi is very specific at killing hydrogen sulfide bacteria. If they’re overgrowing in the gut, it will hit them there first. I do use a very concentrated version of uva ursi. I’ll use a one to one or one to two tincture which can be tough to get. Some good herbal pharmacies do carry it but most of the times in health food stores you’ll find a one to four or one to five. 

Dr. Weitz:                            Are there products on the market that are available to practitioners that you could recommend?

Dr. Khangura:                    We typically just get the tincture from a good herbal dispenser here in Canada. There will be some good herbal tincture dispensaries and pharmacies in the States, I’m sure, that make a one to one uva ursi or a one to two. It’s easy to get a one to four, one to five like at a health food store but the patient would have to take boatloads of it to really work for hydrogen sulfide SIBO case. With a one to two, which is the one I typically use, I’ll do about three and a half to four milliliters twice a day with food. About seven to eight milliliters a day. It does contain hydroquinone, which some people worry that will affect the liver and cause liver damage. There’s always a theory that hydroquinone in uva ursi might but it’s never really been solidified. The hydroquinone in uva ursi is called arbutin and yes, I don’t prescribe an extensive amount of it. I’ll prescribe about two weeks at a time but in my opinion it’s not a big thing to worry about. But if you do the three and a half to four mils of a one to two for two weeks, unless the patient has a history of liver issues and liver disease, I don’t think there’s much of a problem.

                                                That’s one agent I use that can work very specifically for those guys. If you give someone that uva ursi and the patient is getting better, you know you’re specifically treating hydrogen sulfide bacteria. That’s really all that goes after. It doesn’t go after hydrogen or methane bacteria. Now, another product that can be used with uva ursi that can work in a lot of cases is silver agent. Old school colloidal silver is out there but the newer version of silver called silver hydrosol, which instead of the silver bound to the water molecule, the silver is part of the water molecule. The hydrosol version, about 99% is eliminated in 24 hours and about 100% is eliminated in 48 hours. It doesn’t actually pose the risk of giving the patient Blue Man syndrome like standard colloidal silver does because that one, the silver can disassociate from the water molecule in the colloidal silver version. Silver hydrosol it can’t do that. But silver is very antibacterial, as I’m sure you know. Hydrogen sulfide bacter is something it can target. A lot of times I’ll do a silver hydrosol product with uva ursi as a combo, kind of natural therapy or sometimes I’ll do one of those with other herbs because the patient has hydrogenic SIBO as well or they have methane producing SIBO as well.

                                                This is another tangent but the thing is, as well, if someone has one form of SIBO, they usually have … Let’s put it this way. A patient usually has more than one form of SIBO. Sometimes they might just have hydrogenic SIBO and very low methane and no hydrogen sulfide overgrowth. That does happen. But usually if someone’s migratory motor complex isn’t working very well, they are going to have an over pooling of bacteria across the board. Not always all three but usually two of the three. Doing a well rounded treatment, even if the patient has hydrogen sulfide SIBO, is recommended. Sometimes I’ll do a very specific hydrogen sulfide treatment first just to see what gets better first and then move on from there.

Dr. Weitz:                            Okay. Small intestinal fungal overgrowth. This is something that comes up when we have a patient with IBS SIBO type symptoms and the breath test is negative. Then we ask ourselves, “Could this person have SIFO.” How do we diagnose that? How often does that happen? What do we do about it?

Dr. Khangura:                    That’s always the million dollar question is how to diagnose SIFO or just fungal dysbiosis in general. SIFO, obviously, is just a good, obvious buzz term that’s been created because of SIBO. But it’s always been, whatever you want to call it, yeast overgrowth, candida overgrowth, fungal overgrowth. Sometimes it is isolated to the small intestines or that’s where the big problems are happening and sometimes it’s in the colon. But diagnosing it, no matter where it is, can be tough because there is no breath test to determine if someone has SIFO because the only gas those fungal species produce is carbon dioxide. We, as humans, obviously breathe out carbon dioxide. We can’t distinguish what’s from what. There are stool tests that will do yeast cultures and microscopic counts of yeast. If there is an overgrowth of the yeast, at least in the colon, that might be a decent test to diagnose at least colon yeast growth. That might mean they do have too much yeast high up in the small intestines as well. For diagnosis, put it this way, I don’t test for fungal growth as much as I test for SIBO but you can definitely look for hallmarks, again.

                                                Prevalence, I would say SIBO at least being the root cause behind someone’s “IBS” case is higher than a fungal dysbiosis being the root cause. A lot of times they happen together. Sometimes, depending on what SIBO treatment you give, it actually might make the fungal dysbiosis worse as well. You’ve got to keep in mind should I do a fungal treatment along with the SIBO treatment or just wait and see. Some hallmarks for fungal overgrowth, of course-

Dr. Weitz:                            For example, if you use the elemental diet, that tends to promote the growth of fungal because there’s sugar in it.

Dr. Khangura:                    Yeah, exactly. Another thing could be even the pharmaceutical antibiotics. Rifaximin I’m not really worried about it causing a problem because it’s not eradicating good bacteria in the large intestine where fungal growth can start to take hold is in the colon. But those other antibiotics, neomycin, potentially Metronidazole, amoxi/clav, sulfa/trim, they all could make the fungal growth worse as well. But elemental diet, yeah, you’re right. That can be a problem as well. There are some keto versions of the elemental diet out there now, without the glucose, which tastes even worse than the standard elemental diet. Most patients don’t go for it anyway. Basically looking for certain hallmarks as well. What I see in practice at least, maybe you see the same thing, is that when someone has a chronic gastrointestinal fungal issue is that it will present systemically in a lot of ways as well. Maybe it’s oral thrush but maybe a fungal scalp problems or recurrent fungal infections on the skin elsewhere. It doesn’t always have to be scalp or it doesn’t always have to be athlete’s foot. If it’s a female patient and they get recurrent vaginal yeast infections. A lot of these things can stem from a fungal dysbiosis as the root to all these systemic issues.

                                                If you have a patient with a lot of that history, consider that they might be stemming from the gut. Then asking patients specific reactions to things as well. The classic would be the sugar in alcohol because that would be the primary fuel source for the fungal species. What I’ll ask patient about sugar is not just does it cause gastrointestinal symptoms but I’ll ask questions such as, I usually just ask first, “If you eat a candy bar, does anything strange happen?” Just let them answer without me leading them. Then if I need more details I’ll ask, “Okay, if you ate that candy bar, would you feel like you almost had a drink or two an hour later? Almost like that buzzed feeling? Or maybe not the buzzed feeling but you feel like you’re getting a little bit of a hungover feeling a few hours later or even the next morning?” Same thing with alcohol. I would ask, “Are you very sensitive to alcohol? Do you have one drink and feel like you had two or three? Or is it that you only have one drink but the next day you feel like you had two or three? Or even more?”

                                                The big reason for those questions isn’t just that they use it as a fuel source, is that especially candida species, they’re probably most harmful metabolite is acetaldehyde. Acetaldehyde is caused by a neurotoxic and it’s also a carcinogenic. Heavy production of it over years is not very good for us. But that metabolite from fungal species definitely can cause things like brain fog, that hung over feeling, nausea, tachycardia, increased heart rate. If patients are getting those kind of strange reactions when they have high amounts of sugar or alcohol, I’ll definitely start to suspect fungal growth and possibly include a fungal treatment.

Dr. Weitz:                            What’s your favorite fungal treatments?

Dr. Khangura:                    Once again, break it down to pharmaceutical and natural because there’s obviously pros and cons. One of the pharmaceutical agents that I do use is high dose nystatin. I’ll get it, at least here in Canada, we can’t get it in capsules anymore, it only comes in liquid with things like parabens in it and all that. I don’t prescribe that version of it. I get a compound into capsules. I do about three million units a day. One million units three times a day. You can go up to five million units a day but the higher you go, the higher chance of gastrointestinal symptoms. That’s one reason why I go with it is that it’s not really a dangerous medication by any means. It’s nonabsorbable. If it’s going to give side effects it’s usually gastrointestinal side effects. At three million units a day, most patients tolerate it just fine. Because it’s nonabsorbable, it can target the fungal species throughout the GI tract, small intestines and large intestine. You don’t have to worry about it being absorbed before it hits, let’s say colon growths. It’s very effective. Nystatin, it’s old school it’s been around for years but it is still very effective at killing most candida species by disrupting their cell membranes. I do use that one quite often.

                                                I don’t prescribe Fluconazole or other azole antifungals that often. In some cases they are the magic bullet but they do come with a higher list of potential side effects, some more contraindications with other medications which could be dangerous depending which medication the patient is on. Short term use, they’re not that bad but I know of docs that will do two, three, four, five, six weeks of it. It’s still a pretty moderate dose but then you’re running into potential problems. I do find good success with nystatin pharmaceutically. I’ll typically start with that. But naturally there’s some very good options as well. They’re all pretty much fatty acids. A lot of them coconut oil derived but not all of them. Obviously a lot of people know about caprylic acid. Caprylic acid and capric acid from coconut oil are definitely very good antifungals. Those acids don’t only disrupt the cell membrane of the yeast, they also inhibit the hi-fi formation of the yeast. Candida species are polymorphic. They can go from a dormant, uni-cellular form to a multi-cellular form. It’s the multi-cellular form that’s the problem. They can even produce hi-fi, these little legs that come off the cell body to be more invasive. Caprylic acid and capric acid can actually inhibit that. It can also arrest the cell cycle of candida when they replicate. It doesn’t just kill the candida, it can actually inhibit the replication efficacy.

                                                Getting that from pure MCT oil is an option. You can get higher doses much easier. The benefit of doing a caprylic acid supplement like a magnesium caprylate or a calcium caprylate is that when they combine it with the mineral, it will get further down the GI tract. If you are worried about that, just the pure MCT oil version of it, which is easy to get the high dose, it may absorb too quick. That’s the one issue. Then there’s another fatty acid from coconut oil which gets not as much attention-

Dr. Weitz:                           By the way, what’s the dosage you use for caprylic acid?

Dr. Khangura:                    If I was doing … Ideally if you’re doing an MCT oil, I’d go up to three grams two to three times a day, up to.

Dr. Weitz:                           Okay.

Dr. Khangura:                    One to three grams, two to three times a day of pure MCT oil. Some patients don’t do well with high amounts of fat for various reasons. You’ve got to be careful with that. But when it comes to the caprylic acid supplements, the ones that can get a little bit further down, I typically don’t do up to three grams three times a day. I’ll do maybe a gram, 1,000 milligrams three times a day. If that’s a pure caprylic acid supplement or it’s one that has other ingredients in it, they might be taking a bunch of pills compared to eating the oil. But up to tolerance, too. If they can go a little bit higher in the fatty acids not causing any sort of strateria or nausea or anything like that, I’ll push it a little bit, especially if they’re getting better.

                                           The other fatty acid from coconut oil, lauric acid, monolaurin is the supplement version of it. I’m a huge fan of monolaurin. There’s a product at least here in Canada that’s available called Lauricidin. It’s monolaurin in a little tub. Monolaurin comes in this little soft, white pellets and it comes with a scoop. You put a scoop of it in your mouth, you swallow it with water. You don’t chew them or anything like that. It will taste like soap. Make sure to tell your patients not to do that. But monolaurin is very, very antifungal, well proven like caprylic acid. It also inhibits the actual replication efficacy of candida species. The bonus of monolaurin, which caprylic acid doesn’t have, is that monolaurin has also been shown to be very effective against gram positive bacteria. It’s not very effective against gram negative. The problem with SIBO is most SIBO cases have gram negative bacteria overgrowing. In some SIBO cases, if it is gram positive bacteria, monolaurin might actually help. It might cross that threshold and an antiviral as well. Monolaurin, for viruses that have a lipid membrane, monolaurin does have antiviral capabilities against that as well.

Dr. Weitz:                           A number of the antimicrobial herbs like [inaudible 00:58:13] and oregano are known to have antifungal properties as well.

Dr. Khangura:                    Yes, that’s exactly it. There are some herbs, too, that can cross over from the SIBO side of things to fungal. A lot of times when you’re prescribing a patient high dose herbs for their SIBO, you’re actually treating maybe a fungal growth that’s there as well and you don’t even know it. But the patient is getting better. That is true. Allicin extract, [inaudible 00:58:36] is a really good antifungal herb and can work in some SIBO cases as well. When you’re talking specific for fungal, these fatty acids are really where it’s at. There’s another fatty acid from castor oil called 10-undecylenic acid. This has been around for decades. It was one of the original over the counter creams back in the 70s has 10-undecylenic in it. It’s still, to this day, extremely antifungal. It’s just gone to the wayside of popularity. You can still get it in supplement form. Thorn still makes it. They have a funny name for the product but it’s called Formula SF722. That’s their 10-undecylenic formula. It comes in little soft gels. You’ve got to take a high dose of it, four soft gels three times a day is what I would dose it at. But 10-undecylenic acid, it can directly kill the yeast but what it’s really, really good at is inhibiting the yeast from replicating, inhibiting the yeast from wanting to multiply. When you treat fungal species with-

Dr. Weitz:                          Castor oil is pretty toxic, right?

Dr. Khangura:                    Yeah, no don’t drink castor oil. Let’s make it clear on that. This is a fatty acid from castor oil. This is totally safe to take internally. Don’t drink castor oil, everyone.

Dr. Weitz:                          Isn’t that where they get ricin from, I think?

Dr. Khangura:                    Yeah. Is it from castor beans? I don’t know. [crosstalk 01:00:05] I think so. Something like that. Don’t drink castor oil but the supplement 10-undecylenic acid, that’s okay to take. It is very, very effective at inhibiting yeast from being opportunistic. That is a big difference between treating fungal overgrowth and SIBO is that yes, some of the bacteria overgrowth in SIBO could be opportunistic, especially some of those hydrogen sulfide dysbiotic bacteria but the majority of bacteria overgrowing in a SIBO case are not opportunistic. Fungal species are totally different. These candida species are very opportunistic. They wait for a chance to replicate and take over. One thing they can do, when you come at them with artillery and I see this mistake in a lot of practitioners is they’ll just throw a bunch of nystatin at it or a bunch of whatever, caprylic acid at it. The problem is, the candida, when you do that, if they’re already in a stronghold, they can start to multiply faster in the presence of you trying to him them with artillery.

                                          What I like to do with a lot of these yeast cases, I’ll put them on things like a 10-undecylenic or the one reason why I use the monolaurin as well or even caprylic acid is a lot of these natural agents don’t just kill the yeast, they inhibit their ability to be opportunistic. They inhibit their ability to replicate quickly. If you come at them with that aspect, you’re probably going to have more success. Even though I do prescribe nystatin very often, I’ll typically still give 10-undecylenic acid with it or monolaurin with it so we can hit it from multiple viewpoints.

Dr. Weitz:                          Cool. This has been a great discussion Dr. Khangura. Any final thoughts? How can practitioners and listeners and viewers get ahold of you? You have a great course for practitioners available.

Dr. Khangura:                   Like you mentioned at the beginning of the chat, I’m up in Victoria, B.C., Canada. Because I’m doing a lot more stuff in the States I’ve been having a lot of U.S. patients wanting to book. Unfortunately I can’t take any U.S. patients. I still have to keep that to Canadian patients but for any U.S. practitioners that are looking for either the comprehensive course in SIBO and dysbiosis in general, my latest course is called Beyond Superseding SIBO. I’ve had a series of them over the years and my latest one is still up for registration. The website is SupersedingSIBO.CA. Seding is S-E-D-I-N-G, not two E’s. It’s about a six hour course, very comprehensive on SIBO and other dysbiosis including some fungal. Next year I’m hoping by spring 2021 I will have an updated version of this course with more specifics on certain areas. Obviously as time goes by there’s more to learn about and more to teach about. This will be my most comprehensive course at this point.

                                          Otherwise, any closing comments, the one thing I like to mention is that I understand where a lot of practitioners are coming from, is that SIBO seems almost like a fad diagnosis in the last few years. A lot of practitioners are starting to scoff at it because of that saying that it’s the new thing, it’s the new flavor for diagnosis of IBS and all that. The one thing I will tell practitioners that maybe think that’s true is that give it a chance with your patients because if you have not gone down the road with SIBO with most of your “IBS” patients and your looking at your practice and wondering why just cutting out wheat hasn’t helped them, just cutting out dairy hasn’t helped them. Giving them a healthier, more fibrous diet has made them worse but you don’t have any answers for it. Definitely start looking into SIBO specifically as the diagnosis. It’s not an end all, be all by any means for a lot of patients, it’s just part of the problem. I talked to Dr. Ruscio about practitioners really need to be careful not getting into SIBO tunnel vision, once you get that SIBO diagnosis a lot of us just look at that and be like, “We’ve got to tackle this, we’ve got to tackle this.” You’re missing something else.

                                                But for the practitioners out there that don’t even consider SIBO, I really do recommend starting to look into it more because for a lot of patients it really is the very, very specific root cause. We talked about the stubborn cases but some cases will resolve in two to four weeks. We’re talking 10, 20 years of IBS, gone in two to four weeks of treatment. If that’s what the patient needs, that’s what they need. Really, just putting it all together. That’s the way I look at it. That’s what all of us, integrative and functional, whether naturopathic doctors or medical doctors need to do is put it all together from all angles.

Dr. Weitz:                           Excellent, excellent. Thank you.

Dr. Khangura:                    No problem at all.

 

Dr. Julie Greenberg discusses an Integrative Approach to Dermatology with Dr. Ben Weitz.

[If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on YouTube at https://www.youtube.com/user/weitzchiro/]

 

Podcast Highlights

1:26  Conventional Dermatology approaches skin problems as if they totally separate from the rest of the body, but the functional medicine or naturopathic or integrative approach looks at the whole person. This is why the conventional dermatology world is having so much trouble with chronic dermatological conditions like acne, eczema, psoriasis, and rosacea.  Many patients with eczema will be prescribed a steroid, which reduces the symptoms, but once they stop the steroid, the condition tends to come back and then they go back and get more steroid like hamster on a wheel.  We treat the skin condition from the outside in and merely suppress the symptoms. We need to understand that the skin is a reflection of what’s going on inside the rest of the body.  The source of many skin conditions is coming from the gut and what’s going on inside the body.  If we take a Functional Medicine/Integrative approach, we search for the root causes and treat your skin condition from the inside out. Of course, we can also do some topical treatments to help with the symptoms, while we are treating the underlying causes of the inflammation.

4:43  Eczema.  There is much discussion about the microbiome in the digestive tract, but the skin has its own microbiome. Let’s take eczema, we often see the pathogen, staph aureus present on the skin in large amounts. When it is present in the skin, it is usually also overgrown in the GI tract and it often colonizes the nose, so we have to treat the staph not just on the skin, but also in the GI tract, and in the nose.

6:09  Leaky gut is when the intestinal mucosal layer is damaged and allows large molecules and toxins to enter the body, resulting in immune problems. But leaky gut often results in leaky skin, such as in eczema when we see that early skin barrier disruptions can lead to food allergies and asthma. Babies with skin barrier disruptions are six times more likely to develop food allergies.

9:05  Leaky skin is also a reason why you want to treat the skin topically as well as treating the gut and the other underlying, root causes of skin conditions.  With eczema, we want to keep the skin moisturized to help that skin barrier. Skin pH is very important and the skin needs to be acidic to function properly, which is from 4 to 5.5. In nearly every dermatological disease, the skin barrier has become more alkaline.  Staph aureus thrives at a pH of 7.5. This is similar for other common skin pathogens, like strep bacteria, herpes virus, malassezia, or candida, which all want a more alkaline skin pH.  There are certain supplements like L-histidine that can help with this.

11:10  Coconut oil is often touted as being good for your skin, but while it has potentially beneficial antimicrobial properties and can be beneficial to use it to spot treat skin conditions and can be blended with essential oils to kill off things like staph aureus on the skin or malassezia, coconut oil should not be used as your main moisturizer since it can dry out your skin. It is often said that coconut oil has an alkaline pH, but technically oils do not have a pH because pH is based on water. If you want to make your skin more acidic, the water-based products like aloe vera gel, apple cider vinegar, and hydrosols would be the best to use.

14:10  There is a strong gut skin connection and there is a lot of research that correlates an abnormal, dysbiotic microbiome with specific dermatological conditions, such as eczema, psoriasis, and rosacea. With most patients with skin conditions, they have something wrong with their gut, whether it be overgrowth of certain bacteria or protozoans or candida overgrowth. Rosacea is often associated with SIBO and H. pylori.  Psoriasis is often associated with pseudomonas and with streptococcus overgrowth. Acne is often associated with H. pylori. So is alopecia areata.  With eczema there is often a staph aureus component.  Dr. Greenberg likes to run the GI Map stool test and the Organic Acids Test from Great Plains Lab for patients who can afford them, since they are not covered by insurance.  The OAT test will tell if there is a candida overgrowth, that doesn’t always show up on the stool test and the OAT test can also test for fusarium and aspergillus, which would indicate a bigger mold problem. 

19:56  H. pylori. If H. pylori is found on a stool test, it is controversial whether or not it is considered a normal part of the gut (commensal) or is it pathological and should be treated?  There is also controversy about whether H. pylori is associated with hyper or hypochlorhydria.  We know that H. pylori can be present and cause problems or it can be present and not cause problems.  If you see elevated H. pylori and a bunch of virulence factors, this indicates that it is pathological. If H. pylori is present with no virulence factors but all of the dysbiotic and autoimmune trigger bacteria are high and they are low on elastase and the steatocrit is high, then H. pylori is a problem and needs to be treated.  Dr. Greenberg usually sees hypochlorhydria when she sees H. pylori and low stomach acid tends to foster the growth of staph and strep and prevotella and fusobacteria that are often associated with skin conditions.  So reducing the H. pylori is often helpful, which Dr. Greenberg likes to use Pyloricil by Orthomolecular.  She will use mastic gum and DGL and GlutaShield.

25:23  Eczema.  Eczema is also known as atopic dermatitis, which is extremely common in children.  And eczema is probably more common in adults than often recognized, though not every rash is eczema.  Eczema in children is a Th2 driven pathway, though Th1, Th17, and Th22 are immune pathways that may also be involved in eczema. Eczema is often associated with staph infection and such infants are usually deficient in filaggrin, which is a protein in the skin that is a master regulator of the skin barrier, a natural moisturizer, and it controls the pH of the skin. Filaggrin is composed of several amino acids, including L-glutamine and L-histidine.  If you give 4 gms of L-histidine per day to adults for one to three months, this improves the skin barrier and reduces staph bacteria equal to the effectiveness of a topical steroid.  For Children she will use Clark’s rule for dosing and then only for 2-3 months and then ramp down.  Here is a study showing effectiveness of L-histidine in eczema:  Feeding filaggrin: effects of l-histidine supplementation in atopic dermatitis. 

29:47  Topically, it is important to reacidify the skin, since staph bacteria love an alkaline pH.  Apple cider vinegar diluted 50/50 with warm water applied to the skin is a way to make the skin more acidic. Hydrosols, which are the water based product that results from making essential oils, can also be helpful in acidifying when applied to the skin.  Making sure your skin is kept acidic will not only help with reducing eczema, but our skin will age slower and you will have less wrinkles and dark spots.  Dr. Greenberg recommends using aloe vera gel, rosemary hydrosol, and a serum blend that she makes every day to try to keep the wrinkles away. 

There are a number of foods that can be triggers to eczema, including dairy. If you see an infant with bad eczema and cradle cap, then you most likely have an overgrowth of candida in their gut, because cradle cap is a yeast on the scalp called malassezia.  The malassezia eats our sebum and overgrows. As they produce antibodies against the candida, then there is often cross reactivity with the malassezia yeast.  Drinking milk (cow, goat or any mammalian milk) seems to make these infants worse.  They would do better with plant based formulas, according to Dr. Greenberg.

35:40  Low vitamin D is a risk factor for eczema and Dr. Greenberg said that she will add vitamin D for nearly every patient, except for those with rosacea, who have an antimicrobial peptide on their skin called cathelicidin, which gets exacerbated by vitamin D.

36:32  There is a topical vitamin B12 pink cream that you can get compounded in the pharmacy that helps a bit with inflammation that is fairly popular, but this is really a symptomatic treatment and Dr. Greenberg doesn’t use it that much.

37:26  Psoriasis.  We used to think of psoriasis as mostly a Th1 mediated inflammatory disease, but then we discovered Th17 and Th22 as other pathways tied in with mucosal inflammation.  There’s an herb scutellaria baicalensis, which is Chinese skullcap. Research study after research study, it has been shown to decrease Th17 and IL-17 and increase Treg and IL-10.  Psoriasis is an inflammatory system condition that is a response to a massive overgrowth of bacteria, like strep. Pseudomonas can also be a driver for psoriasis. When the psoriatic plaques are tested, we find DNA of gut microbial origin. There is often a compromised skin barrier. On top of the primary infection, such as of strep, there is often also a secondary infection with staph or malassezia or candida yeast. With psoriasis we have to treat the strep in the tonsils and the gut as well as the skin.  For older kids and adults she will use nasal sprays, including colloidal silver, propolis, a saline spray with an essential oil blend. Dr. Greenberg’s go to product is an ACS nasal spray with colloidal silver with echinacea and some herbs. For the strep she likes the Biocidin throat spray.  Bile can also be helpful, so Dr. Greenberg will often use a digestive enzyme formula that included hydrochloric acid and ox bile, like DuoZyme by Karuna or Panplex 2 by Integrative Therapeutics. Herbal bitters can also be used, esp. in kids, who can’t swallow capsules.  There is a topical vitamin D that some practitioners use for psoriasis, but Dr. Greenberg feels that it is not addressing the root cause.  Psoriatic skin pH is alkaline, so using topicals to acidify the skin is beneficial, so she will recommend topical emollients made with indigo naturalis, which is an herb that has been studied with psoriasis and it has been shown to decrease IL-17.  However, this product will have a blue color, so it can stain clothes and sheets.

49:34  Dr. Greenberg does not like skin creams that combine oils with water based products mixed together, since they require a chemical called an emulsifier such as parabens or other endocrine disruptors and a preservative. Plus, a lot of oils in lotions are mineral-based or petroleum-based, which are not good for the skin either.  It is much healthier to have the oil and the water based products in separate bottles and apply these products on the skin separately without emulsifiers and preservatives. 

 

 



Dr. Julie Greenberg is a Naturopathic Doctor who specializes in Integrative Dermatology. She is the founder of the Center for Integrative Dermatology in Santa Monica, California, a holistic clinic that approaches skin problems by finding and treating the root cause. Dr. Greenberg holds degrees from Northwestern University, Stanford University, and Bastyr University. She lectures at naturopathic medical schools and speaks at conferences across the US on dermatology. Her website is IntegrativeDermatologyCenter.com.

Dr. Ben Weitz is available for nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also specializing in Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure and also weight loss, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111 or go to www.drweitz.com.



 

Podcast Transcript

Dr. Weitz:                            Hey, this is Dr. Ben Weitz, host of the Rational Wellness Podcast. I talk to the leading health and nutrition experts and researchers in the field to bring you the latest in cutting edge health information. Subscribe to the Rational Wellness Podcast for weekly updates. And to learn more, check out my website, drweitz.com. Thanks for joining me and let’s jump into the podcast.  Hello, Rational Wellness Podcasters. Thank you so much for joining me again.

Today, we have a fascinating topic, which is integrative dermatology with Dr. Julie Greenberg. We’ll look at a general approach for a naturopathic or integrative approach to dermatology, and we’ll also dial down a little bit on two of the more common and troubling conditions, which are eczema and psoriasis. Dr. Julie Greenberg is a licensed naturopathic doctor who specializes in integrative dermatology.   She’s the founder for the Center for Integrative Dermatology, a holistic clinic that approaches skin problems by finding and treating the root cause. Dr. Greenberg holds degrees from Northwestern University, Stanford, and Bastyr University. Dr. Greenberg, thank you so much for joining us today.

Dr. Greenberg:                 Thanks, Ben. I’m happy to be here.

Dr. Weitz:                         Absolutely. Conventional dermatology approaches skin problems as if they are totally separate from the rest of the body, but the functional medicine or naturopathic or integrative approach looks at the whole person. Can you talk about how your integrative naturopathic approach is different?

Dr. Greenberg:                 Yeah. I think it’s the main point of why we’re having so much trouble in the conventional dermatological world with these chronic dermatological conditions. If you have something acute, if you have a staph infection, you can go to a dermatologist, get a prescription for antibiotics, and the staph infection like an impetigo will be cleaned up right away. But if you have something like eczema or psoriasis or acne, these long-term, rosacea, chronic skin diseases, I think patients and practitioners know that a lot of people experience kind of a hamster wheel where they go in, they get maybe like a steroid for eczema.   The eczema goes down. Then they stop the steroid. The eczema comes back. They have to go back, get more steroid, and you kind of get on this hamster wheel where you have to use more and more topical things and then they’re not working. The reason is because a lot of what we’ve done conventionally is to approach the skin like, oh, it’s happening on the skin, so we’re going to do it from the outside in, and we’re just going to suppress symptoms.

                                                But in the functional medicine and the naturopathic medicine world, we know the patient sitting in front of you is one human, one body, all systems are connected, mind, body, and spirit, and everything affects the other. When it comes to these chronic dermatological conditions, there are so much evidence now that the inflammation that’s happening that’s causing the things to appear on the skin, they’re not happening topically at the skin. I mean, we see them, that’s where the end game is, but the source is actually coming from inside, much of it from the gut.   Therefore, we are not going to successful treat patients and get to the root cause just by coming at it from the outside in and trying to suppress symptoms. We have to take this functional medicine, naturopathic medicine, whole person approach and connect the systems and address it at every level.

Dr. Weitz:                         The skin is really a reflection of what’s going on inside the rest of the body.

Dr. Greenberg:                 Absolutely, and that’s what I tell patients. I think a lot of patients feel that their body has turned on them, like, why is this happening? Why do I have acne or rosacea? Why is my body doing this to me? I try to reframe it for them like, look, your body is always on your side. It’s always trying to do the best for you that it can. And when we see these kinds of skin presentations, whether it’s in an infant having just terrible eczema, I’ve seen 90% of babies covered in crusting bloody lesions or adults who have this chronic nodulous cystic acne, it’s not because your body has turned on you, it’s that it is telling you that it has a problem inside it cannot resolve, and it needs help.  And we’re going to get in there and help it. And that’s all it is, it’s just a signal to your body, to yourself like, we got big problems inside, and we can’t handle it. And that’s why this is happening.

Dr. Weitz:                         Right. And interestingly, most people don’t realize this. They know about the microbiome inside the digestive tract, but the skin has its own microbiome and that’s so important to the health of the skin. We might even consider the skin a part of the digestive system.

Dr. Greenberg:                 Yeah. I mean, for me, again, taking this everything is connected, depending on the disease, like let’s take eczema, I’m thinking about the pathogen staph aureus. It’s always basically present in eczema on the skin in too large of amounts. It’s not an infection like we would see in like an abscess or impetigo, but it’s an over colonization. It’s causing problems on the skin. It also colonizes the nose. And usually when we got tested, it’s overgrown in the GI tract. Again, there’s this concept that we can’t just pay attention to one thing.  The skin microbiome is critical, of course, to what’s happening on the skin, but we have to treat the nasal colonization or the staph will keep coming back, and we have to treat the gut colonization because if you have leaky gut, then leeching staph aureus into the bloodstream as well. It’s critical. The skin microbiome, the oral microbiome, and the gut microbiome are distinctly different. They look very different, but they are all absolutely interrelated and absolutely when it comes to dermatological disease.

Dr. Weitz:                         You mentioned leaky gut. Most of us who deal with patients with gut problems and people who do have chronic gut problems I’m sure have heard this term a lot is that leaky gut is often common at the intestinal mucosal barrier is broken down, allowing toxins and large proteins to get in, which cause immune problems, et cetera. But often people who have leaky gut often have damage to the barrier in the skin. Leaky gut often results in leaky skin.

Dr. Greenberg:                 Yeah, we see both. Anytime the skin barrier gets compromised, you’re going to get leaky skin. There’s an interesting aspect of leaky skin as it pertains to eczema, because we know that for infants and babies that early skin barrier disruptions can lead to food allergies and asthma. The same idea that we have like… I think most of your listeners know what leaky gut and that things are leaking through the intestinal lining, getting into the bloodstream and causing an immune response. The same thing can happen topically with leaky skin.  And it’s actually quite dangerous in infants because their immune system is learning what in the environment is okay and what is not. And if their first introduction to like a pollen or a food protein comes through the skin, that’s an inappropriate presentation to their immune system and they can get primed in a way that’s not good, and it can lead to food allergies and asthma. We know this not just statistically, like because babies with skin barrier disruptions are six times more likely to develop food allergies. I do mean allergies, IgE, not just IgG, IgA.

                                                But they’ve done studies in mice where they’ve actually first created eczema on the backs of mice. These mice had no problem with eggs before, no antibodies. They then taped gauze filled with ovalbumin or egg white protein in cycles to their backs, and they created IgE and IgG antibodies and full blown egg allergies in these mice where they never had them before. We know what happens because of the numbers, but they can actually be created in the lab. You give the mouse eczema and then you can induce a full blown food allergy.  The leaky skin is a huge issue. And it’s something, particularly in my eczema babies, I talk to parents about we really want to try to clean up the skin barrier as quickly as possible. Because for them, it’s a whole different issue than somebody who’s an adult who has skin barrier disruptions.

Dr. Weitz:                         Of course, it’s also a reason why you want to use some topical treatment to treat the skin, as well as treating the inside underlying root causes of the skin condition.

Dr. Greenberg:                 Yeah, absolutely. I mean, we know with eczema, we want to keep the skin moisturized. We want to try to help that barrier. I focus a lot on skin pH.  I think we know the stomach is supposed to be very acidic. The blood is very tightly regulated at 7.4. If the blood pH gets much off of 7.4, we can die. But people don’t realize that the skin has its own pH that’s absolutely critical.  I ask every patient… Now that I’m doing telemedicine, we do a screen share and there’s a slide on pH.   We go through the scale, what’s acidic, what’s alkaline, and I have them just guess, where do you think the skin pH to be? And I think just to feel safe, most of my patients guess seven, like neutral, water, blood, which is a reasonable guess. But the truth is, it’s acidic. The skin needs to be acidic to function properly, which is about anywhere from 4 to 5, 5.5. I definitely do things to help bring that skin pH back down again to protect it. Because we know that in basically every dermatological disease, the skin barrier has become more alkaline.   It’s not at four to five. It’s up higher at six or seven. And that leads you susceptible to pathogens. Staph aureus, for example, it wants 7.5. But if you name any pathogen, whether it’s like a herpes virus, malassezia, or candida yeast or bacteria, all of those pathogens want a more alkaline skin environment so that it can thrive and so that our natural defenses can’t attack it.  If we can do things topically to pull that skin pH back down and internally, there are supplements I use like L-histidine to do that, we can definitely improve the skin barrier and start to see improvements on whatever the skin disease is.

Dr. Weitz:                            Yeah, I find that interesting. Same thing for the importance of hydrochloric acid to help keep the bacteria from overgrowing in the small intestine. I think there’s been this over emphasis in health enthusiasts about having an alkaline system, about being acidic is bad, being acidic causes disease, causes cancer, causes all this stuff, so the answer is to drink alkaline water and to eat this alkaline diet. There’s a lot of problems with that, and especially when it comes to the skin, trying to alkalinize your skin. I talked to Jennifer Fugo about… She’s a big opponent to using coconut oil on the skin, which a lot of people feel is good, but it’s very alkalinizing, and so it ruins the acidic pH of the skin.

Dr. Greenberg:                 Jen and I have had discussions about coconut oil. I know she’s not a fan. I’m not a fan of people using stripped coconut oil day after day as their moisturizer, because it can dry out the skin. I mean, the things that I do to make the skin more acidic, they’re more of the water-based products, things like aloe vera gel, apple cider vinegar, hydrosols. All the water-based products have this acidic pH. Technically an oil doesn’t have a pH, because the pH scale is based on water and stripped oils don’t have it.  It gets a little more complicated when we’re talking about something like coconut oil. I use coconut oil to spot treat topical skin problems, but I only use it to spot treat, and I only use it when we do essential oil blends to kill off things like staph aureus on the skin or malassezia or something like that. I do think it gets overused, and I don’t like people to use it as a general moisturizer.

Dr. Weitz:                         But for therapeutic purposes, coconut oil has this antimicrobial benefit, right?

Dr. Greenberg:                 It does, and there’s plenty of studies that show that use of coconut oil versus let’s say mineral oil or even olive oil in eczema patients, it’s a lot more effective at lowering staph. I do think there is a time and a place for coconut oil, but it’s not kind of the panacea that sometimes… If you look at YouTube, it’s like you can use coconut oil for everything. You can use it for a lot, but I wouldn’t it as your main moisturizer.

Dr. Weitz:                         It’s funny how Google was kind of the bane of our existence for a while. Everybody is saying, “Oh, I just Googled it.” And now everybody is coming in saying, “Oh, I just watched the YouTube video.” We’re having that with chiropractic. “Aren’t you going to do that adjustment? What about the one where you pull the towel and pull on my head? I saw that on YouTube. That fixed everything.” It’s kind of interesting.  In terms of dermatological conditions, we were talking a little bit about the gut bacteria, and I know that you find it super important to look at the gut as a way to analyze what’s going on underneath. Why is gut health so important?  And then what test do you like to do to analyze gut health for patients with skin conditions?

Dr. Greenberg:                 For me, it really is critical to look at the gut so that I can get to the root cause of what’s driving the skin disease. There is a lot of research out there. It’s not pulled together into a cohesive body. But once you start going looking for it, you can do research for each different type of dermatological disease like eczema, psoriasis, rosacea, on and on. And you will find studies and research that show that the gut of patients with chronic dermatological disease is not the same as normal healthy controls. They have too little good gut bacteria, too much bad bacteria.  Often they have candida overgrowth or other problems like protozoa. I think as integrative practitioners, it actually makes sense. 80% of our immune system is coming from the gut. And obviously when it’s disrupted, we get all sorts of problems. It can lead to diabetes. It can lead to heart problems. Just the inflammation through the system is going to cause problems. Now, specifically why certain people are going to get psoriasis versus rosacea, we haven’t really untangled that. We know that there are some element of genetic components to that.   But the important thing is I know when my patient is sitting in front of me, something is wrong with their gut, even with acne. It doesn’t matter what they’re presenting with. Something is wrong with the gut. I need to get in there and try to figure out what it is. For different conditions, I kind of have different suspects at the top of mind. For rosacea, for example, there’s a lot of research that shoes SIBO and H. pylori are at play. Now, that’s now 100%, so I still have to go test them and figure out what exactly is going wrong.

                                                I have two tests that I like to run on every patient who can afford it, because of course, unfortunately, they usually aren’t covered by insurance. One is the stool test. I want to look at what is in the colon, what are the strains of good bacteria, what are the strains of bad bacteria, how many of each, where is the problem. Is it an enormous pseudomonas overgrowth? I see a lot of psoriasis and psoriatic related diseases, there’s a lot of pseudomonas overgrowth that tends to trigger it. It’s high in LPS or endotoxins. With acne, there’s a lot of correlation to H. pylori.  With eczema, of course, there’s a big staph aureus component. With psoriasis, there’s a big strep component. Strep is the number one environmental trigger that we know that can cause psoriasis. I use the stool test and also for their digestive health. To your point, the stool test I use has H. pylori. I have to know what’s the H. pylori situation in their stomach and is their stomach acidic enough.   Because if it’s not acidic enough, then I’m going to see overgrowth of all the commensals, overgrowth of all the dysbiotic and autoimmune ones, and I have to treat the H. pylori since it’s at the top of the stream. If I just go in and treat the overgrowth, but I haven’t corrected the H. pylori and stomach acid problem, we’re going to have this problem and this discussion in a month, and we’re going to keep having it. That’s really critical. And then the other test that I like is an OAT or an organic acids test, which is a urine test.  That one I use because the stool test don’t always pick up candida, because candida tends to overgrow in the small intestine. There’s plenty of times when it won’t come out in the stool test, but it does come out on the OAT. And also the OAT that I use test for fusarium and aspergillus. I need to know not only is there a yeast or a candida problem, is there a bigger mold problem, and then that might lead us to look at mycotoxins.

Dr. Weitz:                         Which OAT test do you like?

Dr. Greenberg:                 I personally like Great Plains OAT and I use the GI-MAP, which I know you’ve had them on. I work with them. That’s the stool test that I prefer. It’s the one that I just find most actionable. Together, I love both of those tests. Once I get those labs back, it’s like suddenly this curtain opens and everything is revealed and I see why exactly what’s happening on their skin is happening. We just go in and we start to address the things one by one, because it’s usually multiple things happening.  Certain diseases like once we get to alopecia areata and we’re attacking hair follicles and it’s full blown autoimmune, I usually see that there is a huge amount of gut dysbiosis that needs to be addressed and usually also a toxic element that needs to be addressed. But I can always start with those two gut tests and start to see great improvement usually within the first month. We come back for our visit and it’s like, yeah, things are definitely getting better. Much better. Baby is sleeping through the night. The rash is gone X percent.  Sometimes it’s just gone, but I have to tell them, we still have to treat all the stuff or it’s going to come back. Patients are usually just thrilled with it. They finally have answers. They finally are getting solutions, and they’re off of this kind of hamster wheel of convention medicine where it’s like, well, I didn’t know what else to use on my baby besides steroids, so that’s what we were using. But I knew it wasn’t right and that’s why I was looking for something else. It’s really fulfilling.

Dr. Weitz:                         You mentioned H. pylori. I know I probably should stay on topic and not jump down a rabbit hole, but I love rabbit holes. Recently I’ve had a number of discussions with different practitioners and there’s a lot of controversy about H. pylori. Should we even treat H. pylori? H. pylori is a commensal. I know Dr. Steven Sandberg-Lewis said for the most part, you usually don’t want to treat H. pylori. It’s a commensal. Other gut experts have said absolutely, it’s crucial. Some people feel that only if there’s certain virulence factor should the H. pylori really be treated.  There’s controversy about whether H. pylori is associated with hyper or hypochlorhydria.  I don’t want to spend too much time on it, but maybe you could just give your take on H. pylori.

Dr. Greenberg:                 Yeah, no, it’s a good point, and I have that issue with H. pylori and then with some of the protozoa, right?

Dr. Weitz:                         Yes. Yes. Right. That whole discussion.

Dr. Greenberg:                 I know. It’s kind of a similar issue, but I’ll stick with the H. pylori for now. Yeah, for me, it definitely depends. I don’t think we fully unraveled the H. pylori story. We know that it can be present and not cause problems and it can cause problems. For me, that’s part of why I’m looking at the stool test in whole. I want to see how much H. pylori is present. I want to see if there’s virulence factors. And then as I start to look down the stool test, that’s where I start to see, is there overgrowth of the normal bacteria? Is there overgrowth of the dysbiotic and potential autoimmune bacteria?

                                                Let’s say I see H. pylori in moderate amounts with no virulence factors, but then the stool test just starts lighting up. All of the normal bacteria are high. All of the dysbiotic and autoimmune are high. Then when I get to the intestinal health section, they’re maybe low on elastase and the steatocrit is high. I know they’re not digesting their food property. Then absolutely for me H. pylori is a problem and I need to treat it.   If the H. pylori is moderately low, the normal is not overgrown, and there’s not a lot of huge overgrowth of the other dysbiotic bacteria and the elastase is good, and they’re digesting their fat, then I probably won’t choose to go after H. Pylori, or I’ll kind of put it in the back of… If I think H. pylori is a problem, it’s one of the first things I go after, because, as we talked about, it’s upstream. But if it’s on the fence and I’m like, well, I’m not entirely sure, I might start with other things. And if I’m not getting the response that I need, then I might add like digestive enzymes.   See did that make a difference? Did adding a little hydrochloric acid help things? And then maybe I will go back and go after the H. pylori. But it is definitely on my radar and I don’t think it’s an innocent bystander. In older patients, we know that already the stomach acid is not as acidic. Is it a 74 year old patient with alopecia areata with H. pylori? Now I’m getting more concerned about that H. pylori than I would in a 21 year old.

Dr. Weitz:                         Because you’re thinking one of the issue is H. pylori tends to be associated with hypo, low hydrochloric acid secretion.

Dr. Greenberg:                 Yes.

Dr. Weitz:                         Even though we first learned about H. pylori as a cause of ulcer from hyperchlorhydria.

Dr. Greenberg:                 Yeah, but I have to say that for me, for the derm stuff that I deal with, really almost 100% of the time the H. pylori is causing hypochlorhydria. The stomach acid is too low. I look for specific strains of oral bacteria that are high. Staph and strep, prevotella and fusobacteria are usually coming from skin and oral. And if those are overgrown, I know they’re not dying in the stomach acid. So yeah, for me, it is so rare that I’m concerned with hyperchlorhydria. It’s almost always hypochlorhydria.

Dr. Weitz:                         What’s your favorite strategy for reducing H. pylori?

Dr. Greenberg:                 I like Pyloricil by Ortho Molecular. I’ll use mastic gum and DGL and GlutaShield and stuff like that. That’s how I tend to go after it. I’m licensed in California, Oregon, and Washington. And with our fun naturopathic licensing by state, I have different scope of practice. In Oregon and Washington, I can prescribe just about anything because it’s physician level. But in California, we’re doctor level. I mostly turn to herbals first unless there’s a skin infection and you need an antibiotic or something, but I tend to mostly use herbs to treat the gut dysbiosis in all states.

Dr. Weitz:                         Have you prescribed mastic gum for kids?

Dr. Greenberg:                 Yeah, mastic gum and DGL. Just kind of using Clark’s rule. They’re pretty safe. It’s helpful. Usually they taste pretty good, and so they’ll take it.

Dr. Weitz:                         Oh really? The mastic gum?

Dr. Greenberg:                 The DGL. Not the mastic gum, but the DGL.

Dr. Weitz:                         Oh okay. The mastic gum has a nasty smell too.

Dr. Greenberg:                 Yeah. I mean, there’s other stuff I use. I use butyric acid on kids, which smells kind of poopy too. A lot of the stuff I feel like you have to hide in other things.

Dr. Weitz:                         Right. Okay. Let’s drill down a little bit on eczema, which we’ve just been talking about kids. And eczema is also known as atopic dermatitis. This is extremely common in children. I have a feeling it maybe more common in adults than commonly recognized.

Dr. Greenberg:                 It’s a little hard in adults. I think a rash is like… Whenever we see a rash, we call it eczema, right? In my mind, there’s like the infant eczema that’s true eczema, that’s this Th2 driven pathway. There’s other immune pathways in eczema that we know like Th1, Th17, Th22, but it’s a heavy Th2 driven pathway. When an adult comes to me and they’re now having rashes for the first time, for me, that’s not eczema. Usually that’s being driven by something else. It can be yeast overgrowth or bacterial overgrowth, but it’s not classic eczema as I think about it.   It’s more of a dermatitis. But in the kids and the babies who come to me, that’s eczema.

Dr. Weitz:                         You mentioned that it’s often associated with staph infection.

Dr. Greenberg:                 Yeah. And I think infection confuses people. It is an infection, but it’s easier for people to understand if we say colonization. The staph will get on the skin. What happens in a lot of these babies is they’re deficient in something called filaggrin. Now, I feel like most of us as doctors haven’t heard of filaggrin, but it’s really important. It’s a protein in the skin and we call it the master regulator of the skin barrier. Filaggrin is something that we use then to create a natural moisturizing factor. We breakdown the filaggrin into its amino acids.  It’s very high in L-glutamine and L-histidine, and then we create acids out of it, and we build natural moisturizing factor. That natural moisturizing factor controls the pH of our skin, which we talked about is so critical. It really is the critical thing to whether or not you have healthy skin, because it keeps the moisture in. If you dry out the stratum corneum, like 20 to 30% of it should be natural moisturizing factor. This is a big deal in the skin.

                                                And a lot of kids have filaggrin gene mutations where they’re not just producing enough filaggrin, and therefore not producing enough natural moisturizing factor. That’s something that needs to be addressed, especially in kind of the early days for them, to try to help them with the skin barrier. The interesting thing is I think we think of skin barrier, well, let’s put something on it, which is true. We know that putting emollients and moisturizers on babies with eczema is helpful.   But there is a very interesting amino acid called L-histidine, which filaggrin used to be called histidine-rich protein, because it was so abundant in it. There’s good evidence, there’s this good study on humans that show that dosing four grams a day in adults for one to three months really improved their skin barrier. They had reductions in their eczema about 30%. The effect was the same as about a mid-potency topical steroid, but with no negative side effects. I use L-histidine widely in everybody from my infant to my adult patients.   Because the nasty thing about staph is there’s 11 different ways that we know of that it attacks the skin and creates just a horrible situation for the person, but a great situation for staph. It is able to more easily kill filaggrin-deficient cells. We need to build up that filaggrin in anybody who’s got staph colonization on their skin and that protects them from the inside out. And then, of course, we’re also doing things topically to address the staph overgrowth. And nasally, as I said. We have to address the colonization in the nose or it just keeps coming back.

Dr. Weitz:                         Give us some specific treatments for staph.

Dr. Greenberg:                 For adults, I use the four grams a day of L-histidine. And then for infants or smaller people, I use Clark’s dosing. I usually keep them on a full dose for like two to three months and then I start to ramp down. Because we don’t have any long-term studies of L-histidine, so I don’t keep them on long-term. Topically, I use lots of things to get that acidic pH. Staph aureus hates acidic pH. It wants 7.5. If the skin can tolerate it, apple cider vinegar diluted 50/50 with water or hydrosol is great. Now, at the beginning, that might be very stingy to really compromised skin.  Hydrosols are wonderful. Hydrosols are gentle, yet powerful, and they’re acidic.

Dr. Weitz:                         What is a hydrosol?

Dr. Greenberg:                 I feel like everyone knows what an essential oil, and they’ve taken over. It worries me that people create their own essential oil stuff at home, which is actually quite dangerous because essential oils are very potent things. Hydrosol is a part of the process of making an essential oil. Let’s say we wanted to make rosemary essential oil. You’re going to take hundreds of pounds of plant material of the rosemary. You’re going to put it in like a copper distiller with water. You heat it up and boil that plant material with the water, and then it’s going to evaporate and cool in a secondary receptacle.   Water evaporates and the volatile oils evaporate. What we collect in the second unit on the top, “the floating top” oily layer, is the essential oil and underneath it is water. And that is the hydrosol. They siphon this top floating layer, and they put it into essential oil bottles. But that water that gets left behind is really a beautiful substance. It’s infused with a lot of the plant properties, so the microbial aspects. I love rosemary hydrosol. It’s got good antibacterial and antifungal action, but it’s very gentle, so you can use it on infants.  You can use it on pets. Essential oils are toxic to cats, so you can kill your cat using essential oils. I don’t like using them on infants, because they’re just too concentrated and we absorb them into our skin. It’s a lot for a baby, but hydrosols are totally safe.

Dr. Weitz:                         That would be a great name for the podcast, how not to kill your cat.

Dr. Greenberg:                 Right. People don’t know. It’s like, oh, essential oils, we’re going to diffuse them day and night and close the windows and the doors. Honestly, if your cat is in there, they can’t detoxify it, and it’s toxic to them. Essential oils is a whole different podcast on how to use them responsibly, but I don’t like to use them on infants and babies if I can help it. And I use hydrosols every day as part of a beauty regimen. Because not only is acidic skin healthy skin in terms of not having eczema, but our skin will age slower. You will have less wrinkles and dark spots if you keep your skin acidic.  I use aloe vera gel, rosemary hydrosol, and then a serum blend that I make every day to try to keep the wrinkles away.

Dr. Weitz:                         Cool. I noticed from reading some of your literature that eating dairy is often a trigger for eczema.

Dr. Greenberg:                 Yeah, there’s lots of different foods that tend to make eczema flare. The problem a lot comes from infants who maybe can’t be breastfed, or they’re being supplemented with cow and goat’s milk. In infants who have bad eczema and cradle cap, once I see cradle cap, then I know that they’ve pretty much got an overgrowth of candida in their gut, because cradle cap is a yeast on the scalp called malassezia. We all have malassezia. It’s a commensal again. But what happens with cradle cap or even dandruff in adults is we have this malassezia on our scalp.  It’s eating our sebum. We think in some level it probably starts to overgrow. But what really goes wrong is instead of looking at it as a commensal, which the body should be doing, suddenly the body is producing an inflammatory response to it. I see clinically and in my test they always have candida overgrowth. I think that internally they’re starting to produce antibodies against the candida, which is a yeast, and then the body I think misfires and sees the malassezia yeast and thinks, oh, well, wait, we’ve got this problem with candida yeast in the gut, and we’re producing antibodies to that.  And this malassezia yeast looks a lot like it, so let’s attack it too, and you get that inflammatory cradle cap. Every time when these babies are on cow or goat’s milk, there’s something about it with the candida overgrowth. Usually we take the cow and goat’s milk away and their skin gets dramatically improved. Sometimes, I don’t know why the parents fight me on it, we have to find other plant-based formulas. It’s hard, but they’re out there.

                                         These kids don’t do well with cow and goat milk, and I just have to talk to the parents and say, “Your baby is not a baby cow. It’s not a baby goat. I know you want to give them milk from a mammal, but it’s just not working.” Every time we pull that other mammalian milk source, usually the skin gets better. Not for human milk, but the other milk sources. And then you get the negotiation, “How about camel’s milk? How about donkey milk?” No. All mammalian milk is out. Unless it’s you, unless it’s human, we have to cut it out. Every time it gets better.

Dr. Weitz:                         You ever do testing for milk allergies or milk sensitivities?

Dr. Greenberg:                 I don’t, because I don’t want to stick an infant. The easiest thing is just to pull it and see if it gets better. There’s plenty of supplements for formulas that we can use to get them through that stage where they still need milk. Yeah, I just don’t like sticking babies, so generally not.

Dr. Weitz:                         I understand low vitamin D is a risk factor for eczema, as it is for almost everything.

Dr. Greenberg:                 I think D is one of those things where we see the test and the D is low, is associated to be low with the conditions, but then we can’t always show that supplementing improves the conditions. But I still think giving D is like giving probiotics. I think it’s one of those things that can’t hurt. I will say, the only condition where I don’t supplement with D is rosacea, because rosacea, there’s something happening with an antimicrobial peptide on the skin called cathelicidin, and we know that it actually gets exacerbated by vitamin D.   That’s the one condition where I don’t supplement with D, but everybody else, I feel pretty good supplementing with D because we’re all deficient. It might help and it’s not going to hurt.

Dr. Weitz:                         I understand there’s a number of topicals for eczema as there is for many of these conditions, and one of them topical B12.

Dr. Greenberg:                 Dr. Peter Leo is an integrative dermatologist and he talks a lot about pink cream. The B12 is kind of antiinflammatory. It comes in as a red or pink powder. If you’re using that ointment, it is going to pink. You can get compounded in the pharmacy. It helps a little bit with inflammation. It’s not one that I tend to use just because again… It’s more symptomatic. It’s not that the person is deficient in B12 on the skin, but it certainly can help with the eczema.   So I’m going at things from a different perspective, but it is popular and it does help improve the skin topically. It seems to be antiinflammatory.

Dr. Weitz:                         Let’s touch on psoriasis a little bit. How has thinking on psoriasis changed, as well as treatments? I know we think of psoriasis as a systemic autoimmune condition.

Dr. Greenberg:                 That’s one of the changes. I mean, we really used to think of psoriasis as, oh, look at what’s happening on the skin. That’s a dermatological disease. This person has a skin disease. And then over the past few decades, it’s really evolved into understanding… And we used to think it was mostly a Th1 mediated inflammatory disease. Then we discovered Th17 and Th22 as another pathway that’s highly tied in with mucosal inflammation. So now we know that psoriasis is a heavily Th17 mediated disease with a dash of Th22 and Th1. There’s a lot going on.

Dr. Weitz:                            What does that really mean though? How that does help us?

Dr. Greenberg:                 It helps the pharmaceutical industry because they’re going for suppressive effects, right? Everything now in the psoriatic is an anti, an anti-IL-17, an anti-IL-23. Those are functions of Th17. For us as functional medicine docs…

Dr. Weitz:                            Blocking agents.

Dr. Greenberg:                 Right, although I will say that I do do research and use certain herbs. There’s an herb scutellaria baicalensis, which is Chinese skullcap. Research study after research study, it has been shown to decrease Th17 and IL-17 and increase Treg and IL-10. There is away that we can use that information herbally.

Dr. Weitz:                            Also, something helpful to reduce cytokine storm.

Dr. Greenberg:                 Right, exactly. Psoriasis, as we know, it is an inflammatory systemic problem. We call it an autoimmune disease, but the interesting thing is we haven’t found what that piece is. The more research I do on it, the more I actually am not sure that it is autoimmune. Not in the same way of like Hashimoto thyroiditis where we can test for antibodies against thyroid. We have never found that for psoriasis. And the more research I do and the more I treat psoriasis, I really think it’s just a response to massive overgrowth of a lot bacteria.   Earlier I talked about strep. Strep is a huge, huge trigger for psoriasis. I see other kind of similarities, like pseudomonas seems to be a big driver of it. But it’s just massive gut dysbiosis, massive leaky gut. It gets into the bloodstream. It gets into the skin plaques. When we test the plaques, we find DNA of gut microbial origin. We find all of these connections to what is happening in the gut. It gets into the bloodstream, and it lodges in the skin. There is a genetic component to psoriasis.

                                                And again, why somebody is getting psoriasis as opposed to another disease, we don’t fully have the answer for that, but it’s massive gut dysbiosis. And once we start to clean that up, then it really starts to resolve. With psoriasis, again, we talk about compromised skin barrier. I’m always thinking about secondary skin infection, so a lot of times there is a secondary staph aureus infection on top of psoriasis, and there can also be malassezia or candida yeast infections on the psoriasis.   We definitely want to treat those as well if that’s a factor, because the psoriasis is only going to get so much better while it’s still got a colonization and an overgrowth of pathogens on the skin.

Dr. Weitz:                            I think I read in one of those courses that strep is often associated with psoriasis as well.

Dr. Greenberg:                 Yeah. It’s the number one most associated environmental trigger. We know that people who have a case of strep throat, that can trigger an outbreak of particularly a guttate psoriasis.

Dr. Weitz:                            What is guttate psoriasis?

Dr. Greenberg:                 There’s different types of psoriasis. The most common and the one that’s most well-known is plaque psoriasis, and those are the big pouches that you would see typically on the outside of the elbows or the knees. Guttate psoriasis are kind of spots or teardrop psoriasis that happen all over. There’s inverse psoriasis that happens in the intratendinous zones or the folds, so women will get it below the breasts, in the armpits, in the groin. There’s different types of psoriasis. Strep is associated with all of them. When I do gut testing, I often see strep overgrowth in the gut.  When they do antibody testing, pretty much everyone with psoriasis has titers or some sort of response to strep, whether they knew that they had it or not. Sometimes in my psoriasis patients, I’ll treat their throat with antimicrobial throat sprays because strep tends to hide and colonize the tonsils. It can form biofilms that it can be hard to get to. This is another instance of… With eczema, we have to treat the staph on the skin, in the nose, and in the gut. With psoriasis, we have to treat the strep in this case in the tonsils and in the gut as well.

Dr. Weitz:                         How do you treat the strep in the tonsils? And then going back to the last discussion, how do you treat the staph in the nose?

Dr. Greenberg:                 The staph in the nose, I use various nasal sprays. There’s a lot of different options. I don’t do this in infants or children because it’s just torture. For this, I just have the parents try to wipe stuff into the nose. But for older kids and adults, it’s nasal spray. I like colloidal silver spray. There’s colloidal silver sprays with herbs in it. There’s propolis sprays. You can take a saline spray and make an essential oil blend and shake it vigorously and spray. There’s a lot of different options for the nasal treatment, but my go-to is like a colloidal silver with herbs.

Dr. Weitz:                         Is there a particular product?

Dr. Greenberg:                 Yeah, there’s an ACS nasal spray that is colloidal silver with echinacea and some herbs, and I like that one. That’s kind of one of my standards. And then for the strep, there aren’t studies and we don’t know for sure if it’s helping, but I like Biocidin throat spray. It’s interesting. They do all these studies with psoriasis patients where they remove their tonsils and they get dramatically better. It is because they’re basically removing the staph. That’s pretty dramatic to remove somebody’s tonsils, right?   But time and time again, you have these small studies, like 15 people, and they removed all their tonsils, and like 13 of them the psoriasis improved. There are significant numbers that we know that this strep colonization is causing problems, but a lower intervention seems to be using a throat spray.

Dr. Weitz:                         Well, in this society, we remove tonsils all the time. It’s not that big a deal. You know?

Dr. Greenberg:                 I know. We remove tonsils. We remove uteruses, appendixes. It’s like, well, we don’t need it. Cut it out.

Dr. Weitz:                         It’s just extra bar. Who really need them?

Dr. Greenberg:                 Exactly. I feel like let’s try to a throat spray before we remove the tonsils and see if that helps.

Dr. Weitz:                         Oh my god, that’s so dramatic. You’re going to take some herbs.

Dr. Greenberg:                 Yeah, exactly.

Dr. Weitz:                         Let’s use surgery. What’s the connection with bile acids in psoriasis?

Dr. Greenberg:                 Bile is really interesting. I think most of us in the functional medicine think of bile as like, okay, we need bile to emulsify fats and digest the food. If we saw high steatocrit…

Dr. Weitz:                         Bile solidify liver and stored in the gallbladder and the intestines.

Dr. Greenberg:                 Exactly. It’s like, okay, yeah, that’s the function of bile is to emulsify fats. And if we see high steatocrit…

Dr. Weitz:                         Except that half the people have had their gallbladder removed too.

Dr. Greenberg:                 Right. Exactly.

Dr. Weitz:                         Get rid of it.

Dr. Greenberg:                 Yup. That’s one of those, like chop it off. Bile is interesting in that it’s actually hugely antibacterial and antimicrobial. There are definitely case studies that have been done trying to treat psoriasis just by using bile acids, just by trying to make sure that when someone is eating, that there’s enough bile to kill the bacteria that’s part of the leaky gut.

Dr. Weitz:                         When you say bile acids, do you mean things like ox bile or drugs like cholestyramine?

Dr. Greenberg:                 Again, I tend to use more herbal protocol, so I use ox bile. Either ox bile by itself or what I usually like are… I like enzymes that have hydrochloric acid, pancreatic enzymes, and bile salts. I tend to use…

Dr. Weitz:                         Is there a particular product that you like?

Dr. Greenberg:                 Yeah, I really like DuoZyme by Karuna. That’s kind of a go-to.

Dr. Weitz:                         I’m not familiar with that one. We usually use Digestzymes from Designs.

Dr. Greenberg:                 But that one I don’t… I don’t know if it has hydrochloric acid and bile salts.

Dr. Weitz:                         It does.

Dr. Greenberg:                 It’s hard to find that.

Dr. Weitz:                         It has a little bit of both.

Dr. Greenberg:                 Oh okay. Panplex 2 by Integrative Therapeutics also has all three. A lot of them will have just the pancreatic or just HCL and pancreatic, but I look for the trio. I’m usually just giving all three together. Bile does an amazing job at killing bacteria. As you’re eating and as there’s a leaky gut, we definitely want to kill off that bacteria.

Dr. Weitz:                         What about herbal bitters to stimulate bile?

Dr. Greenberg:                 Yeah, you can use that too. It’s obviously a higher intervention to give the ox bile. For kids, I have to use more of the herbal bitters, because anybody who can’t swallow a pill, they can’t take ox bile. I have tried. As a naturopathic doctor, I feel like I’m pretty immune smells and taste of things. Andrographis isn’t even that bitter to me. It is possible to ask a patient to take the ox bile and open up the cap? It was so vile, I literally almost vomited. I was like, this is going to be… There’s no way to hide this.  Of all the things I ask patients to do, there’s no possible way to ask them to do this. And somebody who can’t swallow a capsule, it’s going to have to be bitters. If any of your listeners have found a way to get ox bile in somebody not in a capsule, please contact me because it is appalling. It’s just horrific.

Dr. Weitz:                         I know there’s a topical vitamin D that is sometimes used for psoriasis.

Dr. Greenberg:                 Yup. Again, it is used. It can be somewhat helpful. For me, again, it’s not a root cause. I’m not addressing a pathogen overgrowth with it, and I’m not addressing kind of other things. I tend not…

Dr. Weitz:                         Are there any topicals that you like to use for psoriasis?

Dr. Greenberg:                 For me, it’s somewhat similar in terms of addressing the skin pH. Psoriatic skin pH is definitely alkaline. I’m going to pull it back down to acidity and try to improve the barrier. There is a particular herb that is very well researched for psoriasis called indigo naturalis. There are topical emollients like body butters and stuff that are made with indigo naturalis that can be helpful. Indigo naturalis has been shown to decrease IL-17. Again, knowing the cytokine pathways can be helpful for our herbs. It is blue as the name indigo would indicate.  Depending on if they’re making their own, it can stain things, so you should warn them. There are a couple products out there with the indigo that aren’t quite as stainy, but that’s a well-known Chinese herb that’s used topically with pretty good success in psoriasis because we think it’s decreasing the IL-17 in the skin.

Dr. Weitz:                         I noticed in one of your articles you mentioned that when applying things to the skin, that you don’t like… I’m not really familiar with skin creams and stuff. I personally don’t put anything on my skin, but my wife certainly does. One of the products contains oils along with water-based stuff sort of mixed together and you don’t like that. You like doing them separately.

Dr. Greenberg:                 Yeah. I get on my little soap box rant about lotion. I really hate lotion, and I don’t know why it’s so prevalent in our society. But here’s the problem with lotion.

Dr. Weitz:                         You mix it all together and just do one thing.

Dr. Greenberg:                 I know. Yeah, I mean, I guess it’s the convenience. But the problem with mixing it up is this, fundamentally, a lotion is oil and water together. Well, we know from fifth grade science class, when you pour oil and water together, they don’t mix. They float on top of each other. Well, that would make for a horrible product, right? So what the product company needs to do is add a chemical called an emulsifier. An emulsifier will smash together at the molecular level the oil and water and keep it together. Well, now that we have water in this product, we must have a preservative.

                                                You have to or it’s not going to shelf stable and it’s going to be overrun with bacteria and fungus very quickly. Anytime you buy a lotion, what you’re buying is oil, water, emulsifier, and preservative. Those are the bulk of what’s in there. A lot of the oils that are used in classic lotions are mineral-based or petroleum-based, which are not good for the skin either. And a lot of the things like parabens or endocrine disruptors, those are in there as emulsifiers and preservatives. A lot of the products that now we know cause huge problems for people fall into the emulsifier and preservative camp.   For me, it’s like, well, why would we do that? Let’s just keep our water-based products separate from our oil-based products. We don’t need emulsifier. We don’t need preservative. And now we can put 100% good things on the skin just by keeping them in separate bottles. Like how hard is that really?

Dr. Weitz:                         What does that mean?

Dr. Greenberg:                 That means that using things… My water-based products are the things like the aloe and the hydrosol. Those stay in separate bottles. And those you spray on the hydrosol, you let it dry for 30 to 60 seconds. Then you apply the aloe vera gel. You let that dry for 30 to 60 seconds. And then you’re going to apply your body butter or your facial serum separately. We’ve kept all the products separate. We have not mixed the oil and the water. And just literally by keeping them on separate bottles and applying them one after the other, we have avoided emulsifiers, preservatives, and a lot of those chemicals.

Dr. Weitz:                         Forgetting about the skin conditions, what’s the best oil for the skin?

Dr. Greenberg:                 It depends. For the face, I really love pomegranate seed oil. It’s wonderful for antiaging, for helping to prevent wrinkles. It’s got ellagic acid and some special punicic acids. Some special things that we only get from pomegranate seeds. The pomegranate plant is just so wonderful all around. I love that for the face. It’s pretty pricey, so it’s hard to imagine using that as like a full body moisturizer.

Dr. Weitz:                         Besides that, are there other oils for the face?

Dr. Greenberg:                 Mm-hmm (affirmative). Yeah. For acne, I like grapeseed oil because it tends not to cause breakouts. For the body, I mean, I like blends for everything. You can us straight oil. The cheapest thing to do is probably go to like your local market and buy a high quality organic cold pressed avocado oil. You can just keep that in your bathroom and use that as a body moisturizer, and it’s cheap. I don’t like olive oil. It’s high in oleic acid and a lot of people have problems with oleic acid. I don’t actually like products heavy in olive oil.

Dr. Weitz:                         It’s hard to find organic avocado oil.

Dr. Greenberg:                 It’s not. It’s not. If you go to Whole Foods or here in LA, we’ve got fancy places like Erewhon, you can find it. But I also like blends, so I like body butters, which is oils mixed with a shea butter or cocoa butter, and that makes it a little bit thicker. That’s good in the winter, let’s say, where we might need a little more hydration to sit on the skin. But really just all the oils and butters. They’re great for your skin. Just be careful with what you put on the face. I don’t put coconut oil on the face. It’s comedogenic and can pretty easily cause breakouts.  But if you stick with grapeseed or pomegranate on the face, it usually doesn’t cause any breakouts or anything. Yeah, just anything. Grab your avocado oil and lather up.

Dr. Weitz:                         One more obscure comment. I noticed in your webinar you discussed the negative effects of polyamines. I just recently went down a wormhole. I guess there’s a number of articles. One of the polyamines is called spermidine, and I guess there’s some interesting antiaging benefits to spermidine.

Dr. Greenberg:                 I’ve seen those new things out. I mean, I think the problem with polyamines… Polyamines are naturally occurring substances. They do contribute to growth. We tightly regulate them. But what can happen particularly in psoriatic patients is when we eat meat and we don’t digest the meat properly, it goes into the large intestine and it gets fermented by more pathogenic bacteria there that create these polyamines like putrescine and cadaverine, which as the names indicate, oh, it’s putrid, it’s a cadaver. Yes, these are the things that create a stench in rotting meat and corpses.   I think we already know that having high amounts of those is probably not something we want in a living body. There are other polyamines like spermidine and spermidine, which we’re learning about, but these high levels of putrescine and cadaverine and the polyamines are found in the plaques of psoriatic patients and in their blood and urine. When we reduce the levels of these polyamines in psoriatic patients, we see improvement. I personally would not take a spermidine supplement. I don’t want high levels of those. I will wait and see what the research says about it.   So far for the research I’ve done, we really don’t want to be pushing high levels of polyamines. I wouldn’t personally do it.

Dr. Weitz:                         Interesting. Okay, great. Thank you, Dr. Greenberg. This has been a fascinating discussion. How can listeners and viewers get a hold of you, find out about your programs?

Dr. Greenberg:                 My clinic is the Center for Integrative Dermatology. I practice and see patients in California, Washington, and Oregon. My website is integrativedermatologycenter.com. I also do consults for healthcare practitioners nationwide. If you need help on a touch patient, I can help you out. I’ve also got a series. For your healthcare practitioner listeners, they might be interested in a series of 20 CE courses, and they’re AMA… They’re CE accredited for both MDs and NDs. I’m not sure what other ones, but there’s 20 courses.   They’re all free. You can earn up to 10 CE credits, and it’s at learnskin.com. It’s the Naturopathic and Integrative Dermatology Series. I’ve written some of the courses, and I’ve worked with thought leaders on many of the other courses. It’s all the things I’m talking about here. You can find a course on gut health and skin health. You can find a course on skin pH and skin disease. We have specific courses on diseases, so there’s a naturopathic approach to acne or a naturopathic approach to psoriasis.  We’ve really tried to pull together all this information, because there’s so much information out there, but the dots have not been connected well. Either in functional medicine or naturopathic medicine, we don’t have a lot of continuing ed or modules on dermatology. But when you do the research, it’s all there. You pull it together. Clinically you will get results. If anybody’s interested in learning more, it’s free. Head on over to LearnSkin and look for the Naturopathic and Integrative Dermatology Series.

Dr. Weitz:                         Awesome. Thank you, Dr. Greenberg.

Dr. Greenberg:                 Thanks so much for having me, Ben.

 

Dr. Aristo Vojdani speaks about Infections as Triggers for Autoimmune Disease with Dr. Ben Weitz at the Functional Medicine Discussion Group meeting on January 28, 2021.

[If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on YouTube at https://www.youtube.com/user/weitzchiro/]

 

Podcast Highlights

8:10  The way the immune system works is that after infection with a virus you develop antibodies, which disappear after a number of months, but this does not mean that you no longer have immunity.  Our first line of defense is our macrophages which break up the virus particle into smaller pieces called antigens. The antigen is presented to antigen presenting cells, which are T helper cells. T helper cells produce various cytokines, which become cytotoxic lymphocytes, which kill viruses and also target tumor cells. The T helper cells then communicate with B cells, which divide to become plasma cells that produce antibodies against the viral antigens. It takes about 14 days for these plasma cells to produce different isotypes of antibodies (IgM, IgG). If the phagocytes could not finish the job and the cytotoxic lymphocyte could not do the job, then the antibody will bind to the virus and then the complex of the antibody plus the virus will be more easily destroyed by our immune system. Also, when the T helper cells become activated and present the information to the B cells, another subset of T helper cells, memory T cells will be created that last forever and give you lifetime immunity.  There are also memory B cells that are also in your body forever.  If the same virus were to re-enter the body, the memory T and the memory B cells will produce antibodies within hours that will protect you against the virus.

14:57  We often hear public health experts on TV saying that we don’t yet know if you get long term immunity after getting COVID-19, but Dr. Vojdani says that we should expect that there will be long term immunity because this is what always happens after viral infection. This is written in immunology textbooks and this infection is similar to others in many ways.  When the body gets exposed to any antigen, including the SARS-COV-2 viral antigen, IgM antibodies will be produced, followed by IgG antibodies. IgM will stay in the body for two to four weeks and the IgG will typically stay in the body for up to three months. The same thing happens when you get vaccinated.  When you get your second vaccination you will get a similar IgM response but the IgG response will be 10 times the original IgG response.  But then within 3 months the antibodies will tend to fade to a low background level or disappear.

18:42  Viruses have been in the environment for millions of years and scientists estimate that 380 trillion viruses live on or inside the human body.  There is a lot of discussion about the microbiome, but few people talk about the virome. And there are many beneficial viruses in our body. Viruses are made up of particles of DNA and RNA and they cannot replicate on their own. They have to infect cells in order to replicate and once they get inside a cell, they use material from that cell in order to replicate. During this replication, the virus mutates to acquire proteins that share that homology, so that it can hide from the immune system. This encourages cross reactivity of the immune system, which may result in autoimmunity.  Dr. Vojdani published about cross reactivity between wheat gliadin and the brain.  The lymphocytes react to wheat gliadin and make antibodies against gliadin. Because components of gliadin look like cerebellar tissue, the immune system will attack the cerebellum of the brain.  This is an autoimmune reaction against the brain resulting from eating wheat due to cross-reactivity.  Cross-reactivity is also why off target vaccines such as with the BCG vaccine or certain childhood vaccines can cause secondary activation of adaptive immunity and induction of effective secondary hypo-inflammatory antiviral immune response.  This can cause a drastic reduction in CD3 T cell activation, dampening of innate immune hyper activation, and finally, the result of that will be regeneration and recovery of the host health and survival.  So, that’s why giving vaccines other than SARS-CoV-2 to individuals suffering from COVID-19 may help to subvert the immune system from attacking the tissue through this process and save that individual from the virus.

27:05  Dr. Vojdani has published lots of scientific papers about cross-reactivity, including the following article in 2018 in the Journal of Alzheimer’s Disease: Vojdani A, Vojdani E, Saidara E, Kharrazian D. Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer’s Disease. J Alzheimer’s Disease, 2018;63(2):847-860.  Dr. Vojdani looked at various pathogens, toxins, and foods that show cross-reactivity against amyloid peptide antibodies and this is part of Cyrex’s screen for the triggers of Alzheimer’s Disease, the Alzheimer’s LINX testThis includes an oral pathogen, enterococcus bacteria very similar to E.coli in our gut, cytolethal distending toxin, candida albicans, Giardia, Borrelia burgdorferi the agent of Lyme disease, and then some molds such as aspergillus and penicillium. These potential triggers also include HSV1 and EBV.  This test can play a role in screening for autoimmune reactivity and then use Dr. Bredesen’s methodologies for the 46.7 million Americans who have preclinical Alzheimer’s but do not have obvious symptoms and the two and a half million who have mild cognitive impairment. The earlier we can detect these preclinical triggers and make lifestyle changes, the better we can prevent Alzheimer’s Disease.  Here is the paper that Dr. Vojdani mentioned that was published by Dr. Christiana Franke, et al. published in Brain, Behavior, and Immunity in December 2020 on High Frequency of Cerebrospinal Fluid Autoantibodies in COVID-19 Patients with Neurological Symptoms.

35:24  Many pathogens can be triggers for autoimmune diseases, including bacteria, viruses, parasites, molds, yeast, and spirochetes like Lyme.  These are included in Cyrex’s Array 12, which is the Pathogen Associated Immune Reactivity Screen.  Dr. Vojdani recommends using a panel like this to test for antibodies against mold rather than using a urine mycotoxin test, which might be measuring mycotoxins coming from the food you are eating.

              

                                      



 

Dr. Aristo Vojdani is the Father of Functional Immunology and he has dedicated his life’s research to helping us figure out what are the triggers for autoimmune diseases and many of the tests he has developed for Cyrex Labs are focused on this.  Dr. Vojdani has a PhD in microbiology and immunology and he has authored over 200 scientific papers published in peer reviewed journals. Dr. Vojdani is the co-owner of Immunosciences Lab in Los Angeles, which offers testing for various types of infections, including Lyme Disease. He is the Chief Science advisor for Cyrex Labs, whom he has developed all of the testing for. He is also a professor in the Department of Preventative Medicine at Loma Linda University.  Dr. Vojdani recently published the following paper:  Vojdani A, Vojdani E, Kharrazian D. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases. Front. Immunol., 19 January 2021.

Dr. Ben Weitz is available for nutrition consultations, including remote consults via video or phone, specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also specializing in Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure and also weight loss, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111 or go to www.drweitz.com. Phone or video consulting with Dr. Weitz is available.

 



 

Podcast Transcript

Dr. Weitz:                            Hey, this is Dr. Ben Weitz, host of the Rational Wellness Podcast. I talk to the leading health and nutrition experts and researchers in the field to bring you the latest in cutting edge health information. Subscribe to the Rational Wellness Podcast for weekly updates, and to learn more, check out my website, drweitz.com. Thanks for joining me, and let’s jump into the podcast.

                                                Autoimmune diseases are on the rise today, and there are at least 100 different autoimmune diseases and at least 40 other diseases that are suspected to have an auto-immune origin. If we include diseases that have an autoimmune basis, autoimmune diseases are the third leading cause of death in the United States, since most of these diseases are chronic and often life-threatening. Some of them are common autoimmune diseases, including Alzheimer’s disease, Parkinson’s disease, rheumatoid arthritis, Hashimoto’s hypothyroid, celiac disease, Graves type one diabetes, psoriasis, multiple sclerosis, Crohn’s disease and irritable bowel disease. But most of you probably know this already.  The immune system is designed to protect us from bacteria and viruses and parasites, et cetera, and to repair our tissues went damaged among other functions. Auto-immune diseases, as most of us know, are diseases where the immune system, instead of attacking pathogens, start attacking our own cells and organs. The immune system is out of balance, often referred to as immune dysregulation. While the conventional medical community is often content with simply prescribing an immune blocking or modulating medication to help control symptoms such as Humira or Enbrel. as functional medicine practitioners, we want to find out what are some of the root causes and correct these.

                                                There are three major categories of triggers for autoimmune diseases, and these are toxins like pesticides, bisphenol A, heavy metals, mycotoxins. We have food sensitivities and we have infections, which are our topic for tonight.  Now I would like to invite Heather Ngo from Cyrex Labs, who is our sponsor for this evening, to tell us some information about Cyrex Labs. Heather, go ahead and unmute yourself.

 



Heather Ngo:                     Hello, everyone. Thank you so much. My name is Heather Ngo, territory manager at Cyrex Labs, and our lab is based in Arizona and our focus is auto-immunity. We do offer barrier testing, evaluating the intestinal and blood-brain barrier integrity. We have environmental trigger testing, identifying reactivity, which includes dietary proteins, chemicals, and heavy metals. We have predictive antibody testing to define precursors of autoimmune disorders. A panel of cognitive health, identifying early signs of neural cognitive decline.

                                                We also have a saliva test evaluating possible outcomes of a compromised mucosal tolerance. We can ship out the serum or saliva kit directly to your patients, especially during this crazy time. And we are providing a show special for today.  It is $100 off on our pathogens panel. This panel has a 29 markers, consists of viral, bacterial, spirochete, parasite, yeast, and mold.  We are assessing just the IgG, the latent pathogens that may lead to multiple autoimmune reactions.  I just want you to know this promotion expires March the 15th, ’21, of this year, and if you have any questions or would like to schedule a one-on-one education, please call, text, email me to schedule it. I will also provide my contact information via the chat room. Thank you so much, Dr. Weitz, for having us, and I’m going to pass this invisible mic back to you. We’re so excited to listen to Dr. Vojdani’s presentation.

 



 

Dr. Weitz:                            Absolutely. Me too, and I promise not to drop the invisible mic. So our speaker for tonight is Dr. Aristo Vojdani, who I’m sure most of you already know. He is the father of functional immunology, and he’s dedicated his life to helping us figure out what are the triggers for autoimmune diseases, and many of the tests that he has developed for Cyrex Labs are focused on this, including the Array 12, which is the pathogen associated immune reactivity screen that Heather referred to. Dr. Vojdani has a PhD in microbiology and immunology, and he’s authored over 200 scientific papers published in peer reviewed journals. Dr. Vojdani is the co-owner of Immuno Sciences Lab in Los Angeles, which offers testing for various types of infections, including Lyme disease. He is the chief science advisor for Cyrex Labs, whom he has developed all the testing for.  He’s also a professor in the Department of Preventative Medicine at Loma Linda University, and I would like you to indulge me for one minute to tell you an anecdotal story. So I’ve been putting on these Functional Medicine meetings for about five years, and we’ve been honored to have Dr. Vojdani speak almost every year, except for last year. Usually I get the opportunity to have dinner with Dr. Vojdani about a week or so before we have the meetings so I can find out what he’s going to be talking about and I’m in a better position to try to ask some intelligent questions.  Usually Dr. Vojdani shows up for dinner with this huge stack of scientific papers that we ended up discussing, which is very exciting for a research geek like myself.  But the reason I’m telling you this is that if you don’t know, any statement that Dr Vojdani makes is informed by hundreds of scientific research papers.  So thank you so much for honoring us with your presence tonight, Dr. Aristo Vojdani.

Dr. Vojdani:                        Thank you.

Dr. Weitz:                           So Dr. Vojdani, if questions come up, would you like me to chime in, or do you want me to wait till the end?

Dr. Vojdani:                        Wait to the end and then please read the questions for me.

Dr. Weitz:                           Okay. You got it.

Dr. Vojdani:                        Okay. Thank you so much. So, first of all, thank you, Dr. Weitz, for your introduction. I’m happy to see many of you, many familiar faces. Heather, Michelle from Cyrex and in particular, I’m very proud to see my son Elroy. He’s one of the doctors who is participating tonight in this Zoom. So I’m going to talk about chronic infections as triggers for auto-immune diseases. So this is my disclosure. Already Dr. Weitz talked about this, Immuno Sciences Lab, Cyrex and Loma Linda University. 

There is a reason I’m going to start with the immune system tonight because, honestly, in the past year, almost past year or so, we heard so much about antibody, antibody, antibody.  And the antibodies do disappear after a month or two months and three months, and after that, we don’t have immunity against COVID.   That’s the reason I’m putting this slide to clarify this point.  So when we get exposed to a virus such as corona, SARS-CoV-2, this virus particle is too big for our T cell and B cells.  So macrophages, which are part of first line of defense, our innate immunity, will taking that up and breaking into smaller pieces called an antigen. Then they take that antigen, presenting that to antigen presenting cells, presenting that to T helper cells. However, let’s stop for a few seconds in here. So what will happen to that virus when macrophages is breaking that to smaller pieces?  It’s not anymore a virus.  So this is the most important part of our defense system, that our macrophages should be able to take that virus and break that to the pieces, and then give that to antigen presenting cells to the T helper cells.  This process will take probably a few seconds or few minutes. So that’s the most important part of our immune defenses. Then the antigen presenting cells, presenting that antigen to T helper cells.  T helper cells, by producing different types of cytokines become, cytotoxic lymphocytes. What is the job of cytotoxic lymphocyte? If the macrophages were not able to take care of some of these viruses and break them down to smaller pieces, the cytotoxic lymphocyte will go after any virus particles in our cells. Any cells, in fact, which are infected with that virus and destroy that virus, plus the cell, which is infected with that virus. This process will take few hours. Also, the job of cytotoxic lymphocyte is to kill tumor target cell. So this is our defense also against tumor cells.

                                         Now, T helper cells in the presence of different type of cytokines become T helper 1, or T helper 2, and then T helper cells communicate with B cells, giving all the information to the B cells about this viral antigens to start to divide to become plasma cells and to start producing antibodies against the viral antigens, process which takes about 14 days. Why it takes 14 days?  Because all this process of putting together the factory that manufactures antibody takes about 14 days. So after 14 days, these plasma cells will produce different isotypes of antibodies.  So if in case the phagocytes could not do the job or finish the job, the cytotoxic lymphocyte could not do the job. The antibody will bind to the virus and now complex of antibody plus viruses will be destroyed by our immune cells.    Furthermore, I would like to present in here that when T helper cells become activated and present the information to the B cells, another subset of T helper cells, which I don’t have it in here, just imagine should be right here, is going to be called memory T cell. That memory T cell will remember forever that had some kind of reaction to, in this case, SARS-CoV-2. Could be Epstein-Barr virus. So remember that computer called memory T cell is going to stay in the body forever.

Dr. Weitz:                           Is there any controversy about that, or is that absolute, definitely true, no matter what?

Dr. Vojdani:                        It is absolutely true, no matter what. Thank you for asking that. Okay, there is a reason, again, I put this slide in the beginning. So memory T cells, there are short-term memory T cells, as you see the name, may disappear in few months.  But there are long term memory T cells, will stay in our body forever. Now you see in here, I emphasized memory B cells.  Also, they are short-term and long-term.  The long-term memory B-cell will stay in our body for forever. So together memory T cell and memory B cells are going to be in our body. They’re waiting for entry of the same virus into our body for second time or the third time, and this time they are not going to wait 14 days to start making the antibodies. They will start making antibodies within hours and maximum within 24 hours. That was the reason I decided to put this slide.

Dr. Weitz:                           But why do we hear all these public health experts say, “Well, we don’t really know if there’s long-term immunity.”

Dr. Vojdani:                        I’m sorry. They are not public health experts. They don’t understand immunology. This is written in a textbook of immunology. Memory T cells and memory B cells stay in our body forever. They are talking about disappearance of antibody.  Yes, antibody will disappear in some people after 30 days, in some people after 60 days, in some people after 90 days. So that’s why I emphasize here the memory B cell when second time the same virus get into the body, they are going to react to that and immediately they are going to produce antibodies. So when, for the first time, our body get exposed to that antigen, in this case SARS-CoV-2, IgM antibody is going to be produced, followed by IgG.  IgM is going to stay in the body for about, let’s say, two weeks.  Maximum, three weeks, not longer than four weeks.  The IgG will pick up and stay in the body up to three months.  Okay, and then we’ll go down almost to background level.

                                                Now when the same virus … So imagine that you had your first vaccine. Okay? So this is what happened when you had your first vaccine. This is your IgM, and this is your IgG. Now you are going to get your second vaccine. Look what is going to happen. Immediately your body is going to produce IgM the same level as before, but the IgG is going to be 10 times. This is logarithmic. If this was only, let’s say, 50 units, now you’re going to produce 500 units of antibody. Because the half-life of IgG is about 21 days, if you made 500 units of IgG, imagine how long that is going to be in your body. Probably months or sometimes years. So therefore this is the principle of vaccination and if you get the third vaccine or the third antigen, this time this antigen goes all the way up to the roof.

Dr. Weitz:                           But does that really matter if we have long-term memory T cells? Do we really want that? Does it help?

Dr. Vojdani:                        The memory T cells and memory B cells are going to immediately to wake up the B cells to start making antibodies.

Dr. Weitz:                           So do we really need the second big spike in IgG?

Dr. Vojdani:                        The second spike in IgG we need. The more antibody, the better virus will be neutralized if the virus will get into our body.

Dr. Weitz:                           Only during the period of time that the IgG antibodies are here.

Dr. Vojdani:                        Yes, otherwise the antibodies circulating in blood, doing nothing. We need those antibodies only if the virus get into our body, and the antibody is going to bind to the receptors or antigens and the virus, neutralizing it and preventing the virus from division and replication. Okay?

Dr. Weitz:                           Okay.

Dr. Vojdani:                        All right. Now, viruses have been in the environment for millions of years. This is absolutely true. Actually, I took all of this from an article from Science about two months ago. Scientists estimate that 380 trillion viruses live on or inside the human body. The human virome is 10 times the number of microbiome.  Guess what?  We always hear about our microbiome.  We hear nothing about our virome.  Believe me, there are many, many beneficial viruses in our body.  Not all viruses are bad.  So almost half of all the biological materials within our body is not human, meaning it’s bacteria or viruses or fungi or parasites.

                                           So what are viruses made up? They are made up pieces of DNA and RNA. They’re biological particles. They cannot replicate on their own, but they do it with the help of the host. That’s why they have to infect cells, epithelial cells, nerve cells, heart or muscle cells. As soon as they get inside the cell, they use whatever material available from that cell and replicate, and from one they become two and then four and thousands and millions. Unfortunately, during this replication, the virus mutate to acquire proteins that share homology.  Remember, tonight, I’m going to talk a lot about this. With human tissue cells, which they reside. Why they do that? To hide from the immune system. The viruses use this strategy to look like human tissue antigens. In the process, they hide from immune attack. We’ll talk more about this later.  So what is mimicry or similarity or cross-reactivity?  Cross-reactivity refers to the direct competition between two different molecules for the same binding site, and an antibody due to structural similarity. You’ll see example here.  I published about 10 years ago, published an article about wheat gliadin cross react with cerebellum.  So when our lymphocytes react to wheat gliadin, they make antibodies against gliadin.  But because components of gliadin looks …  So anti-gliadin binds to gliadin, right?  But because components of gliadin partially looks like cerebellum, the same antibody also react to cerebellum.  We call this cross reactivity.  Let me give you another example, because cross reactivity is not only about IgG.  Could be about the IgE.  Imagine that you are allergic to house dust mites. So every time you get exposed to house dust mites, you sneeze and you have type one IgE mediated allergic reaction.  But because, I’m giving you an example, peanuts or cat or dog danders also cross react with house dust mites, so your memory lymphocytes remembering your reaction to house dust mites. Now you get exposed to the dog dander, immediately also you start sneezing.  This is cross reactivity between house dust mites and antigen from dog or cat or food antigens such as peanuts. So the world of cross-reactivity is very vast.  So that’s why the virus trying to change its structure to look like human cells in order to hide from the immune system.  But there will be a huge price we are paying for that strategy. I will explain that later on.

                                                So I did publish an article, but I’ll talk about that later, but this article in Frontiers in Immunology, it’s all about potential cross-reactivity, cross-reactive immunity, to SARS-CoV-2 from common human pathogens and vaccines.  You heard that if you get vaccinated with polio or with child vaccines or with BCG, you will not get infected with SARS-CoV-2.  Is this true?  Absolutely, yes.  So here an article and a slide from an article in Journal of Immunology, they called that off target revaccination. So imagine, say, an individual is having high load of SARS- CoV-2, and having severe inflammation, cytokine storm and all of that, which we know what is the consequences of that. But if we take that person and give him BCG, they call that off target vaccination. What will happen? Causes secondary activation of adaptive immunity and induction of effective secondary hypo-inflammatory antiviral immune response. Drastic reduction-Drastic reduction in CD3 T cell activation, dampening of innate immune hyper activation, and finally, the result of that will be regeneration and recovery of the host health and survival.  So, that’s why giving vaccines other than SARS-CoV-2 to individuals suffering from COVID may help to subvert the immune system from attacking the tissue through this process and save that individual from the virus.  There was a question there?

Dr. Weitz:                           No, we’ll save it to the end. I mean, there’s lots of questions that have been coming in.

Dr. Vojdani:                        Yes, please. Okay. Now back to the world of cross-reactivity, as you know, I published lots of articles about cross-reactivity, one of them in 2018, in Journal of Alzheimer’s Disease. What did we do in this case?  We took antibodies made against amyloid beta peptide 1-42, which is responsible for production of amyloid plaque. When we applied that to 30 or 40 different pathogens, we found that amyloid peptide antibody not only reacted with amyloid peptide itself, this is like the hundred percent reaction, but reacted with oral pathogen. That’s why oral pathogen is playing a role in Alzheimer’s disease, enterococcus bacteria very similar to E.coli in our gut, candida albicans, Giardia, Borrelia burgdorferi the agent of Lyme disease, and then some molds such as aspergillus and penicillium.  These pathogens, if we make antibody against them, those antibodies can turn against our amyloid beta causing amyloid beta aggregation. That’s the message. Furthermore, that antibody reacted slightly with West Nile virus HSV1. That’s why HSV1, herpes type 1 playing a role in Alzheimer’s. EBV, early antigen, Influenza. So, I’m not here to answer or say whether or not you should be vaccinated with influenza A and B. Cross-reactivity with amyloid beta, rabies and look at HPV. Again, I’m not here to say get vaccine against HPV or do not get vaccine against HPV. The data is very clear. These viruses and bacteria cross react with amyloid beta. Some may…

Dr. Weitz:                            I would just like to point out to everybody that Cyrex has the Alzheimer’s LINX test, and you can use that to screen patients for all these different pathogens and other immuno reactants for preventing Alzheimer’s disease.

Dr. Vojdani:                        Thank you, Ben. Some may explain this a little bit different saying, well, if we vaccinated with HPV we make antibody against amyloid beta. It’s good because they inject monoclonal antibodies against amyloid beta to prevent Alzheimer’s disease. Then my question is, did it work? The answer is no. Close to 40 different monoclonal antibodies were tried for Alzheimer’s disease prevention and treatment, and based on articles published in the literature, I believe none of them worked.   So, this is the world of cross-reactivity, you can interpret the results both ways. That’s why I’m showing here the pathogens, and Ben was kind enough to mention what Cyrex is doing. And we’re very proud with our publications emphasizing the oral pathogens, E. Coli, bacterial cytolethal distending toxin and herpes type 1 and why it’s important to detect some of these cross reactivities. Because, we do not work today or sleep tonight and we wake up tomorrow with dementia or Alzheimer’s disease. From normal to abnormal, sometimes takes many many years. It takes years to get from normal to early Alzheimer’s, 20 years or more before diagnosis. 46.7 million in America, they’re in preclinical Alzheimer’s but they do not have obvious symptoms. Two and a half million, they have mild cognitive impairment which can get better with Dr. Bredesen’s methodologies, and finally three and a half million with dementia.

                                                So, ladies and gentlemen, we should not wait until 46.7 million to end up either with mild cognitive impairment or with dementia. If we detect the environmental triggers, we change our lifestyle, all of the above can prevent individual to move from normal to preclinical stage, from preclinical stage to mild cognitive impairment, and from mild cognitive impairment to full-blown dementia. This is the panel that Alzheimer’s LINX that Dr. Weitz was talking about. It’s not about cross-reactivity just with pathogens, cross-reactivity with foods such as casing and gliding toxic peptides. We test for blood-brain barriers, we test for gut barriers and we test for proteins involved in Alzheimer’s and Parkinson’s disease, and also the nerve growth factors as well. Also, let’s not to forget the [interregnum 00:07:59] which is major component of this panel. I highly recommend to do these tests and if any abnormalities, then you remove some of these cross-reactive foods and hopefully by that you will stop progression of Alzheimer’s from the first stage to the second and third and fourth.  Here is an article from Alzheimer’s and Dementia, forecasting the prevalence of preclinical and clinical Alzheimer’s disease in the United States. The diagnosis of persons with preclinical disease is potentially important because persons may be more likely to benefit from disease modifying treatments such as the one Dr. Bredesen is doing, such as the one my son Elroy is doing. If interventions occurred before the occurrence of significant brain damage. Doctors can help you before significant damage is done to the brain. That’s the message of this article.

Now, let’s go to additional pathogens, pathogens in general, pathogens associated immune reactivity screen. Bacteria, viruses, parasites, molds, yeast, spirochetes, all of these have a component, antigens, which cross react with human tissue. That’s why I emphasized in the beginning the issue of what viruses are doing in order to hide from the immune system. Same thing bacteria, parasites, spirochetes and yeast are doing in order to hide from the immune system. They have a component which is similar to human tissue including brain, the brain.  That’s why Cyrex is offering these 29 different antibody for 28 different antigens and if you have any elevation of antibodies against some of these pathogens, then the doctor will help you to treat and reverse the course of auto-immune diseases. In particular, I would like to draw your attention to the three molds in here. I know most of you when you have patients with mold exposure, you do not measure the most important lab test which is measuring antibodies against the mold antigens itself, aspergillus, penicillium, and stachybotrys, which is part of this panel. What most of you do, going measuring mycotoxins in the urine which nobody knows where really they are coming from. Are they from the food? Are they from the bacteria? Are they from the viruses in the gut? Nobody really knows. But when you make antibodies against the aspergillus, penicillium, stachybotrys, that shows that you live in the moldy environment, the mold releases the antigens, get into your body and you make antibody against them. Please ladies and gentlemen, do not waste your money on useless testing such as-

Dr. Weitz:                            Urine mycotoxin.

Dr. Vojdani:                        … Urine mycotoxin which is not a reliable method. Maybe it’s important for some other environmental factors, but they are not meant to measure exposure to molds Aspirgillus, penicillium and stachybotrys. Thank you so much. I made my point. Now, let’s have some fun. You see this beautiful slide, very simple right? So far in the literature, Epstein-Barr virus was the queen of auto-immunity. For years, the scientist, the auto-immunologists were discussing and claiming that we should find a vaccine against EBV because EBV is responsible for 20 different auto immune diseases, including Lupus and multiple sclerosis. This was true and it’s still is true, but HHV-6 came along, she started saying that I am the queen of auto immunity. Believe it I’ll show you some data that it is true that HHV-6 is so far the queen of auto immunity, more than EBV. But that was true until a year ago, 10 months ago, who? SARS-CoV-2 was discovered.   When there is conversation… There’s by the way, a comic that Joel and I we are putting together, hopefully we’ll be able to finish it soon, next year or next time I’ll present it to you. There is conversation between EBV, HHV-6 and SARS-CoV-2. Who is the real queen of auto immunity? So, after back-and-forth, SARS-CoV-2 saying that I am the queen of auto immunity, if you don’t believe me, look at my structure. If you don’t believe me, then why they call me Corona? Meaning I have many crowns on my surfaces. Believe me, you’ll see some data that I’m presenting to you that after, EBV was the first one, HHV-6 the second one, but now number one, queen of auto immunity is SARS-CoV-2. So I’m going to share with you.

Dr. Weitz:                            That Dr. Vodjani, does it really make any sense to give people a vaccine against EBV to prevent auto-immunity when isn’t it quite likely that the same immuno reactivity that occurs from the virus is likely to occur in the vaccine?

Dr. Vojdani:                        Absolutely. Let’s get to last sentence of my talk tonight, will be exactly about that. So, here test results of a patient, 58 years old lady went to 10 different doctors and had a pile of laboratory test results, including urine mycotoxin. Honestly, none of them could help her, and I’ll tell you why. Until one of the doctors sent the request for viral panel and Lyme disease from Immunosciences Lab, which is our specialty. When I got the results, look at some of the abnormalities, HSV-1 and 2 IgM red, highly positive compared to the highest normal range. EBV early antigen very high, meaning EBV reactivation. EBV nuclear antigen IgM, highly elevated. CMV IgM, elevated. Measles IgM, can you believe it? One probably in a hundred tests that we do, measles IgM is positive. But look at this, three times of the reference range. Then, when I looked at HHV-6 results, very high level of HHV-6 IgM.

                                                Then next slide. When we looked at lyme disease, six different antigens from Borrelia elevated antibody against that. Four different subspecies are elevated. Three different co-infections, Babesia, Ehrlichia and Bartonella elevated. So what’s happening in here? The patient is having Lyme disease, herpes infection, EBV infection, cytomegalovirus infection, measles, ongoing measles infection, and HHV-6. What do you think? Which one is the right diagnosis in here? And by the way, it is a requirement by department of health if measles IgM is elevated and Borrelia IgM is elevated, we have to report that to department of health. Think about the laboratory who do not have an immunologist like me. They are going to report this to department of health saying that we have patient with measles. So, what I did I called the doctor, I said, doctor, please tell me if your patient is having any symptoms of ongoing measles infection. I was told no, absolutely not.  Then, I came to conclusion actually, it is reaction to HHV-6 and IgM antibody produced against HHV-6 cross-react with measles, with CMV, with EBV and HSV-1 and 2. I told the doctor, if you treat your patient for HHV-6, all these antibodies will disappear probably in three months. I hope that’s the case, this is ongoing right now. That’s very important. It is very important to use a laboratory with an individual who is able to interpret the test results for you the way that can help the patient and can help the doctor as well. Because imagine that department of health are busy with COVID, now we are going to overwhelm them with measles and Lyme infection unjustified. I wanted to share with you that case.

                                                Now, lets go to the COVID, the queen of auto-immunity. Between March and April 2020, upon the availability of blood test for SARS-CoV-2 we took first five and later additional blood specimens that had been confirmed positive for COVID-19 and tested them for biomarkers of auto immunity, ANA, ENA, double-stranded DNA, Actin, mitochondrial antibody, rheumatoid factor and immune complexes. Elroy and I were very surprised to find out that three of the five initial specimens had significant elevation in the biomarkers of auto-immunity. Usually we find this in one in 20, one in 50, but here three out of five. So these results, I would like to show you how the brain of researchers work. These promoted us to investigate patterns of cross-reactivity between SARS-CoV-2 and auto immune target proteins.

                                                Now, when we reviewed the literature, so far during 2020, at least 10 different groups published articles about anti-nuclear antibody and COVID, lupus anticoagulant, ENA, cardiolipin. Our work, ANA, ENA, Actin, mitochondrial antibody, anti interferon, anti MDA5 antibody, myelin basic protein antibody, NMD receptor antibody, and more. These are all in COVID patients. So, upon availability of mouse and rabbit monoclonal antibodies made against the spike protein of SARS-CoV-2 and nuclear protein, we took those antibodies made specifically against SARS-CoV-2 antigens and applied them to 50 different tissue antigens, and we found that those antibodies reacted with mitochondria, with ENA, anti-nuclear antigens, Actin, Actomyosin, Tropomyosin, collagen, Thyroid peroxidase, brain growth factors and brain antigens, blood brain barrier proteins, MBP (myelin basic protein) in the brain, Transglutaminases, scheme in the gut and tight junction proteins, occludin, zonulin, claudin, also found in epithelial cell tight junctions of the lungs.

                                                So, compare that to reaction of monoclonal antibody to SARS-CoV-2 spike protein which is a hundred percent, look at transglutaminase 3, look at extractable nuclear antigens, mitochondria. So, SARS-CoV-2 cross-react with many human tissue antigens and no one can deny this fact. Also, we took anti nuclear protein antibodies and reacted to those 50 human tissue antigens. Look at mitochondria as if this is nuclear protein or SARS-CoV-2, again, ENA, ANA, Actin, actomyosin, thyroid peroxidase, Thyroglobulin, transglutaminase 6, myelin basic protein, other antigens as well. So, let me go back to this and then I will share with you another piece of the story. When we send this for publication to clinical immunology… within 24 hours at that time around May was accepted for publication. In clinical immunology, it was online, 24 or 48 hours later, but it was published in August 2020 officially. When this article was published, some of my colleagues were saying that the antibody that used are made in mouse and rabbit. “These are not kind of antibodies that are humanized antibodies that are used or will be used for treatment of patients with COVID. Why don’t you do the same study with human monoclonal antibodies?” Okay. I said, “Thank you so much, but those are not available.”   So while I was thinking about this on July 7, I got exposed to SARS-CoV-2. Two weeks later, I had to be hospitalized, Ellroy took me to the hospital. And you see couple of days later, my CRP, 156, my ferritin… But thanks to the treatment at Cedars, four days later I got released from the hospital and by July 29 and August, everything is back to normal.

Dr. Weitz:                           What treatment did you receive?

Dr. Vojdani:                        Remdesivir and Dexamethasone.

Dr. Weitz:                           Okay.

Dr. Vojdani:                        Okay. Now, I really don’t know, you see the knee, right? For almost 90 days post COVID, I was suffering from knee pain and knee inflammation. Was that because of the medication or because of COVID? And again, I would like to share with you that in my family, my mother suffered from rheumatoid arthritis and osteoarthritis for 47 years and she passed away from the disease, so that’s the weak part of my body. So is it because of COVID or because of the medication? I really don’t know. Okay. So this experience made me more serious to further investigate cross-react activity between SARS-CoV-2 with human tissue using monoclonal antibodies, human monoclonal antibodies.  So what is human monoclonal antibody? The polyclonal antibody, let’s say we inject something to a rabbit many clones from spleen or lymph nodes, they are going to make that different type of antibodies. The antibodies made by different clones that’s why they call them polyclonal antibodies. If we inject that to human, that will develop some kind of sickness, we can not do that. Maybe once is good, but if you repeat that the individual will develop serum sickness or something like that.

                                                Monoclonal antibody is an antibody is made by a clone of cells, but many very recently, they found that if we take an individual human lymphocytes from individual infected with a virus, and by the way, this is the memory lymphocytes, okay? And we take that memory lymphocyte who knows how to produce antibody IgG antibody against SARS-CoV-2, that lymphocyte becomes activated and ready to produce antibodies. There is a method in the clinical labs or research labs called immortalization of B cells. For example, if you add Epstein-Barr virus, Epstein-Barr virus is going to activate the B cells to divide crazy and make antibodies. So they add all kinds of reagent and these cells become immortalized.

                                                But if we take one of these cells or some of these cells, okay? Which became activated, they know how to produce antibodies against SARS-CoV-2, fuse them with human myeloma cell, human myeloma cell is a factory for production of proteins in this case antibody. So that’s why you see half of these cell is called human hybridoma, half of it from myeloma, the other half is from B cell. And then when these cell, hybridoma cell make antibodies, we call that human monoclonal antibodies. You can inject them safely to human without having any side effects. So that was important to explain to you.

                                                So when human monoclonal antibody became available around August 2020, immediately we purchased those antibodies. And we repeated that experiment that I explained before. And we reacted it this time with 55 different tissue antigens, 28 of them reacted from moderate to strongly. And by the way, whatever I’m going to explain to you from an on is published in Frontiers in Immunology, very prestigious journal eight days ago. And if you look at the journal right now, we had more than 20,000 views, which is unheard of in this journal. That shows how much people and scientists are interested about possible cross-reactivity between SARS-CoV-2 and human tissue and its implication for auto-immune diseases.

                                                So here are the results, they are almost similar to what I showed you. So this is nice because not only polyclonal antibody reacted with human tissue, now monoclonal antibody made against spike protein reacted almost with the same antigens, okay? Acting mitochondria, ANA, histone, brain antigens, collagen, alpha-myrosinase, thyroid peroxidase, liver gut 65, transglutaminases and tight junction proteins. Also, we used human monoclonal antibody made against nuclear protein, the results, again, identical with some variation, but very similar. Look at mitochondria almost, I would say 60% reaction of monoclonal antibody to nuclear protein, which is in red, two items, mitochondria and insulin receptor reacted very, very strongly, occludin claudin which are tight junction proteins, which are measuring antibodies. Part of array too cross-reacted strongly with SARS-CoV-2 proteins. So brain alpha-myrosinase, liver gut 65 and tight junction proteins are cross reacting with SARS-CoV-2 nuclear protein.

                                                In order to show specificity of this antigen-antibody reaction, meaning monoclonal antibody reaction to specific antigens when you do serial dilution like what we did in here from 1 to 200 to 1 to 25,600, you should see the decline in the level of the antibody, and that’s the case. Also, we did inhibition study and again, in proportion to the amount of antigen put in competition, we see decline in the antigen-antibody reaction. All of that support, that the reaction that we detected between monoclonal antibodies made against SARS-CoV-2 spike and nuclear protein with human tissue antigens is very specific.

                                                So when we send this for publication, the reviewers from the journal asked us to do epitope mapping. What is epitope mapping? Another meaning compare peptides from human tissue to SARS-CoV-2 and see if their fingerprint is similar to each other, if that’s the case, then proves that our experiments are 100% correct. So we did that. And they asked us to do it with mitochondria. And we found 30 different peptides from mitochondria that had more than 50% identity or similarity with spike protein, but less with nuclear protein. I’m showing only two peptides. So in order to clarify this for you, ladies and gentlemen, you need only five of these red amino acids to be similar between mitochondria and spike protein in order to cross-react with each other, meaning antibody against mitochondria will react with spike. Antibody made against spike will react with mitochondria. And here we have eight of them. And we had cases even we had more than that. So that’s about mitochondria.

                                                How about actin? The same thing about actin, we found between 20 to 30 proteins for peptides who cross-reacted with spike protein. And finally, they asked us to do it with thyroid peroxidase. Again, we see a significant cross-reactivity between TPO and spike protein. What does that mean? Patient with COVID may develop thyroid auto-immunity in the future, or even some individuals get vaccinated may have cross-reactive antibodies against CPO? Time will tell. We don’t know. I cannot really answer that question, but I’m just asking that question.

                                                So we proved that concept of cross-reactivity, it is real antibody made against spike protein. And nuclear protein react with cellular components, such as mitochondria with liver, muscle, joints, thyroid nervous system, skin, GI and tight junctions, and some other antigens that I’m not mentioning here. So if that is the case, okay? Are we the only one?  No, I already shared with you earlier that there are at least 10 different groups who showed auto antibodies in patients with SARS-CoV-2.  Not only auto antibodies under top right here. Also, look at diseases detected in patients with SARS-CoV-2, type one diabetes and Guillain-Barre syndrome, vasculitis, and many other auto-immune diseases. By the way, the credit for this slide is going to Professor Schoenfeld who presented this in a mosaic of autoimmunity about a month ago.  So we are not the only one claiming that there is cross-reactivity between SARS-CoV-2 and human tissue.   So molecular mimicry between SARS-CoV-2 to spike glycoprotein and mammalian proteomes implication for the vaccine. And this was published by professor from Italy, by the name of Kanduc with Yehuda Schoenfeld.  [Kanduc, Schoenfeld. Molecular mimicry between SARS-COV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.And another article by Schoenfeld group and Gilad Halpert, SARS-CoV-2, the auto-immune virus. And then I did not put additional slides that by scientists from the U.S. Lyons Weiler, professor Ernfeld also from Israel, professor from Germany, her name is-

Speaker 1:                           Franke.

Dr. Vojdani:                        Yeah, Dr. Franke or Professor Franke, who published a very elegant, I’ll show you the slide later on an article that recently. So I am not alone, we are not alone. At least 10 to 15 different groups in the world published about SARS-CoV-2 an auto-immunity and cross-reactivity and even showed epitope mapping similarities between SARS-CoV-2 and human tissue. So what is the meaning of cross-reactivity? So in this very simple slide, we get infected with the virus, or we get injected with the vaccine. Our plasma cells are going to produce antibody to SARS-CoV-2 or to the vaccine antigen.  These antibodies are going to bind to the receptor on the virus and neutralizing the virus, and the virus will not be able to bind to ACE receptor, that’s the goal. But unfortunately, due to cross-reactivity, some of these antibodies may bind to different human tissue antigens and causes auto-immunity 5 years down the road, 10 years down the road, a year down the road due to mimicry. So remember this very simple slide, our goal is to make neutralizing antibodies to neutralize the virus. But unfortunately some of those antibodies act like friendly fire causing auto-immune reactivity at this level, I’m calling it not auto-immune disease.

Dr. Weitz:                           Can I just throw in a question right here? Dr. Rahbar had asked after someone gets infected, do they get just IgG antibodies or do they have neutralizing antivirus? There been a big controversy in popular press or the doctors who come on TV who say, well, you may have antibodies, but if they’re not neutralizing antibodies then they’re not going to be protected.

Dr. Vojdani:                        I am sorry. Again, they are not immunologists, okay?  I don’t call them experts.  You make antibodies, your body is making neutralizing antibodies.

Dr. Weitz:                           So there’s no situation where they make antibodies that are not neutralizing.

Dr. Vojdani:                        I don’t think so. Let’s say if you make 100 units of antibodies, at least 50% of those are neutralizing antibodies.

Dr. Weitz:                           Does it matter how severe an infection someone has? Like if somebody has more severe infection, do they get more protection or more antibodies versus somebody who has a mild infection?

Dr. Vojdani:                        Really, we don’t have the answer for that.

Dr. Weitz:                           Okay.

Dr. Vojdani:                        Okay. So let’s continue. And I’m very close to finishing my talk in about 10 minutes. So after this introduction, look at this very simple slide, immunity from the virus, like the one I have, or from the vaccine, we know antibody against the virus cross-react with human tissue. We know antibody made against component of the virus, which is this fight proteins also cross-react with human tissue. So what will be the future consequences?  Time will tell.  However, let’s go ahead and look at this slide. We know that when we make IgG, IgM antibodies against SARS-CoV-2 spike protein, they disappear after 30 days, in some people earlier, even that. But these antibodies unfortunately appear in the body with additional auto-antibodies, anti-nuclear antibodies, rheumatoid factor, [inaudible 01:13:03], interferon gamma antibodies, MDA5 antibodies, myelin basic protein antibodies, tight junction protein antibodies, all of that.  So we know there is some consequence of auto immunity due to viral infection. So we should not vaccinate the public and let them develop the disease, some of them will die and some of them may develop auto-immune disease. But we are lucky that these antibodies are shorter because if those antibodies will stay in the body for a long time from auto-immune reactivity may end up with auto-immune disease. So that’s one side of the coin. The other side, we vaccinate, we make circulating IgG and IgM antibody against spike protein. Our goal is to repeat the vaccine and make enough antibodies to stay in our body for a long term. But the question I’m going to ask, what will be the consequence of these long-terms or presence of these long-term antibodies made against spike protein that cross-react with human tissue? Again, the answer, time will tell.

                                                So I just wanted to share with you this article by Dr. Franke from Germany. Look at the title, just published very recently. I think I end of up December, high frequency of cerebrospinal fluid auto-antibodies in COVID-19 patients with neurological symptoms. So where they did from very severe-ill patients removed serum and spinal fluid, majority of these patients unfortunately died. They reacted them with myelin basic protein and tissue antigens, you will see the results and they reacted with many, many sections of mouse brain cells, which is identical to human brain cells. And also they detected antibodies in blood, I guess, myelin basic protein and NMDA receptor.  So auto antibodies may already now explain some aspects of multiorgan disease in COVID-19 and can guide immunotherapy in selected cases. So here clear picture when they took spinal fluid from COVID patients and added them to brain cells, you see that fluorescents indicate reaction of those antibodies in spinal fluid with brain cell antigens, in this case, best cells in the brain, Purkinje cells neurons in the brain, and many other components of the brain. [Dr. Christiana Franke, et al. published in Brain, Behavior, and Immunity in December 2020 on High Frequency of Cerebrospinal Fluid Autoantibodies in COVID-19 Patients with Neurological Symptoms.]

                                                This is very elegant study proves the concept of cross-reactivity and auto-immunity against the brain due to COVID. The article was so important that Dr. Kreye in that Nature Reviews Immunology wrote this commentary, “In summary cross-reactive antibodies generated in response to SARS-CoV-2 may contribute to some of the clinical phenotypes seen in COVID 19, and could provide a mechanistic explanation for the persistence of symptoms in patients who have recovered from initial viral infections. Finally, although preliminary, these findings suggest that monitoring for self reactive antibodies and post challenge auto immunity should be incorporated into vaccination trials.” And with that before recommending type of testing.

PART 3 OF 4 ENDS [01:18:04]

Dr. Vojdani:                        For recommended type of testing and I would like to read the final couple sentences, and I would like all of you to remember that Aristo Vojdani on the January 28, 2021 said the following, “While I am not against vaccination, I am worried about the rise of autoimmunity post COVID vaccination. Okay. Until the time will tell, please consider to test your patients for possible autoimmune reactivity, not autoimmune disease, autoimmune reactivity, as part of their yearly checkup.”   And with your permission, I’m going to read this because history will judge me in the future.   “While I’m not against vaccination, I’m worried about the rise of autoimmunity post COVID vaccination. Until the time will tell – as I mentioned in my slides – please consider to test your patients for possible autoimmune reactivity as part of their yearly checkup”   How to do that? By considering Array five, multiple auto immune reactivity screen from Cyrex, or simple auto immune panel from Immuno Sciences Lab. And I’m not really selfish in here. You can use any laboratory you want to do anti-nuclear antibody, rheumatoid factor, immune complexes, acting and mitochondrial antibodies, which you saw the evidence of cross-reactivity with SARS-COV-2 antigens. Thank you.

Dr. Weitz:                           So we got a bunch of questions here. One of the questions is, is there cross-reactivity between flu vaccine and COVID?

Dr. Vojdani:                        The answer is yes, there are lots of publication who shows that memory lymphocytes, memory lymphocytes taken from patients with flu vaccine, who had flu vaccine before, put them in culture with COVID antigens. Those memory lymphocytes immediately started reacting to COVID antigens. And so therefore that’s the best indication of cross-reactivity between flu and SARS-COV-2. But we can go on online NIH Plus and look for structural similarity and believe me, it does exist,

Dr. Weitz:                            [inaudible 01:21:27]

Dr. Vojdani:                        but this is the most elegant way of to show first memory lymphocytes stay in the body, and also you can demonstrate evidence of cross-reactivity

Dr. Weitz:                           By the way- [crosstalk 01:21:44].

Dr. Vojdani:                        In SARS-COV-2.

Dr. Weitz:                           Is there a way to test for memory B cells or memory T cells?

Dr. Vojdani:                        Yes.

Dr. Weitz:                           How?

Dr. Vojdani:                        You just put them in culture with what antigen you think the memory T-cells and B-cells for SARS-COV-2.

Dr. Weitz:                           Yes.

Dr. Vojdani:                        Okay. So if you have a patient where you’re not sure the antibody is negative, but you think the patient had SARS-COV-2 or COVID.

Dr. Weitz:                           Okay.

Dr. Vojdani:                        You can take blood from that patient, put them separate the white blood cells, put them in culture with COVID specific antigens and incubate that in incubator at 37 degrees for 48 hours. And then you look at finger print of cytokine production, interferon, gamma, even you can wait for few days and check for antibody production. So yes, that is possible. There are methodologies and it is possible to do that.

Dr. Weitz:                           Right. But there aren’t any labs available right now?

Dr. Vojdani:                        No, no, no.

Dr. Weitz:                           Okay.

Dr. Vojdani:                        Only for research.

Dr. Weitz:                           So Dr. Rahbar asked another question. What is the mechanism of persistent IgM in Chronic Lyme?

Dr. Vojdani:                        I think most of the Chronic Lyme is due to cross-reactivity that we call it Chronic Lyme [crosstalk 01:23:21] and I showed you, but, but, [crosstalk 01:23:24] but I’ll answer that question. And because we have memory lymphocytes, right, Dr. Rahbar and Dr. Ben. If my memory lymphocytes made against EBV and I did publish an article, then EBV cross react, with Borrelia burgdorferi, agent of Lyme disease. So now imagine I have memory lymphocytes for Epstein-Barr virus or vice versa, have memory lymphocytes for Lyme, and these memory lymphocytes can cross with each other. So I can get [inaudible 01:24:29] my memory lymphocytes could be exposed to EBV antigens and produce antibodies against burgdorferi or release cytokines. And that’s why I’m really against the method, that first of all, I published about it about 10, 12 years ago, that you can culture lymphocytes with Borrelia antigens and look for cytokine production.

                                                So now there is a method called Elispot. Instead of measuring the level of cytokines, you look at the spot formation and they call, if that spot is positive, this is the lab in Germany, and you say, they say you have Lyme disease, but I argue with that, you could have also memory lymphocytes made against EBV. You expose it in culture with Lyme antigens, now they produce the same cytokines and will give you positive spot. And you tell the doctors that your patient is having chronic Lyme. So chronic Lyme could be due to cross reactive memory B cell, which can make cross-reactive antibodies.

Dr. Weitz:                            So if somebody chose to get a COVID vaccination to protect themselves, what we know so far about the two vaccines that are available, the Pfizer and the Moderna, and soon we’ll have the Johnson and Johnson, and with a different mechanism of action is if you were to just speculate, would you think one of them would be more or less likely to lead to possible autoimmunity or immunoreactivity in, you know, as somebody who just happens to be vulnerable to that.

Dr. Vojdani:                        First of all, we are right now in the dark. That’s why I emphasized time will tell. All of them they are using, I think the same, almost the same, RNA. RNA For spike protein.

Dr. Weitz:                           I think the first-

Dr. Vojdani:                        Even if they use, even if they use RNA for another fruit in nuclear protein, and if you read my article, by the way, that we use two other antigens as well, those other two antigens, the membrane and the nucleocapsid, and whether the two more antigens – it’s in the article, in Frontiers in Immunology – also cross-reactive with many tissue. And so the world of crushed the activity is not limited only to spike protein. It also applies to other antigens of SARS-COV-2. That’s why I called the COVID or SARS-COV-2, the queen of autimmunity after EBV, NHS, V6.

Dr. Weitz:                           Right, I don’t know a lot about this, but I believe that the AstraZeneca and Johnson and Johnson have a slightly different mechanism than the Pfizer in the Moderna. And they use an adeno virus as part of how they provide protection rather than a strand of messenger RNA.

Dr. Vojdani:                        Yeah. It doesn’t matter, honestly. What is the goal? The goal of vaccine is the patient or the individual will produce antibodies that, if in the future will be exposed to the virus, will have enough neutralizing antibodies to neutralize the action of the virus. That’s the goal.   Now, really, we don’t know any if these viruses that were injected the patients made antibodies, how much antibodies they made, how much neutralizing antibody they made. We are going to learn more in the future. That’s why I said I’m not against vaccination. They’re vaccines right now saving lives. Because if not, they will get the disease like I got. And not everybody is lucky like me, who I survived, but many people died from the disease. So I’m not again against the vaccine, but we should learn more about mechanism of action of the vaccine and whether or not these cross-reactive antibodies that our body is going to generate. Is it going to protect us or is it going to damage our tissue? And again, time will tell.

Dr. Weitz:                            Are you going to consider getting a vaccine in six months?

Dr. Vojdani:                        Because I got the disease, no.

Dr. Weitz:                            Okay. Somebody asked about patients who already have, say, elevated antiphospholipid antibodies. Are they more at risk for, you know, immunoreactivity, if they either get sick or get a vaccine?

Dr. Vojdani:                        Okay. I have many relatives. Unfortunately, some of them have autoimmune disease. They called me and they wanted my advice. And this is my advice to my own family. I’m sorry, I don’t want to generalize these. Okay. I told them if you have an autoimmune disease, please wait at least six months. Let’s see what will be the results of vaccinations and then consider vaccination.

Dr. Weitz:                            For somebody who’s sick, as part of their treatment, would you think that monoclonal antibodies or convalescent plasma therapy, meaning taking antibody, say from somebody like you, would one of those more likely be effective and/or safer?

Dr. Vojdani:                        I know they’re using lots of monoclonal antibodies. And from patients who had the disease, the latest article about a week ago I read, was that when they take plasma from a person like me, of course now I don’t have the antibody anymore, let’s say two weeks after I released from the hospital, it doesn’t work. It didn’t work.

Dr. Weitz:                            Okay.

Dr. Vojdani:                        But again, this is only one study that I read.

Dr. Weitz:                            Yeah, somebody has the same thing. Let’s see. Same question. Why are some people asymptomatic if there is so much cross-reactivity? I think that just depends on the person, right? Do you have an opinion as to the efficacy of the PCR test for viral?

Dr. Vojdani:                        Unfortunately, many false positives, many more false positives than false negatives. Also the antibodies I had experience with our employees in here that some of them were tested in two different labs, you know, we let them go for 14 days and we wanted them to be negative, right? And they were tested again and again and again, one lab negative, the other lab positive. So what do you do? Tell them stay home again. And so, unfortunately it turned out one of the labs was reporting many, many false positive results for antibody and antigen even.

Dr. Weitz:                            I think the latest guidelines from the CDC are that after you test positive, after 10 days, you can return to wor if you don’t have symptoms. They recommend not testing again, because it’s not unusual for people to test positive for two or [crosstalk 01:33:24]

Dr. Vojdani:                        Because at my work, we have one person who did not develop the disease and we wanted, we did not want to put him in the injured. So we told the person until you bring the evidence of negativity, you cannot come back to work.

Dr. Weitz:                            Right. People ask is it being recorded. Yes. It’ll be included in my weekly podcast. I’ll post it sometime next week. You can listen to it on Apple podcasts, and there will be a video version on YouTube autoimmune disease.

                                           Why did ferrets die after exposure to Coronavirus after vaccination? Are you concerned about this?

Dr. Vojdani:                        Again again? Can you repeat?

Dr. Weitz:                           This is referring to animals. Why did ferrets, I guess these furry animals, apparently they died after exposure to Coronavirus after getting vaccinated.

Dr. Vojdani:                        I’m not aware of that, I’m sorry.

Dr. Weitz:                           Okay.

Dr. Vojdani:                        The person can educate us. I’ll be very happy to.

Dr. Weitz:                           Yeah.

Dr. Vojdani:                        [01:34:37]

Dr. Weitz:                           Dr. Lalazar, are you, are you still on the call? Did you want to unmute yourself and ask the question again?   Maybe she’s not. Let’s see. What do you think about the recent paper in Nature, “Immunology to suggest in cases of severe COVID long term antibody mediated immunity to the virus has been shown to be absent” cardiovascular 19, or COVID 19 disease can yield development of new auto-immunity the messenger RNA vaccines may confer protection against both effects”?

Dr. Vojdani:                        Well, first of all, the first part is yes. I agree that the antibody disappeared. My antibody disappeared after 60 days.

Dr. Weitz:                           Right.

Dr. Vojdani:                        But the second part [crosstalk 01:35:32]

Dr. Weitz:                           Doesn’t matter if it’s severe or not severe.

Dr. Vojdani:                        Yeah. The second part was about autoimmunity. Cardiovascular. What? I didn’t understand.

Dr. Weitz:                            I’m sorry. I think I said it wrong. I was saying cardiovascular. I think he just abbreviated COVID-19 can yield development of new auto-immunity. We know that. I think the point he’s trying to make is does the messenger RNA vaccine protect against the auto-immunity and I think you’ve answered that question.

Dr. Vojdani:                        Again. Time will tell, I don’t know if these antibodies that right now people are producing they’re protective or pathogenic. Time will tell, they are protective against the virus, but against autoimmunity, we don’t know.

Dr. Weitz:                           Okay. So the virus is mutating. Do we think it’s likely that somebody like yourself who has protection against the SARS-COV-2, would you still have protection against these mutated forms and the same question related to vaccination?

Dr. Vojdani:                        Yes. Thank you. I believe that I will have 99.9% protection. 

Dr. Weitz:                           That sounds pretty good to me.

Dr. Vojdani:                        That is when you’ll get sick and then you’ll have memory T-cells in your body that stays forever.

Dr. Weitz:                           Right.

Dr. Vojdani:                        So.

Dr. Weitz:                           I’m curious if you got the flu shot. Is this the reason you got so sick? Because you did not?

Dr. Vojdani:                        No, I never got flu shot. And because again, I believe in cross-reactivity and immunity. Because of my family history of autoimmunity, I never considered flu shots. I believe in my new strength of my immune causal immune system, how to keep my new causal immune system, my first line of defense strong in order to keep me safe against viruses. But unfortunately that was enough against our scope to.

Dr. Weitz:                           Is there a big benefit to doing antibody testing? And if so, when’s the best time to do it?

Dr. Vojdani:                        Antibody testing against what?

Dr. Weitz:                           Let’s say you contracted the virus afterwards. Is there a benefit to testing your antibodies? Does it really matter?

Dr. Vojdani:                        Well, if they disappear after two or three months, I don’t think that it does matter.

Dr. Weitz:                           Okay. But,

Dr. Vojdani:                        But, but if you get vaccinated-

Dr. Weitz:                            Right.

Dr. Vojdani:                        And you have long-lasting antibodies, I will test, as I recommended, I will test for possible autoimmune reactivity once a year, in order to make sure an individual with family history of autoimmunity are not going to develop an autoimmune disease.

Dr. Weitz:                            Right. I didn’t really understand this question. J.L. Asked, why are some patients asymptomatic? I think that’s just people have different reactions to any disease, right?

Dr. Vojdani:                        Okay. The answer is that really it’s the inoculum or the number of viruses that we get get into our body also plays a role. And also the not – we each one of us, we have different number of receptors and our epithelial cells or [crosstalk 01:39:18].

Dr. Weitz:                           Like the Ace 2 Receptor, which is [crosstalk 01:39:19].

Dr. Vojdani:                        Yes [crosstalk 01:39:20] So that’s really is another factor. So more number of viruses attacking you at the same time, you get more sick than the one who less viruses are attacking.

Dr. Weitz:                           And we know the level of vitamin D, it plays a big role in how likely you are to get sick, the status of your immune system.

Dr. Vojdani:                        Absolutely. Vitamin D is because strengthening your immune system.

Dr. Weitz:                           Absolutely.

Dr. Vojdani:                        It regulates your T-Reg cells. You know that.

Dr. Weitz:                           Absolutely. And of course we know about the benefits of vitamin C and zinc, and quercetin and melatonin.

Dr. Vojdani:                        Right. Right.

Dr. Weitz:                           So we’ve been infected – It’s the same question again, if you’ve been addicted, are you permanently protected? Most likely.

Dr. Vojdani:                        Yes. I believe I said 99.9%. Let’s say 99%. I believe I’m protected. And all these claims that even if you are, had the disease, even if you have been vaccinated, there is some information on the internet. Still, you have to wear a mask still. You have to do all steps required by law.

Dr. Weitz:                           This question is, let’s say you recovered from SARS-COVID-2, you get the autoimmune screen and you have autoimmune reactivity, what do you do to prevent yourself from getting an autoimmune disease?

Dr. Vojdani:                        There is a lot you could do, you know, you find what are the triggers and remove the triggers and you’ll reverse or stop the course of autoimmune disease. That’s really my, you know, I wrote that in my book in relation to food. Hopefully one day I’ll have time to finish the other two books. One about toxic chemicals, the other about pathogens. But then unfortunately this year I became busy with SARS-COV-2 and research and all of that.

Dr. Weitz:                           Right.

Dr. Vojdani:                        I could not finish my second book.

Dr. Weitz:                           Well, I think the answer is from a functional medicine approach. There’s usually not just one trigger for an autoimmune disease. So even though you may have reactivity from SARS-COVID-2, there are likely going to be other triggers. You may have toxins, you may have food sensitivities.

Dr. Vojdani:                        Or pathogens.

Dr. Weitz:                           Yes. You want to clear all those out, reduce your overall level of immune reactivity. And then even if you have some reactivity to a virus you’re less likely to develop the full disease. And this’ll be the last question.   What is happening in the brain post vaccination? When people get a memory loss, brain fog, is that a guaranteed blood-brain barrier breach and autoimmunity, or it could have been some other mechanism?

Dr. Vojdani:                        I think the article by Dr. Franke, which I highly recommend to read is very clear that the antibodies made against SARS-COV-2 attacking different components of the brain and causing damage to the neurons.

Dr. Weitz:                           Okay. Excellent. Thank you. Thank you so much for your valuable time. I know you actually have another presentation.

Dr. Vojdani:                        Thank you very much.

Dr. Weitz:                           Thank you so much Dr. Vojdani, that was awesome.